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 i 
Abstract 
 
Endoglin is an accessory receptor for the transforming growth factor beta family. 
Patients carrying mutations in the endoglin gene develop the inherited vascular 
dysplasia, Hereditary Haemorrhagic Telangiectasia (HHT). However, it is becoming 
apparent that endoglin may also be important in acquired cardiovascular diseases such 
as hypertension, atherosclerosis and heart failure. The work in this thesis investigates 
the role of endoglin in the structure and function of the adult cardiovascular system by 
utilising a conditional endoglin knockout model and murine cardiac magnetic 
resonance imaging (CMR). 
 
I established and validated murine CMR at Newcastle University allowing accurate 
quantification of in vivo cardiac structure and function in a number of mouse models 
of cardiac disease either at single time points or in longitudinal studies. 
Immunohistochemical analysis confirmed that endoglin is expressed in the 
endocardium and vasculature of the adult mouse heart. Following myocardial 
infarction there was increased endoglin expression which co-localised with 
endothelial cells and myofibroblasts. Cre-lox genetics was then used to ubiquitously 
knockdown endoglin in the adult mouse. This resulted in significant ventricular 
remodelling within three weeks, with ventricular dilatation associated with 
cardiomyocyte hypertrophy. These changes gradually progressed over three months 
following endoglin knockdown; however, overt heart failure was not seen within this 
time frame. Invasive measurement of ventricular function suggested an impairment of 
vasomotor control and reduced contractile reserve following endoglin knockdown. 
Also, using an endothelial-specific endoglin knockdown mouse I demonstrated that 
these novel cardiac changes were due to endoglin depletion in endothelial cells. 
Together these data suggests that the alterations in cardiac structure and function are 
secondary to alterations in the wider cardiovascular system. This is supported by 
evidence of eNOS uncoupling following endoglin knockdown. 
 
The results reported in this thesis describe a novel phenotype and highlight the 
importance of endoglin in the maintenance of cardiac structure and function. Further 
work will clarify the mechanism behind these alterations.
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Chapter 1  Introduction 
 
In the UK approximately 146,000 people suffer an acute myocardial infarction (MI) 
each year (Allender et al., 2008). ST elevation myocardial infarction (STEMI) results 
from thrombotic occlusion of an epicardial coronary artery. The time from onset of 
STEMI to reperfusion (total ischaemic time) is of paramount importance as longer 
times result in larger area of infarction and increased mortality (Reimer and Jennings, 
1979; Gersh et al., 2005). For this reason emergency restoration of antegrade flow in 
the infarct related artery, with either primary percutaneous coronary intervention 
(PCI) or fibrinolysis, improves outcome following acute MI (Fibrinolytic Therapy 
Trialists' Collaborative Group, 1994; Keeley et al., 2003; Keeley and Hillis, 2007). In 
the UK, 95% of patients with STEMI receive primary PCI as the initial reperfusion 
therapy (Gavalova and Weston, 2012). However, in addition to ischemic myocardial 
injury a further insult to the myocardium occurs at the time of reperfusion. There are a 
number of pathological mechanisms that result in reperfusion injury which include 
oxygen free radical formation, resulting in myocyte and endothelial injury, and 
dysfunctional intracellular calcium homeostasis, resulting in mitochondrial injury and 
cell death (Sharma et al., 2012). Potential therapeutic options to ameliorate 
reperfusion injury include ischemic preconditioning (Murry et al., 1986), ischemic 
postconditioning (Tsang et al., 2005) and a number of pharmacological agents 
(Sharma et al., 2012). The consequence of ischemic and reperfusion injury is myocyte 
necrosis and myocardial dysfunction resulting in neurohormonal activation and 
adverse ventricular remodelling resulting in a further decline in cardiac function 
(McKay et al., 1986; J. M. Pfeffer et al., 1991; Cohn et al., 2000). Pharmacological 
therapy with inhibitors of the renin-angiotensin-aldosterone and sympathetic nervous 
system, aimed at reducing adverse cardiac remodelling, have also lead to significant 
improvements in morbidity and mortality following MI (Flather et al., 2000; Packer et 
al., 2001; Pitt et al., 2003). Despite these improvements, ischaemic heart disease still 
remains the leading cause of heart failure and new strategies are needed to further 
improve long term prognosis following MI. 
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1.1 Infarct Healing 
Myocardial infarction usually results following rupture of an unstable coronary 
atherosclerotic plaque, subsequent thrombus formation and coronary occlusion. The 
resultant myocardial ischaemia causes cardiomyocyte necrosis and leads to a series of 
events that culminates in a ‘wound’ healing process and the formation of a mature 
scar. This healing process has three overlapping phases: the inflammatory phase, the 
proliferative phase and the maturation phase (figure 1.1). Infarct healing is closely 
intertwined with the structural and functional changes seen in the infarcted and non-
infarcted myocardium following MI, a process called ventricular remodelling 
(Frangogiannis, 2008). 
 
Following myocardial infarction there is a rapid and robust inflammatory response. 
Cardiomyocyte ischaemia and cell death leads to activation of the complement 
cascade, free radical release and activation of Toll Like receptors and Nuclear Factor 
κB (NF κB) signalling pathways (Frangogiannis, 2008). There is increased synthesis 
of chemokines and cytokines with up regulation of adhesion molecule expression in 
endothelial cells and leukocytes. The infarcted myocardium is rapidly infiltrated by 
neutrophils and macrophages, which are involved in phagocytosis of dead cells and 
extracellular matrix debris, synthesis of cytokines and growth factors and regulation 
of matrix metalloproteinase activity (Dewald et al., 2004). 
 
The transition from the inflammatory phase to proliferative phase is marked by the 
suppression of pro-inflammatory mediators by cytokines such as interleukin-10 and 
transforming growth factor-β (Dobaczewski et al., 2010). Granulation tissue 
consisting of fibroblasts and endothelial cells infiltrate and proliferate in the wound. 
Within the healing infarct, fibroblasts undergo a phenotypic change to become 
myofibroblasts, with features of smooth muscle cells including expression of α-
smooth muscle actin (Willems et al., 1994; Gabbiani, 1998). Cardiac fibroblasts play 
an important role in healing post MI by regulating the degradation and synthesis of 
extracellular matrix proteins (Porter and Turner, 2009). Myofibroblasts orientate 
themselves parallel to adjacent surviving cardiomyocytes (Willems et al., 1994) and 
the contractile properties of myofibroblasts contribute to the tensile strength of the 
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infarct (Blanjesteijn et al., 2001). During this phase vascular cells also proliferate to 
form an extensive microvascular network in the infarcted region. 
 
During the maturation phase there is loss of cellularity within the healing infarct with 
apoptosis of cardiac fibroblasts and endothelial cells. The collagen secreted by the 
myofibroblasts forms cross linked bundles resulting in the formation of a mature scar. 
Myofibroblasts have been shown to have a persistent presence within the infarct scar 
(Willems et al., 1994). 
 
1.2 Ventricular Remodelling 
Following myocardial infarction there are changes to ventricular architecture that 
initially may be an adaptive response to the sudden decrease in cardiac function but 
may ultimately result in deterioration of cardiac function and is associated with an 
adverse prognosis (M. A. Pfeffer and Braunwald, 1990; J. M. Pfeffer et al., 1991). 
This process affects both the infarcted and non-infarcted myocardium and is termed 
ventricular remodelling (McKay et al., 1986; White et al., 1987; M. A. Pfeffer and 
Braunwald, 1990) and begins within the first few hours post MI (Cohn et al., 2000). 
Ventricular remodelling can be divided into two phases; early (within 3 days) and late 
(after 3 days) remodelling.  
 
Following the breakdown of the extracellular matrix, but before there is extensive 
collagen deposition and an increase in tensile strength, the infarct region can thin and 
elongate, this is called infarct expansion (Hutchins and Bulkley, 1978). It has been 
shown to be the result of slippage between muscle bundles leading to a reduced 
number of cardiomyocytes across the left ventricular (LV) wall in the infarct region 
(Weisman et al., 1988) and is defined as ‘acute dilatation of the area of infarction not 
explained by additional myocardial necrosis’ (Hutchins and Bulkley, 1978). This is 
the predominant cause of early infarct remodelling. The extent of infarct expansion is 
proportional to the size and transmurality of MI (Hutchins and Bulkley, 1978; J. M. 
Pfeffer et al., 1991) and can range from clinically unapparent to ventricular rupture.  
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Figure 1.1 The phases of cardiac healing following myocardial infarction. 
Adapted from Frangogiannis N.G. Pharmacological Research, 2008;58(2):88-111 (Frangogiannis, 
2008) and Dobaczewski et al Journal of Molecular and Cellular Cardiology (2010) (Dobaczewski et al., 
2010). 
 
Ventricular remodelling also affects healthy, remote myocardium in a process that 
begins immediately following MI and can last for several months.  The increase in 
volume load leads to volume overload hypertrophy with lengthening and hypertrophy 
of the non-infarcted cardiomyocytes (McKay et al., 1986). This further increases left 
ventricular dimensions, resulting in a more spherical left ventricle (McKay et al., 
1986; Mitchell et al., 1992).  
 
Cardiac remodelling is influenced by haemodynamic loading conditions and by 
neurohormonal activation via the sympathetic nervous system and renin angiotensin 
aldosterone system (Cohn et al., 2000). Activation of the sympathetic nervous system 
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initially results in increased myocardial contractility and heart rate, thereby increasing 
cardiac output. Its activation also results in increased sodium and water retention, 
peripheral vasoconstriction, increased electrical instability and activation of the renin 
angiotensin aldosterone system (RAAS). RAAS activation results in augmented 
production of angiotensin II, an important mediator of adverse ventricular 
remodelling. Increased angiotensin II levels leads to sodium and water retention and 
peripheral vasoconstriction. It also mediates myocyte hypertrophy and interstitial 
fibrosis. Its actions are mediated via angiotensin type I (ATI) receptors. Initially these 
alterations in the sympathetic and renal angiotensin aldosterone systems are adaptive 
responses to maintain cardiac function post MI and may be beneficial but have 
deleterious long term haemodynamic consequences (Opie et al., 2006). Inhibition of 
both these systems has lead to an improvement in mortality in patients with heart 
failure (Flather et al., 2000; Packer et al., 2001; Pitt et al., 2003).  
 
1.3 Cardiac fibroblasts 
The cardiac extracellular matrix is comprised of interstitial collagens (predominantly 
type 1 and type 3), proteoglycans, glycoproteins, matrix metalloproteinases (MMPs) 
and their inhibitors (tissue inhibitor of matrix metalloproteinases, TIMPS) (Porter and 
Turner, 2009). Cardiac fibroblasts play a key role in the normal maintenance of the 
cardiac extracellular matrix which in turn regulates cardiac structure and hence 
mechanical, chemical and electrical function. The adult human heart comprises 30% 
cardiomyocytes and 70% non-myocytes, the majority of which are cardiac fibroblasts 
(Jugdutt, 2003). They are arranged parallel to muscle fibres and help to maintain 
normal cardiac function by maintaining the continuity between cells and the structural 
integrity in the myocardium (Weber, 2004; Brown et al., 2005; Camelliti et al., 2005; 
Kohl et al., 2005; Banerjee et al., 2006). During infarct healing cardiac fibroblasts 
undergo phenotypic modulation to myofibroblasts (Weber, 2004; Brown et al., 2005; 
Camelliti et al., 2005). This phenotypic change can be induced by TFG-β (Eghbali et 
al., 1991b). These differentiated myofibroblasts secrete collagen and other 
extracellular matrix proteins, activate and regulate MMPs and TIMPs (table 1.1), thus 
playing a key role in ventricular remodelling (Brown et al., 2005; Vanhoutte et al., 
2006; Porter and Turner, 2009). Cardiac fibroblasts play an important role in infarct 
healing and left ventricular remodelling and their regulation, particularly in response 
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to TGFβ, may represent a potential therapeutic target for promoting efficient cardiac 
repair. 
 
Table 1.1 The temporal and spatial expression of MMPs and TIMPs following myocardial 
infarction. 
Reproduced from Vanhoutte et al. Cardiovascular Research 2006:69(3);604-613 (Vanhoutte et al., 
2006). 
Temporal and spatial window 
Early wound healing: 
0-7 days 
Granulatory - early remodelling: 
7-21 days 
Late remodelling phase: 
8 weeks 
Class 
Remote Border Infarct Remote Border Infarct Remote Border Infarct 
Collagenases          
MMP1 ↑* ↑* ↑* ND ND ND ≈ ↓ ↓:UD 
MMP8 ≈ ≈ ≈ ↑* ↑* ↑* ≈ ↑ ↑ 
MMP13 ↑* ↑* ↑* ↑* ↑* ↑* ≈ ↑ ↑ 
Gelatinases          
MMP2 ↑ ↑ ↑ ↑ ↑ ↑ ≈ ↑ ↑ 
MMP9 ↑ ↑ ↑ ↑ ↑ ↑ ↑ ↓ UD 
Stromelysins          
MMP3 ND ND ↑ ↑ ↑ ↑ ≈ ≈ ↓ 
MMP7 ND ND ND ND ND ND ≈ ↓ ↓ 
MT1-MMP ≈ ≈ ≈ ≈ ≈ ≈ ≈ ↑ ↑ 
TIMPs          
TIMP1 ≈ ≈ ≈ ↑* ↑* ↑* ≈ ↓ ↓:UD 
TIMP2 ≈ ≈ ≈ ↑* ↑* ↑* ↓ ↓ ↓:UD 
TIMP3 ND ND ND ND ND ND ↓ ↓ ↓:UD 
TIMP4 ≈ ↓* ↓* ND ND ND ≈ ↓ ↓:50% 
 
MMP: matrix metalloproteinase; TIMP: tissue inhibitor of MMPs; UD: undetectable; ND: not determined; ↑increase; 
↓: decrease; ≈: remains at basal level; ∗: activity levels were measured without distinction between indicated areas. 
 
1.4 Transforming Growth Factor Beta 
Transforming growth factor β1 (TGFβ1) regulates many of the cardiac repair 
processes outlined above. It is the archetypical member of the TGFβ superfamily, a 
group of evolutionarily conserved, pleiotropic cytokines that regulate many cellular 
functions, including cell growth, adhesion, migration, cell fate determination and 
differentiation, and apoptosis (Schmierer and Hill, 2007). Several human diseases, 
such as cancer, organ fibrosis, atherosclerosis, hereditary haemorrhagic telangiectasia 
and pulmonary artery hypertension, are associated with disordered signalling of TGFβ 
superfamily members (Blobe et al., 2000; ten Dijke and Arthur, 2007).   
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TGFβ1 is synthesised as a dimeric pre-proprotein and is secreted in latent form being 
non-covalently attached to the latent binding protein.  This latent complex is found 
mainly as a component of the extracellular matrix. It requires further activation to 
liberate active TGFβ1 ligand (Annes et al., 2003; Gordon and Blobe, 2008). 
 
TGFβ1 ligand mediates its action by binding to high affinity homodimeric complexes 
of type I and II receptors (Shi and Massagué, 2003). The constitutively active type II 
receptor then phosphorylates the type I receptor leading to its activation. This allows 
recruitment and subsequent phosphorylation of receptor regulated SMADs (R-
SMADs), which then forms a complex with the common mediator SMAD (co-
SMAD: SMAD 4). SMAD complexes are then shuttled to the nucleus where they 
directly regulate gene transcription (Shi and Massagué, 2003; Schmierer and Hill, 
2007). There are also inhibitory SMADs (I-SMADs: SMAD 6 and SMAD 7), that can 
antagonise TGFβ signalling by inhibiting the activation of R-SMADs (figure 1.2) (ten 
Dijke and Arthur, 2007). TGFβ1 can also signal through non-canonical signalling 
pathways. These include MAP kinase, JNK and phosphatidylinositol-3-kinase 
pathways (Derynck and Zhang, 2003). 
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Figure 1.2 TGFβ family signalling pathways. 
TGFβ1 normally signals via Tgfbr2/Alk5 receptor complex whereby binding of TGFβ1 results in 
phosphorylation of Smad2/3, this then associates with Smad 4 (the common Smad (Co-Smad)) and this 
complex then translocates to the nucleus where it results in transcription of effecter genes such as Pai-1. 
In endothelial cells (as depicted here) TGFβ1 can also signal via the Tgfbr2/Alk1 receptor complex, 
with the resulting transcription of genes such as Id1. Inhibitor Smads (Smad 7 is depicted here) inhibit 
both Smad2/3 and Smad1/5/8 signalling in response to TGFβ1. Adapted from ten Dijke et al 
Angiogenesis 2008:11(1): 79-89 (ten Dijke et al., 2008).
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1.5 Endoglin 
Endoglin (CD105) is an 180kDa type I integral membrane glycoprotein expressed as a 
homodimer with each subunit consisting of a 561 amino acid extracellular domain, a 
hydrophobic transmembrane domain and a short cytoplasmic tail (figure 1.3) (Gougos 
and Letarte, 1990; Mahmoud et al., 2011). The extra cellular domain of human 
endoglin contains a tripeptide arginine-glycine-aspartic acid (RGD) domain which is a 
key recognition structure for cellular adhesion (Gougos and Letarte, 1990). However, 
murine endoglin lacks this structure (Duff et al., 2003). There are two isoforms of 
human endoglin which differ in the length of the intracellular domain. L-endoglin has 
a cytoplasmic tail of 47 amino acids and in S-endoglin it is 14 amino acids (figure 
1.3) (Bellón et al., 1993). Endoglin is primarily expressed in vascular endothelial cells 
(Gougos and Letarte, 1990) but is also expressed in fibroblasts (Leask et al., 2002; K. 
Chen et al., 2004), myofibroblasts (Torsney et al., 2002), vascular smooth muscle 
cells (Adam et al., 1998), monocytes (Pedro et al., 1992) macrophages (Lastres et al., 
1992), and adult mesenchymal stem cells (Barry et al., 1999; Smith et al., 2007). 
 
Endoglin is a TGFβ accessory receptor which is structurally similar to betaglycan 
(López-Casillas et al., 1991; Cheifetz et al., 1992). Endoglin is not directly involved 
in cell signalling but modulates the response to several TGFβ superfamily ligands 
(Lastres et al., 1996). In endothelial cells TGFβ is able to signal via two type I 
receptor pathways, ALK1, which stimulates endothelial cell proliferation and 
migration, and ALK5, which inhibits these responses through activation of different 
R-SMADS (figure 1.2) (Goumans et al., 2002). Subsequent experiments 
demonstrated that endoglin is responsible for modulating this response to TGFβ. 
Lebrin and colleagues demonstrated that endoglin is necessary for TGFβ/ALK1 
signalling and indirectly inhibits TGFβ/ALK5 signalling (Lebrin et al., 2004). The 
different isoforms of endoglin may also play a role in this differential regulation of 
TGFβ. For example, in endoglin deficient L6E9 myoblasts ectopic expression of L-
endoglin results in enhanced signalling via the TGFβ/ALK1 pathway whereas S-
endoglin promoted the TGFβ/ALK5 pathway (Velasco et al., 2008). These effects of 
the different endoglin isoforms may be significant in age related vascular disorders as 
the expression of S-endoglin is associated with endothelial senescence (Blanco et al., 
2008). 
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The extracellular domain of endoglin can be cleaved from the surface of cells and 
circulates in the blood as a 65kDa protein, termed soluble endoglin. Soluble endoglin 
is found at increased levels in patients with pre-eclampsia (Venkatesha et al., 2006), 
atherosclerosis (Blann et al., 1996), familial hypercholesterolaemia (Blaha et al., 
2008) and heart failure (Kapur et al., 2010; Kapur et al., 2012). It is cleaved from the 
cell surface by MMP14 (Hawinkels et al., 2010) and its levels are increased by TNFα 
in vitro (Cudmore et al., 2007; Ikemoto et al., 2012). Its exact function in the 
cardiovascular system is unknown but it has been shown to bind to and inhibit TGFβ 
(Venkatesha et al., 2006; Walshe et al., 2009). The role of soluble endoglin in the 
cardiovascular system will be discussed in further detail below. 
 
 
 
Figure 1.3 Structure of Endoglin. 
Endoglin is divided into 3 distinct regions: the extracellular (EC) domain, important for ligand binding, 
the transmembrane (TM) and intracellular (IC) domain. Alternative splicing generates two different IC 
domains for endoglin (L-Eng and S-Eng). Adapted from (Mahmoud et al., 2011). 
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1.6 Endoglin in cardiovascular disease 
Haplo-insufficiency for endoglin has been shown to be responsible for hereditary 
haemorrhagic telangiectases (HHT) type 1, a rare familial vascular disorder 
characterised by cutaneous telangiectasia and arteriovenous malformations 
(McAllister et al., 1994). The clinical phenotype of fragile vessels, haemorrhage and 
vascular malformations in these patients points to the importance of endoglin in the 
development and maintenance of the vasculature. However, ongoing research 
suggests that endoglin is also important in more common cardiovascular diseases. 
 
1.6.1 Endoglin in atherosclerosis 
In addition to being expressed in vascular endothelium endoglin is also expressed in 
smooth muscle cells and macrophages in human atherosclerotic plaques (Adam et al., 
1998; Conley et al., 2000; Ma et al., 2000; Piao and Tokunaga, 2006). It is 
predominantly the L isoform of endoglin that is expressed in atherosclerotic plaques 
(Conley et al., 2000). Increased endoglin expression is also associated with more 
advanced lesions (Piao and Tokunaga, 2006). In vitro vascular smooth muscle cells 
express endoglin and its expression is increased by TGFβ1 and reduced by TNFα 
(Conley et al., 2000). Endoglin has also been shown to be up regulated following 
balloon injury to porcine coronary arteries (Ma et al., 2000). Inhibition of endoglin 
antagonised the TGFβ1 mediated inhibition of smooth muscle cell migration (Ma et 
al., 2000). This may be of importance in arterial healing following percutaneous 
coronary intervention; particularly given that immunosuppressant drugs, similar to 
those used to reduce neointimal hyperplasia following PCI, have been shown to 
enhance endoglin expression (Albinana et al., 2011; Giordano et al., 2012). 
 
In addition to endoglin expression in vascular smooth muscle cells and macrophages 
of atherosclerotic plaques, its microvascular expression also appears to be important 
in the stability of the plaque. In a study examining the expression of endoglin in 
coronary atherosclerosis in autopsy specimens, microvascular endoglin was correlated 
with plaque haemorrhage and deep seated inflammation. Both of which are features 
associated with plaque vulnerability (Xiaofei Li et al., 2012). 
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One group in particular has examined the effects of dyslipidaemia and its treatment on 
endoglin expression using the ApoE/LDL receptor double knockout mouse. They 
demonstrated that the HMG-CoA-reductase inhibitor atorvastatin, used in the 
management of dyslipidaemia and secondary prevention in coronary artery disease, 
enhanced the expression of endoglin and resulted in an increase in Smad2, pSmad2/3 
and endothelial nitric oxide synthase (eNos) (Nachtigal et al., 2009). Subsequently 
they have shown that a high cholesterol diet led to a reduction in endoglin expression 
in atherosclerotic plaques along with a reduction in Alk1 and pSmad2, with soluble 
endoglin being increased in the serum of these mice (Strasky et al., 2011). In another 
paper they then demonstrated that treatment of these mice, fed a high cholesterol diet, 
with atorvastatin led to a reduction in atherosclerotic lesion size and reduced levels of 
soluble endoglin (Rathouska et al., 2011). Finally they confirmed that treatment with 
atorvastatin reduced cholesterol levels and plaque size and this was associated with an 
increase in plaque endoglin, Alk1, pSmad1, pSmad2, Vegf and eNos expression 
(Vecerova et al., 2012). The effect of hypercholesterolaemia on soluble endoglin was 
also seen patients with Familial Hypercholesterolaemia. Blaha and colleagues 
demonstrate that soluble endoglin was elevated in these patients and that cholesterol 
reduction, using extracorporeal elimination therapy, resulted in a reduction of soluble 
endoglin levels. They demonstrated that this effect was not due to the capture of 
soluble endoglin in adsorption and filtration columns used in this therapy (Blaha et 
al., 2008). The authors suggest that this reduction in soluble endoglin may be due to 
removal of atherogenic elements resulting in a reduction in endothelial activation and 
hence reduced release of soluble endoglin (Blaha et al., 2008). 
 
In patients with stable coronary artery disease following percutaneous coronary 
intervention, levels of circulating soluble endoglin was an independent risk factor for 
the development of major adverse cardiac events (Ikemoto et al., 2012). In addition 
increased circulating soluble endoglin is associated with diabetes and hypertension, 
both of which are risk factors for the development of atherosclerosis. The level of 
soluble endoglin positively correlated with HbA1c (a measure of glycaemic control, 
with higher levels showing poor control) and systolic blood pressure (Blazquez-
Medela et al., 2010). Although not commented on in the study, the absolute levels of 
soluble endoglin were higher in the healthy controls, suggesting that there was a 
modifying influence in the diabetic and hypertensive groups. Statin therapy is widely 
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used in both these groups and may have resulted in lower soluble endoglin levels in 
these patients.  
 
1.6.2 Endoglin in heart failure 
Endoglin expression is increased in the left ventricles of patients with end-stage heart 
failure referred for mechanical left ventricular assist devices (LVAD) (Kapur et al., 
2012). Off loading of the left ventricle with these devices was associated with a 
reduction in tissue endoglin expression back to the levels in patients without heart 
failure, suggesting an association of endoglin levels and pressure overload in the 
failing heart (Kapur et al., 2012). A previous study has demonstrated that circulating 
soluble endoglin levels are also increased in patients with heart failure compared to 
controls (Kapur et al., 2010). Serum levels of soluble endoglin were inversely 
correlated with left ventricular ejection fraction and positively correlated with left 
ventricular end diastolic pressure and cardiac functional class (Kapur et al., 2010). In 
a smaller group of patients (n=10) who were admitted for in-patient management of 
their heart failure, a reduction in soluble endoglin levels was seen following treatment 
and was associated with a reduction in pulmonary capillary wedge pressure (a 
measurement of left ventricular filling pressures) (Kapur et al., 2010). Furthermore, 
circulating soluble endoglin levels are lower in smokers with heart failure compared 
to non-smokers with heart failure. There was also greater flow mediated dilatation (a 
measure of endothelial function) in smokers with heart failure. However there was no 
difference in soluble endoglin between smokers and non-smokers without heart 
failure (Heffernan et al., 2011). This study suggests that reduced soluble endoglin 
levels are associated with improved endothelial function in heart failure. 
 
However, alterations in soluble endoglin appear to be more complex as demonstrated 
by the effect of myocardial infarction on soluble endoglin levels. Levels of soluble 
endoglin in patients presenting with MI were significantly lower than in healthy 
controls and these levels fell further in the first 48 hours after admission (Cruz-
Gonzalez et al., 2008). There was no correlation between soluble endoglin level at 
admission and clinical outcome but a greater reduction in soluble endoglin over 48 
hours was associated with increased mortality. In fact the percentage reduction in 
soluble endoglin levels was an independent predictor of post MI mortality (Cruz-
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Gonzalez et al., 2008). This reduction in serum soluble endoglin following a major 
vascular event was also seen in patients presenting with subarachnoid haemorrhage 
(SAH) (Dietmann et al., 2012). This study also demonstrated that both lower serum 
levels of soluble endoglin and higher plasma levels of TGFβ1 were associated with 
complications following SAH and low mean soluble endoglin levels over the study 
period were associated with a poor, long term functional outcome (Dietmann et al., 
2012).  
 
1.6.3  Endoglin in the regulation of vascular tone and oxidative stress 
One of the pathological manifestations of HHT are cutaneous telangectases, which are 
post capillary venule dilatations connecting directly to dilated arterioles (Braverman 
et al., 1990).  This suggested that endoglin may be involved in regulation of vascular 
homeostasis and led Jerkic and colleagues to investigate the effect of endoglin on 
vascular tone. They demonstrated that in endoglin heterozygous mice mean arterial 
pressure was slightly (6mmHg) higher than in controls. There was also an attenuated 
hypotensive response to the endothelium dependent vasodilators bradykinin and 
acetylcholine (Jerkic et al., 2004). In an isolated hind limb perfusion model they 
determined that this attenuated response was due to impaired vasodilatation in 
endoglin heterozygous mice. This was consistent with reduced levels of endothelial 
nitric oxide synthase (eNOS) in endoglin heterozygous mice and the authors showed 
that levels of eNOS were related to endoglin expression in vitro (Jerkic et al., 2004). 
 
This reduction in eNos levels in endoglin heterozygous mice has been confirmed by 
others (Toporsian et al., 2005). They demonstrated that this reduction in eNOS was 
due to a reduction in the stability of eNOS protein in endoglin deficient mice where it 
has a significantly reduced half life. In addition, they demonstrated that endoglin 
resides in the caveolae where it is associated with eNOS suggesting a mechanism for 
its stabilising function. However, in isolated, pre-constricted mesenteric arterioles 
from endoglin heterozygous mice Toporsian and colleagues demonstrated an 
enhanced vasodilator response to acetylcholine compared to controls. This was due to 
eNOS uncoupling and increased production of reactive oxygen species (ROS) 
(Toporsian et al., 2005).  
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The same group subsequently showed that, compared to control mice, endoglin 
heterozygous mice have dilated pulmonary arteries and there is an enhanced 
vasorelaxant response to acetylcholine in pre-constricted pulmonary artery ring 
segments ex-vivo, a response that was inhibited by L-NAME (an NO inhibitor) 
suggesting eNOS dependence (Belik et al., 2009). They also demonstrated increased 
ROS production and eNOS uncoupling in the lungs of endoglin heterozygous mice 
compared to controls (Belik et al., 2009). This suggests that the increased pulmonary 
vasorelaxation seen in endoglin heterozygous mice is due to increased eNOS 
dependent ROS production (Belik et al., 2009). 
 
1.6.4 Transforming growth factor β and endoglin in cardiac repair 
Following surgically induced myocardial infarction in animal models TGFβ 
expression is upregulated. However, the different TGFβ isoforms display different 
temporal and spatial expression patterns. TGFβ1 and TGFβ2 mRNA follow a similar 
time course with their expression increasing 6 hours post infarction, reaching a peak 
after 3 days (Deten et al., 2001; Dewald et al., 2004). Thereafter, they decrease but 
remained elevated 2 to 3 fold, with TGFβ2 having a second peak after 21 days (Deten 
et al., 2001).  In the same study, TGFβ2 expression was much more pronounced in the 
non-infarcted versus the infarcted LV in the first day following MI (Deten et al., 
2001). TGFβ3 demonstrated quite a different time course. TGFβ3 mRNA levels were 
not significantly increased until 6 days post MI, reaching a peak on day 32 and 
remaining elevated for the length of the study which was 82 days (Deten et al., 2001). 
In addition to increased TGFβ1 expression in the infarct scar, there is also an increase 
in Smad 2, 3 and 4 in both infarcted and non-infarcted myocardium following 
experimental MI (Hao et al., 1999).  In a study by Bujak et al, levels of 
phosphorylated Smad2 (pSmad2) were significantly elevated in infarcted mouse 
hearts within the first 24 hours, suggesting activation of the Smad 2/3 pathway (Bujak 
et al., 2007). This western blot data was supported by immunohistochemical staining 
for pSmad2, which identified immunoreactive cells in the granulation tissue of the 
infarct border zone (Bujak et al., 2007). The western blot analysis also showed an 
increase in pSmad1 at 24 and 72 hours post MI, and a corresponding decrease in 
inhibitory Smad 7 (Bujak et al., 2007). This study also showed the importance of 
Smad3 in the cardiac fibrosis response. Smad3 knock out mice demonstrated a similar 
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density of macrophages to controls but reduced neutrophil infiltration and reduced 
chemokine and proinflammatory cytokine expression (Bujak et al., 2007). There was 
no difference in the time taken for the inflammatory infiltrate to resolve. However, 
there was an increase in myofibroblast density but a reduction in collagen synthesis 
and interstitial fibrosis, which resulted in an improvement in diastolic function in 
Smad 3 null mice (Bujak et al., 2007). 
 
Due to its pleiotropic nature, TGFβ1 plays a complex role in infarct healing. It affects 
multiple cell types involved in the healing response (figure 1.4). TGFβ1 is a potent 
chemo-attractant of monocytes and it regulates cytokine and chemokine expression by 
monocytes and macrophages. Its primary effect on macrophages is the suppression of 
chemokine and proinflammatory cytokine synthesis (Bujak and Frangogiannis, 2007). 
TGFβ1 appears to have a cardioprotective effect in the early phase post MI. Lefer and 
colleagues demonstrated that administration of TGFβ1 at the time of experimental MI 
reduced levels of TNF-α and attenuated neutrophil adhesion to vascular endothelium 
(Lefer et al., 1990; Lefer et al., 1993). Similarly inhibition of TGFβ1 at the time of 
MI resulted in increased infiltration of neutrophils into infarcted tissue and an increase 
in the synthesis of proinflammatory cytokines and chemokines. This exacerbated LV 
dilatation and increased mortality (Ikeuchi et al., 2004). Thus all three studies show 
that the immunosuppressive action of TGFβ1 around the time of MI is cardio-
protective. 
 
TGF-β stimulation also has a pro-fibrotic effect. It induces synthesis of the major 
extracellular proteins, fibronectin and collagen (Ignotz and Massague, 1986). In 
cardiac fibroblasts, TGFβ has been shown to increase type I and III collagen in vitro 
(Eghbali et al., 1991a), and induce the transformation of cardiac fibroblasts to a 
myofibroblast phenotype (Eghbali et al., 1991b), suggesting that TGFβ is important in 
the development of cardiac fibrosis. In contrast to inhibition of TGFβ at the time of 
MI, delayed inhibition of TGF resulted in reduced LV volumes and improved 
function combined with reduced interstitial fibrosis. This suggests that TGFβ 
inhibition post MI exacerbates early cardiac dysfunction but prevents late adverse 
remodelling (Ikeuchi et al., 2004; Okada et al., 2005). Angiotensin II, an important 
mediator of adverse ventricular remodelling, induces TGFβ both in vivo, following 
experimental MI, and in vitro, in cardiac fibroblasts, leading to increased collagen 
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synthesis (Sun et al., 1998; Gao et al., 2009). Angiotensin type 1 (AT1) receptor 
antagonism resulted in an attenuation of both TGFβ and collagen synthesis (Sun et al., 
1998; Yu et al., 2001). 
 
 
Figure 1.4 The diverse, multifunctional, and pleiotropic effects of TGF-β on cell types involved in 
infarct healing. 
From Bujak, M. et al. Cardiovasc Res 2007 74:184-195 (Bujak et al., 2007). 
 
Endoglin has an important role in blood cell mediated vascular repair (van Laake et 
al., 2006). It is strongly expressed in the infarct area 1 week following MI and the 
data from this study suggested that endoglin expression was confined to endothelial 
cells (van Laake et al., 2006). However, the temporal and spatial expression of 
endoglin in the heart following MI has not been studied in detail and will be 
addressed in this thesis. Following surgical MI, endoglin heterozygous mice have 
significantly reduced cardiac function compared to control mice. They also exhibited 
impaired angiogenesis in the infarct region suggesting that this may result in greater 
adverse remodelling following myocardial infarction. Intravenous injection of bone 
marrow mononuclear cells from healthy human donors significantly improved cardiac 
function but cells from donors with HHT1 (i.e. patients who were heterozygous for 
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endoglin mutations) did not (van Laake et al., 2006). This impaired ability, of bone 
marrow mononuclear cells from HHT1 patients, to augment cardiac repair appears to 
be due to impaired homing of these cells to the infarcted heart and a disruption of the 
SDF1-CXCR4 axis (Post et al., 2010). This clearly shows a role for endoglin in 
infarct healing and cardiac repair de novo as well as following adult stem cell 
transplantation. One of the goals of this thesis was to investigate the role of endoglin 
in cardiac repair in more detail. Interestingly, during the course of this study, endoglin 
heterozygous mice were shown to have improved survival and cardiac function in a 
pressure overload model of heart failure (Kapur et al., 2012), and is discussed further 
below. 
 
1.6.5 Endoglin in fibrogenesis 
Studies have shown that endoglin is expressed in cardiac fibroblasts either freshly 
isolated or in culture (K. Chen et al., 2004; Shyu et al., 2010; Kapur et al., 2012). 
Endoglin has also been shown to be expressed in other cell types involved in 
extracellular matrix regulation in other organs. For example, cutaneous fibroblasts 
(Leask et al., 2002), intestinal fibroblasts (Burke et al., 2010), hepatic stellate cells 
and portal fibroblasts (Meurer et al., 2010), mesangial cells (Diez-Marques et al., 
2002) and chondrocytes (Finnson et al., 2010). 
 
Angiotensin II stimulation of rat cardiac fibroblasts has been shown to result in 
increase expression of endoglin which was mediated via the AT1 receptor and the 
MAP kinase pathway (K. Chen et al., 2004). In this study the induction of collagen 1 
and suppression of MMP1 by angiotensin II was antagonised by an endoglin specific 
antibody (K. Chen et al., 2004). TGFβ1 stimulation of rat cardiac fibroblasts also 
results in induction of endoglin and collagen 1. However, this induction was mediated 
via the PI3 kinase, Akt and Smad3 pathways but not the MAP kinase pathway. 
Inhibition of endoglin by siRNA resulted in a significant reduction in collagen 1 
synthesis in response to TGFβ1, suggesting that endoglin may play a role in fibrosis. 
Interestingly, suppression of TGFβ1-induced collagen 1 synthesis by atorvastatin 
occurred independently of the presence or absence of endoglin (Shyu et al., 2010). 
Both these studies confirm that the profibrotic cytokines angiotensin II and TGFβ1, 
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induce endoglin expression in cardiac fibroblasts and that endoglin is a positive 
regulator of collagen production.  
 
The effect of endoglin on models of fibrosis in other organ systems has also been 
studied. Hepatic stellate cells are pericytes found in the perisinusoidal space of the 
liver and are an important cell type in hepatic fibrosis. A study by Meurer and 
colleagues demonstrated that endoglin expression is increased in rat models of 
experimental liver fibrogenesis and confirmed that endoglin is expressed in rat hepatic 
stellate cells. This expression of endoglin is up regulated by TGFβ1 (Meurer et al., 
2010). In these cells, TGFβ1 stimulation results in Alk5 dependent, phosphorylation 
of Smad1/5, Smad2 and Smad3.  Transient over expression of endoglin enhanced 
Smad1/5 phosphorylation and resulted in an increase in expression of alpha smooth 
muscle actin (αSMA, also known as Acta1) (Meurer et al., 2010). These data also 
suggest that endoglin is a positive regulator of fibrogenesis. 
 
Human mesangial cells, present in the kidney and important in glomerulosclerosis, 
also express endoglin in culture. TGFβ1 stimulation of these cells results in increased 
expression of endoglin, TGFBR2 and TGFβ1 along with the extracellular matrix 
proteins collagen I, collagen IV and fibronectin (Diez-Marques et al., 2002). This 
study also demonstrated that the composition of the extracellular matrix influences the 
expression of endoglin, with increased expression in mesangial cells cultured on 
collagen coated plates (Diez-Marques et al., 2002). Finally, they investigated the 
effect of over expression of endoglin in a mouse fibroblast cell line. In endoglin 
transfected cells the levels of collagen I was lower in both untreated and TGFβ1 
treated cells (Diez-Marques et al., 2002). From this they concluded that endoglin is a 
negative regulator of collagen synthesis. This finding is in contradiction to those 
discussed above that indicated endoglin was a positive regulator of collagen synthesis. 
However, a number of other studies, where endoglin is over-expressed, also suggest 
that over-expression of endoglin is a negative regulator of the TGFβ1 induced fibrotic 
response. For example in an intestinal fibroblast cell line over-expression of endoglin 
resulted in an abrogation of the increased expression of connective tissure growth 
factor (CTGF) seen in control fibroblasts following TGFβ1 stimulation (Burke et al., 
2010). In the same study they also knocked down endoglin in primary intestinal 
fibroblasts with siRNA. This resulted in a small non-significant increase in CTGF 
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protein expression following TGFβ1 stimulation in endoglin depleted fibroblasts 
compared to control. However, there was a significant increase in collagen gel 
contraction (an in vitro model of connective tissue remodelling) by endoglin depleted 
fibroblast under basal conditions and following TGFβ1 stimulation (Burke et al., 
2010). 
 
Scleroderma (systemic sclerosis) is a chronic autoimmune disease characterised by 
progressive fibrosis of the skin, blood vessels, muscles and other internal organs. It 
has been found that endoglin is over-expressed in dermal fibroblasts cultured from 
patients with scleroderma and the expression of endoglin increases with progression 
of the disease (Leask et al., 2002). However, over expression of endoglin in dermal 
and NIH3T3 fibroblasts blocked the TGFβ1 induction of CTGF (Leask et al., 2002). 
Another study by the same group confirmed the overexpression of endoglin in dermal 
fibroblasts from patients with scleroderma and that betaglycan (another TGFβ type III 
receptor) expression was also increased (Holmes et al., 2011). Similarly, basal 
transcription of CTGF and collagen I was increased in sclerodermal fibroblasts but 
these cells showed a decreased responsiveness to TGFβ1 when compared to control 
fibroblasts. Once again, over-expression of endoglin inhibited TGFβ1 induced CTGF 
activity. However, over expression of betaglycan enhanced basal and TGFβ1 induced 
activity. The same response was seen when endoglin and betaglycan were co-
transfected (Holmes et al., 2011). These data support endoglin as a negative regulator 
of the fibrotic response in scleroderma but suggest that the different type III receptors 
may have antagonistic roles in this response. 
 
However, a recent study by Morris et al. (Morris et al., 2011) casts doubt on endoglin 
as negative regulator of the fibrotic response in scleroderma. In this study they 
knocked down endoglin, using siRNA, in dermal fibroblasts from patients with 
scleroderma and normal controls. They found no effect of endoglin knock down on 
CTGF or collagen I gene expression. However, in fibroblasts from patients with 
scleroderma they found that endoglin knockdown resulted in down regulation of both 
CTGF and collagen I. These results suggest that endoglin is a positive regulator of 
extracellular matrix production in scleroderma (Morris et al., 2011). 
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These studies all examine the effects of endoglin in vitro and the precise culture and 
experimental conditions may explain the contradictory results. It may therefore be 
more informative to investigate the role of endoglin on the fibrotic response in vivo. 
In the heart the role of endoglin has been studied in two in vivo models of heart 
failure; myocardial infarction (van Laake et al., 2006) and pressure overload 
following transverse aortic constriction (Kapur et al., 2012). The study by van Laake 
and colleagues has been discussed above and demonstrated that cardiac function 
following surgically induced myocardial infarction is significantly reduced in 
endoglin heterozygous mice compared to controls (van Laake et al., 2006). In a study 
using pressure overload as a model of heart failure, Kapur and colleagues 
demonstrated that there is improved cardiac function and reduced fibrosis in endoglin 
heterozygous mice compared to controls. They noted that there was no difference in 
the LV hypertrophy induced by aortic constriction between endoglin heterozygous 
mice and controls. However, there was an increase in myocardial capillarity in 
endoglin heterozygous mice compared to controls. Their study suggested that reduced 
endoglin limits fibrosis by limiting TGFβ1 signalling via the SMAD2/3 and ERK1/2 
pathways (Kapur et al., 2012). They also investigated the effects of endoglin on 
human cardiac fibroblasts in vitro. They found that inhibiting endoglin resulted in 
reduced type 1 collagen production. Interestingly, they found a paradoxical 
attenuation of type 1 collage production when they over expressed endoglin in these 
fibroblasts, similar to some of the scleroderma data discussed above. Kapur et al 
demonstrated that soluble endoglin antagonised TGFβ1 signalling and confirmed that 
there was increased soluble endoglin in the conditioned media of cardiac fibroblasts 
over expressing endoglin (Kapur et al., 2012). This suggests that it is increased 
soluble endoglin, not the over-expression of endoglin, which is responsible for this 
paradoxical response and potentially explains the differing result previously seen in 
scleroderma fibroblasts.  
 
In the kidney endoglin haploinsufficiency also results in reduced fibrosis following 
irradiation compared to controls (Scharpfenecker et al., 2009). Further research by the 
same group demonstrated that this reduction in fibrosis was associated with a reduced 
macrophage infiltration and cytokine production (interleukin 1 beta and interleukin 6) 
in the endoglin heterozygous mice (Scharpfenecker et al., 2012). This role of endoglin 
in modulating the inflammatory response has been demonstrated by other groups. In a 
The Importance of Endoglin for Cardiac Structure and Function 
 
 22 
renal infarct reperfusion injury model, endoglin heterozygosity is protective against 
infarct reperfusion injury and is also associated with reduced macrophage infiltration 
(Docherty et al., 2006). This may be due to the effect of endoglin on leucocyte 
adhesion and endothelial transmigration. Transendothelial transmigration of 
leucocytes during inflammation has been shown to be impaired in endoglin deficient 
mice (Elisa Rossi et al., 2013). In vitro studies suggest that the RGD motif of 
endoglin is responsible for this adhesion and transmigration (Elisa Rossi et al., 2013), 
which is interesting as murine endoglin does not possess this motif (Duff et al., 2003). 
Also soluble endoglin was demonstrated to abolish this endoglin dependent leucocyte 
adhesion (Elisa Rossi et al., 2013).  
 
Clearly endoglin plays an important role in regulation of fibrosis but it is unclear from 
these studies if these effects are due to the effect of endoglin directly regulating TGFβ 
collagen production or indirectly by its effects on inflammation or indeed both. 
Therefore one of the goals of this thesis was to investigate the role of endoglin in 
collagen production by cardiac fibroblasts.  
 
1.7 Mouse models 
Significant advances in mouse genetics have provided powerful in vivo models with 
which to study gene function. In the case of endoglin, null embryos show embryonic 
lethality due to defects in angiogenesis (Arthur et al., 2000). However, mice 
heterozygous for the endoglin gene develop normally with no effect on survival. They 
show reduced levels of endoglin and serve as a model of HHT type 1 in the 129/Ola 
background (Arthur et al., 2000). In order to study the effects of this essential gene in 
adult life a different approach is needed, using conditional knockout mice. This allows 
the tissue specific inactivation of a target gene at a specific point in time. Our group 
has developed an inducible endoglin knockout model (Allinson et al., 2007). This is 
achieved by flanking specific exons of the target gene (in this case, exons 5 and 6) by 
loxP sites. In the presence of the enzyme Cre-recombinase, these exons are excised to 
inactivate the gene. In the case of the inducible endoglin knockout mouse an inducible 
version of Cre (CreERT2) is used and is activated by tamoxifen (figure 4.5). Within our 
group we have two inducible Cre lines, Cdh5(PAC)-CreERT2 (an endothelial specific 
Cre line) and Rosa26-Cre ERT2 (in which Cre is ubiquitously expressed). Both lines 
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were used in the work described in this thesis to investigate the roles of endoglin in 
cardiac function. The different in vivo and in vitro experimental approaches that were 
used are introduced in the relevant chapters. 
 
1.8 Magnetic resonance imaging to assess cardiac structure and function in mice 
In parallel with the increased use of genetically modified mouse models in the study 
of cardiovascular development and disease, improved techniques to analyse their 
cardiac function have evolved. Magnetic resonance imaging (MRI) allows for an 
accurate and reproducible, non-invasive assessment of cardiac structure and function 
(Florentine et al., 1986; Shapiro et al., 1989; Ruff et al., 1998). Although, given the 
small size of the mouse heart and high physiological heart rates, this assessment 
remains technically challenging. Each aspect of the experimental process requires 
careful consideration to optimise image quality and to ensure accurate and 
reproducible data collection (Johnson, 2008). Important factors include choice of 
hardware, anaesthetic agent and gating strategy used. Here I will initially discuss the 
physics of nuclear magnetic resonance to explain how magnetic resonance images are 
obtained. I will then discuss the experimental factors that influence image quality. 
Finally, I will discuss the use of MRI for the assessment of cardiac function in mice. 
 
1.8.1 Nuclear magnetic resonance 
In order to understand how MRI images are generated it is important to understand 
the basic structure of atoms. An atom consists of a central nucleus, made up of 
protons and neutrons, and orbiting electrons. Within the atom there are three kinds of 
motion, electrons spinning on their own axis, electrons orbiting the nucleus and the 
nucleus spinning on its own axis. Nuclei with an odd mass number (total number of 
protons and neutrons) have net spin or angular momentum and are MR active nuclei. 
It is the spinning of specific nuclei present in biological tissue that underpins the 
principles of MRI. The hydrogen nucleus consists of a solitary proton which gives it a 
relatively large magnetic moment. It is the most abundant atom in biological tissue. 
Both these facts make hydrogen the ideal MR active nuclei for magnetic resonance 
imaging (Westbrook et al., 2005). 
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The fundamental laws of electromagnetism state that a magnetic field is created when 
a charged particle moves. Thus the spinning of a positively charged hydrogen nucleus 
induces a magnetic field around it. It is easiest to conceptualise these protons as tiny 
magnets or “spins”. Normally these protons are randomly orientated but the 
application of a strong external magnetic field (B0) causes them to align with the 
magnetic field. Some will align parallel (in the same direction) and some will align 
anti-parallel (in the opposite direction) to the magnetic field. There is a small excess 
of protons aligned parallel to the magnetic field resulting in a net magnetic moment 
called the net magnetisation vector (NMV) and this magnetisation within a subject 
allows the generation of the MR image (see below) (Westbrook et al., 2005). 
 
The influence of the strong magnetic field also produces an additional spin or wobble 
of the magnetic moments of hydrogen nuclei around B0. This is called precession. The 
circular path they follow around B0 is called the precessional path and the speed at 
which they move around this path is called the precessional frequency. The 
precessional frequency is governed by the Larmor equation. The Larmor equation 
states that: 
ω0 = B0 × γ 
where: 
ω0 is the precessional frequency (measured in megahertz (MHz)) 
B0 is the magnetic field strength of the magnet (measured in tesla, T) 
γ is the gyromagnetic ratio (unit is megahertz per tesla (MHz/T)). The gyromagnetic 
ratio for hydrogen is 42.57 MHz/T (Westbrook et al., 2005). 
 
If a radiofrequency (RF) pulse is then applied at the same frequency as the 
precessional (Larmor) frequency for hydrogen then the hydrogen nuclei gain energy 
and resonate. The result is that the NMV rotates away from the longitudinal plane 
(which is in the same direction of the magnetic field) towards the transverse plane, 
which is at 90° to the longitudinal plane. This is a process called “excitation.” The 
magnitude of this rotation (terned the “flip angle”) is dependent on the magnitude and 
duration of the RF pulse. The other result of resonance is that the magnetic moments 
of the individual hydrogen nuclei move into phase with each other (Westbrook et al., 
2005). When the RF pulse is switched off then the hydrogen nuclei lose the energy 
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and the NMV realigns with the magnetic field. At the same time but independently 
the magnetic moments of hydrogen nuclei lose coherency due to dephasing. Together, 
these processes are called relaxation. Relaxation results in the decay of transverse 
magnetisation, due to nuclei exchanging energy with their neighbouring nuclei, called 
T2 decay and the recovery of longitudinal magnetisation, due to the nuclei giving up 
energy to their surrounding environment, termed T1 recovery (Westbrook et al., 
2005). 
 
If a radiofrequency receiver coil is placed in the transverse plane then an electrical 
current is produced when in-phase magnetisation cuts across it. This current 
constitutes the MR signal. The time between the applications of RF pulses, during 
which relaxation occurs, is called the repetition time (TR). The time from the 
application of the RF pulse to the peak signal induced in the receiving coil is called 
the echo time (TE). Both are measured in milliseconds. 
 
Tissue contrast is produced due to the fact that molecules in biological tissues relax at 
different rates. The useful example is to compare fat and water. Fat molecules contain 
atoms of hydrogen, carbon and oxygen where the hydrogen atoms are closely packed 
and relatively immobile relative to one another. Water is comprised of two hydrogen 
atoms with one oxygen atom and its molecules are widely spaced. These differences 
in structure influence the time for which individual protons can interact with each 
other and other atoms in their local environment. Consequently relaxation in fat is 
quicker than in water. This results in fat having a short T2 (fast signal decay) and 
short T1 (fast recovery of longitudinal NMV). The opposite is true for water. 
Selection of appropriate MRI scan parameters are used to sensitise the image to these 
differences and create contrast between different tissues. For example, in T1 weighted 
images, where fat appears bright and water dark, the TR and TE are both short. 
Whereas, in T2 weighted images, where fat appears dark and water appears bright, the 
TR and TE are both long. The use of MR contrast agents can significantly alter the 
local T1 and/or T2 resulting in an increased or decreased signal intensity and hence 
positive or negative tissue contrast. Examples of such agents include gadolinium, 
manganese and iron (Westbrook et al., 2005). 
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1.8.2 Experimental Factors 
1.8.2.1 Hardware 
Given the small size of the mouse’s heart an optimised hardware setup is required 
(Schneider et al., 2006). Cine MRI of mice hearts has been described using magnetic 
field strengths between 1.5T (Gilson and Kraitchman, 2007) and 11.4T (Schneider et 
al., 2003). However, increasing magnetic field strengths benefits the signal to noise 
ratio (SNR) allowing improved spatial resolution and can reduce time required to 
collect MR images (Schneider et al., 2006). Most magnets used for murine CMR have 
a horizontal bore. However, some older experimental high field magnets (≥11T) were 
built with vertical bores (Wiesmann et al., 2001a; Schneider et al., 2003). This 
potentially poses a problem as mice have to be imaged with an upright body position 
which is not physiological. Wiesmann et al. (Wiesmann et al., 2001a) showed that 
following a transient drop in left ventricular (LV) systolic pressure on vertical tilting, 
which returns to baseline by six minutes, a vertical body position did not affect 
invasive hemodynamic parameters over a follow up period of 60 minutes. When 
applied to a high field, vertical bore MR system, a vertical body position did not 
affect measured cardiac function parameters when compared to a horizontal bore 
system (Schneider et al., 2003). The pre-clinical magnet at Newcastle University and 
used in the work described in this thesis has a horizontal bore so the animals are 
placed prone, which is a more physiological position for mice. 
1.8.2.2 Gating 
The imaged generated is built up using a number of signal excitations, with the 
duration of the scan (from milliseconds to minutes) being dependent on the type of 
scan and the contrast required. The MRI process assumes that the object being imaged 
is not moving and so any uncontrolled movement results in image blurring. As the 
heart is constantly beating and moving with respiration, cardiac MR is severely 
affected by both cardiac and respiratory motion artefacts. This is exacerbated by the 
high mouse heart rate (400-600 beats per minute (bpm)) and fast respiratory rates. 
These are minimised by the use of physiological gating to trigger the start of a scan 
and synchronise the image sequence to the beating heart. Cardiac gating is essential 
and image quality is improved with respiratory gating, which becomes more 
important at higher field strengths (> 7T) (Schneider et al., 2003; Cassidy et al., 2004). 
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The maintenance of a steady state level of magnetisation during respiration without 
acquiring image data has also been shown to improve image quality (Cassidy et al., 
2004). Although initial experiments were performed using only cardiac gating the 
majority of the work described in this thesis used both respiratory and cardiac gating. 
1.8.2.3 Anaesthetic 
Mice need to be anaesthetised for the duration of an MRI scan. The choice of 
anaesthetic influences the quality of data depending on the duration of action and the 
effects on cardiac function. An echocardiographic study comparing inhaled halothane 
to a ketamine and xylazine combination showed that ketamine/xylazine produced 
significant reductions in heart rate, left ventricular fractional shortening and cardiac 
output (Chaves et al., 2001). Anaesthesia was induced with the ketamine/xylazine 
combination (80/10 mg/kg i.p.) within 5 to 20 minutes of injection with duration of 
action between 30 and 60 minutes. Whereas, halothane (0.25-0.75% in 95% O2) 
induced anaesthesia in less than 5 minutes of inhalation, maintained an adequate 
depth throughout and mice recovered to ambulatory activity within 2 minutes of 
halothane withdrawal (Chaves et al., 2001). Further studies have confirmed the 
myocardial depressive nature of ketamine/xylazine (Roth et al., 2002; Kober et al., 
2004). Roth et al. (Roth et al., 2002) compared a range of anaesthetic agents. They 
found that inhaled isoflurane produced higher initial heart rates of about 550 beats per 
minute but gradually declined over the 20 minute study period to about 400 beats per 
minute. Isoflurane provided the most stable cardiac function over this time and was 
the most reproducible in repeat studies. The concentration of isoflurane (1.25% versus 
2.00%) was found to affect respiration rate in a concentration dependent manner but 
did not affect cardiac function (Kober et al., 2004). Mouse cardiac MR scans 
normally take between 45 and 60 minutes and cardiac function needs to remain stable 
during this time. As a result of its ease of use and cardiac stability, isoflurane is 
commonly used in murine MRI experiments (Ruff et al., 1998; Wiesmann et al., 
2001a; Wiesmann et al., 2002; Schneider et al., 2003; Cassidy et al., 2004). 
1.8.3 Assessment of cardiac function with MRI 
Cardiac magnetic resonance imaging (CMR) provides three dimensional images of 
the heart with high spatial and temporal resolution. It has been used to accurately and 
reliably assess cardiac function in both humans (Sechtem et al., 1987; Cranney et al., 
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1990) and large animal models (Florentine et al., 1986; Shapiro et al., 1989). The 
small size of the mouse heart and its high physiological heart rate provide additional 
challenges for the study of murine cardiac function. However, Ruff and colleagues 
(Ruff et al., 1998) demonstrated that small volumes could be accurately measured 
with high resolution magnetic resonance imaging. They also found that there was 
precise agreement between left ventricular mass calculated by MRI and at autopsy. 
Finally, they were able to show that the assessment of cardiac function by MRI was 
highly reproducible with low inter-observer and intra-observer variability. 
Echocardiography is an alternate imaging modality that has been validated for 
assessing LV mass and function (Manning et al., 1994; Gardin et al., 1995). However, 
echocardiography relies on geometric assumptions which may limit its accuracy in 
hearts with abnormally shaped left ventricles that may result from disease (Dulce et 
al., 1993 125). The development of three dimensional echocardiography, which does 
not rely on geometric models, may reduce this limitation (Dawson et al., 2004). The 
complex geometry of the right ventricle (RV) makes assessment of its function more 
difficult. Nevertheless, assessment of RV size and function can be accurately made 
using CMR in humans (Sechtem et al., 1987) and mice (Wiesmann et al., 2002). MRI 
allows accurate assessment of cardiac function without relying on geometric models 
and provides valuable three dimensional structural information. 
 
Magnetic resonance imaging has been successfully applied to several mouse models 
of cardiac disease. Siri et al (Siri et al., 1997) were able to show that MRI could be 
used to assess changes in LV mass, geometry and function in a mouse model of left 
ventricular hypertrophy. Following myocardial infarction (MI) cardiomyocyte loss, 
fibrosis and neurohormonal changes lead to LV wall thinning, LV dilatation and 
impaired regional function. These changes in structure and function have been serially 
assessed in a mouse model of reperfused myocardial infarction using MRI (Ross et al., 
2002). They demonstrated that at 1 day following MI the LV function had declined by 
greater than 50% and remained depressed for the duration of the study. Over the 
course of the next 4 weeks the left ventricle progressively dilates. They also showed a 
transient reduction in contractile function in regions remote from the infarcted 
myocardium. This resolved by 7 days post infarct, but was followed by a late phase of 
myocardial dysfunction that became fully manifest by 28 days. This reduction in 
contractile function in non-infarcted regions was also demonstrated by Yang et al. 
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(Yang et al., 2004). However, their study only assessed LV function at a single time 
point (24 hours post MI) and therefore did not demonstrate an early and late phase of 
contractile dysfunction. Together these studies demonstrate that ventricular 
remodelling is a dynamic process and highlights the value of MRI to serially evaluate 
cardiac function in the same animal, at different time points post MI. In addition to 
global myocardial function, regional function can be assessed by measuring 
myocardial torsion with magnetic resonance tagging (Henson et al., 2000) or 
myocardial velocity mapping using phase contrast MRI (Nahrendorf et al., 2006). 
 
Magnetic resonance contrast agents can be used to assess myocardial perfusion, 
infarct size and myocardial viability. In clinical studies gadolinium based agents are 
used as these increase the intensity of T1 weighted images. The principles underlying 
this technique are that the first pass of gadolinium through the heart demonstrates 
myocardial perfusion since the contrast agent is essentially only within the 
vasculature at this time. The gadolinium then accumulates in the abnormal 
interstitium of the infarcted region. This results in increased T1 weighted image 
intensity in the area of infarct after a delay of 5 to 20 minutes. This technique is called 
late gadolinium enhancement. In a mouse infarct model, there was good agreement 
between infarct size as assessed by late gadolinium contrast enhancement and 
histological staining with 2,3,5-triphenyl tetrazolium chloride (TCC) (Yang et al., 
2004). Manganese is another MR contrast agent used in preclinical models and 
Manganese-Enhanced Magnetic Resonance Imaging (MEMRI) can indirectly assess 
myocardial calcium influx (Hu et al., 2001). To image calcium influx MEMRI 
exploits 2 properties of the manganese ion: one is that the ion is divalent and so enters 
the cardiac myocyte through the L-type calcium channel (or potentially other routes of 
abnormal calcium cell entry), and secondly, that it is a contrast agent on T1 weighted 
images. These 2 properties allow us to non-invasively monitor myocyte calcium 
uptake in-vivo. Hu et al, demonstrated that manganese enhanced MRI (MEMRI) can 
be used to assess calcium influx and inotropic state of the heart (Hu et al., 2001). The 
same group showed that MEMRI was able to accurately assess infarct size in vivo as 
measured by TCC staining post mortem. It also allowed the simultaneous evaluation 
of LV function and viability (Hu et al., 2004). 
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In conclusion magnetic resonance is a versatile tool for the accurate and reproducible 
assessment of cardiac function in vivo. It has been used in several models of 
cardiovascular disease to assess the effects of gene mutations, response to 
pharmaceutical therapies and response to cell therapies (Akki et al., 2013). However, 
it is expensive and requires careful optimisation to achieve these results. At the time 
of starting my PhD studies, cardiac MRI of mouse models had not yet been 
established in Newcastle and this was therefore one of the first aims of my project. 
 
1.9 Aims 
1. To establish and validate murine cardiac MRI at Newcastle University using a 
7T Varian magnet. 
2. To evaluate applications of cardiac MRI in three mouse models of cardiac 
disease. 
3. To investigate the role of endoglin in endogenous cardiac repair. 
a. To establish the temporal and spatial expression of endoglin in the 
heart following myocardial infarction. 
b. To establish a ubiquitous endoglin knockdown mouse model using 
tamoxifen treated Engfl/fl;Rosa26-CreERT2 mice. 
c. To use this mouse model to investigate the effects of endoglin 
depletion on infarct size and myocardial function in vivo using cardiac 
MRI. 
4. To investigate the role of endoglin in primary cardiac fibroblasts in vitro 
during the pro-fibrotic response to TGF-β stimulation.
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Chapter 2  Materials and methods. 
 
2.1 Suppliers. 
All chemicals and reagents were purchased from VWR International, Sigma-Aldrich, 
Vector Laboratories, Thermo Scientific, GE Healthcare, Pierce Biotechnology, 
Qiagen, Roche or Invitrogen. 
 
All plastic ware and apparatus for Western blotting and general laboratory use was 
purchased from BioRad Laboratories, Iwaki, Greiner, RA Lamb, or Scientific 
Laboratory Supplies. 
 
Oligonucleotides were purchased from Integrated DNA Technologies. 
 
2.2 Mice strains and genotyping. 
All animal experiments were performed under Home Office personal and project 
licences in accordance with the Animals (Scientific Procedures) Act 1986 and had 
local ethical approval. 
 
2.2.1 Mouse strains. 
For the MRI validation experiments and the myocardial infarction model C57Bl/6 
mice were used. For the manganese enhanced MRI experiments delta-sarcoglycan 
deficient (Scgd-/-) mice, a model for limb girdle muscular dystrophy type 2 (Nonaka, 
1998), were used with age matched C57Bl/10 mice used as controls. The Engfl/fl mice 
were developed in my host laboratory (Allinson et al., 2007) and were homozygous 
for the floxed endoglin allele, with loxP sites flanking exons 5 and 6 (figure 4.5). To 
achieve ubiquitous or endothelial specific endoglin knockdown the Engfl/fl mice were 
crossed with the tamoxifen inducible Rosa26-CreERT2 (generated in Dr A. Joyner’s lab, 
New York, and were obtained from Dr C Guo, University of Connecticut) or 
Cdh5(PAC)-CreERT2 mice (Dr Ralf Adams, CRUK, London). 
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2.2.2 DNA extraction. 
The solutions needed were made up from stock solutions as follows: 
Lysis buffer 1 (25mM NaOH/0.2mM EDTA). 
2.5ml of 0.5M NaOH + 0.02ml 0.5M EDTA in 50ml sterile double distilled H2O, 
adjusted to pH12. 
Lysis Buffer 2 (40mM Tris-HCl). 
4ml of 0.5M Tris-HCl in 50ml sterile double distilled H2O adjusted to pH 5 with HCl. 
 
Ear clips of adult mice were incubated with 100µl of lysis buffer 1 in a thermomixer 
at 95°C, 350 rpm for 60 minutes. Following a quick vortex, 100µl of lysis buffer 2 
was then added. This solution was then quickly vortexed and centrifuged for 5 
minutes at 13,000g. The resultant supernatant contained the DNA, 2µl of which was 
then used in the subsequent PCR reaction, with the majority of undigested tissue and 
impurities remaining at the bottom of the tube. 
 
2.2.3 Genotyping. 
All genotyping was carried out using polymerase chain reaction (PCR). To genotype 
the Engfl/fl;Rosa26-CreERT2 and Eng fl/f;Cdh5(PAC)-CreERT2 mice a four primer mix 
(table 2.1) was used to amplify part of the endoglin gene and part of the Cre gene. 
Each PCR reaction was carried out in 0.2ml thin walled PCR tubes. Individual 
reaction mixes consisted of 2µl of extracted DNA, 1µl of 20µM primer mix, 2.5µl of 
25mM MgCl2, 2.5µl 10x Reaction Buffer IV, 0.2µl Red Hot Taq DNA Polymerase 
(all purchased from ABgene, Thermo Scientific), 0.5µl of 10mM dNTPs (New 
England Biolabs) and 16.8µl dH2O to make a reaction volume of 25µl 
. 
Table 2.1 Primers used for genotyping Engfl/fl;Rosa26-CreERT2 and Engfl/fl;Cdh5(PAC)-CreERT2 
mice. 
Primer Sequence (5’-3’) Product size 
engF6 GACGCCATTCTCATCCTGC 
engR7 CCACGCCTTTGTCCTTGC 
500bp 
Cre5F TGCCACCAGCCAGCTATCAACT 
Cre5R AGCCACCAGCTTGCATGATCTC 
191bp 
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PCR reactions were carried out using the GeneAmp® PCR System 2400 (Applied 
Biosystems). The PCR cycle program used was as follows: 
 
Initial denaturing step: 95°C    - 2 minutes 
Denaturing step:   95°C    - 15 seconds 
Annealing step:  58°C    - 30 seconds   x35 cycles 
Extension step:  74°C    - 1 minute 
Final extension step:  74°C    - 7 minutes 
 
PCR products were then resolved on 1.5% agarose gels. These were made by heating, 
in a microwave, 1.5g DNA agar (Seakem LE Agarose for gel electrophoresis) in 
100ml of 1xTAE buffer (40mM tris base-acetate and 1mM EDTA) to generate a clear 
solution. This was allowed to partially cool before 10µl of 10,000x GelRed (Biotum 
Inc) was added. The gel was then poured in to horizontal gel tray with combs. Once 
cooled and fully set the gel was fully submerged in a gel electrophoresis tank 
containing 1xTAE buffer and the comb carefully removed. Prior to loading the DNA 
samples into the gel they were mixed with a DNA loading dye (0.25% bromophenol 
blue, 0.25% xylene cyanol FF and 40% sucrose in dH2O) allowing the DNA to sink to 
the bottom of the wells and visualisation of DNA migration during electrophoresis. A 
1kb DNA ladder (Invitrogen) was loaded alongside the samples to enable accurate 
sizing of the DNA product. Following electrophoresis the DNA bands were visualised 
by exposure to UV light and the image captured using a GeneGnome System and 
GeneSnap Software (Syngene Bio Imaging). 
 
2.3 Magnetic resonance imaging. 
Magnetic resonance images were acquired on a horizontal bore 7.0T Varian 
microimaging system (Varian Inc, Paulo Alto, CA, USA) equipped with a 12-cm 
microimaging gradient insert (40 gauss/cm). Animals were anaesthetised with 
isoflurane (5% with 1l/min oxygen for induction followed by 1-2% with 1l/min 
oxygen for maintenance) via a facemask and positioned on a custom built sled (Dazai 
Research Instruments, Toronto, Canada), with integrated electrocardiographic (via 
electrodes in contact with the shaved chest with conductive hydro-gel), respiratory 
(via a pneumatic pillow) and cutaneous temperature monitoring. An SA Instruments 
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Inc. (Edison, NJ, USA) small animal system was used for physiological monitoring 
and gating. A 30mm or 39mm quadrature birdcage coil (Rapid Biomedical, GmbH) 
was used to transmit/receive the MR signal. Global cardiac function was measured 
using an ECG triggered, respiratory gated gradient echo (FLASH) cine MR sequence. 
The sequence was triggered by the R wave of the ECG, which was end diastole. Scout 
images were obtained and orientated to the short axis and 2 long axes (horizontal and 
vertical) of the heart (see chapter 3 for further details). T1 weighted scans from 8 to 
10 contiguous short axis slices were obtained covering the whole left ventricle. Single 
horizontal and vertical long axis slices were also obtained. The following imaging 
parameters were used: TE 1.42ms, TR 5ms, flip angle 15°, matrix 128x128 (zero 
filled to 256x256), field of view 25.6x25.6mm, slice thickness 1mm, number of 
averages 4. 
 
2.3.1 MRI based measurement of myocardial mass and cardiac function. 
Myocardial mass. 
1. Using the Image J (NIH) software package, the area between the epicardial and 
endocardial borders were measured in all slices at end diastole and end systole 
(figure 2.1).  
2. Left ventricular (LV) myocardial area is the area between the epicardial (yellow) 
and endocardial (red) borders and was calculated for each slice using: 
Myocardial area per slice = epicardial area – endocardial area 
3. LV myocardial volume for each slice was calculated using: 
Myocardial volume per slice = area × slice thickness 
4. The total myocardial volume was calculated using: 
Total myocardial volume = ∑ myocardial volume per slice 
5. LV mass was calculated using: 
LV mass (mg) = Total myocardial volume × myocardial specific gravity (1.05g/cm3) 
6. The mean myocardial mass was calculated from the myocardial mass at end 
diastole and end systole. 
7. To ensure accurate measurement of myocardial mass was made, there should be 
no more than a 5% difference in the myocardial mass calculated at end diastole 
and end systole. 
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Global systolic function. 
1. The measurements from the endocardial border for each slice (figure 2.1) at end 
diastole and end systole were taken. The LV chamber area is that within the 
endocardial border. 
2. The LV chamber volume for each slice at end diastole and end systole was 
calculated using: 
LV volume per slice = LV area × slice thickness 
3. The LV end diastolic volume was calculated using: 
LVEDV (µl) = ∑ LV volume per slice at end diastole 
4. The LV end systolic volume was calculated using: 
LVESV (µl) = ∑ LV volume per slice at end systole 
5. Various function parameters were calculated from these volumes as follows: 
Stroke volume (SV) (µl) = LVEDV – LVESV 
Ejection fraction (EF) (%) = (SV/LVEDV) × 100 
Cardiac output (CO) (ml/min) = (SV × heart rate)/1000 
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Figure 2.1 Mid-ventricular short axis slice showing epicardial (yellow) and endocardial (red) 
borders of the left ventricle. 
Border lines were manually traced using ImageJ software. 
 
2.3.2 Reproducibility of MRI measurements. 
To assess reproducibility of MRI measurements I performed all measurements on two 
separate occasions. Intra-observer variability was calculated for each subject as the 
standard deviation of the measurements divided by the mean of the measurements 
multiplied by 100. The mean value and standard deviation for all subjects was used as 
a summary measure for each variable. 
 
2.3.3 Measuring size of myocardial infarct. 
The infarcted myocardium is characterised by thinned, akinetic area of myocardium. 
The infarct size, as a percentage of the left ventricular myocardium can be calculated 
by measuring the left ventricular epicardial (Tep) and endocardial (Ten) 
circumference as well as the infarct length (Iep and Ien) at end-diastole (figure 2.2) 
(Schneider et al., 2006). The infarct size can then be calculated by: 
 
Infarct size= 1/NSLICES ∑ 1/2(Iep/Tep + Ien/Ten).100% 
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Figure 2.2 Mid-ventricular short axis slice demonstrating how infarct size is measured. 
A. Traces of left ventricular endocardial (dark grey) and epicardial (light grey) circumferences. The 
area of myocardial infarction is indicated. B. Cartoon indicating the measurements needed to calculate 
infarct size. Taken from (Schneider et al., 2006) 
 
2.4 Coronary artery ligation. 
Myocardial infarction was induced by permanent coronary artery ligation. Mice were 
anaesthetised with isoflurane. They were then intubated and ventilated (Harvard 
Minivent 230Vac) with anaesthesia maintained with 2% isoflurane/98% oxygen. 
Body temperature was maintained by means of a heated blanket. A left thoracotomy 
was performed, the heart exposed and the left anterior descending artery identified. 
This was then permanently ligated using 7-0 prolene suture 1 to 2 mm from the 
inferior border of the left auricle. The area of infarction can be visualised as it quickly 
blanches (figure 2.3). The wound was then closed in layers using 5-0 vicryl suture. 
The mice were then allowed to recover in a temperature controlled incubator at 33°C. 
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Analgesia was provided by an intraoperative, subcutaneous injection of 
buprenorphine. A soaked diet was used post operatively. The operative mortality for 
all surgery performed during these experiments was 20%. 
 
 
Figure 2.3 Macroscopic image of a mouse heart following LAD ligation. 
The suture can be seen with the faint outline of the LAD below (indicated by the branched blue line in 
upper inset). The infarcted myocardium can be easily seen by the blanching of the myocardium 
(indicated by the dotted blue line in lower inset). Image courtesy of Dr Rachael Redgrave. 
 
2.5 Invasive measurement of cardiac function. 
These experiments were performed under terminal anaesthesia. Measurements were 
made in closed chest, spontaneously breathing mice as follows. The mice were 
anaesthetised using isoflurane as for the MRI experiments. Body temperature was 
maintained by means of a homoeothermic blanket (Harvard Apparatus). Following an 
inverted T shaped, mid-neck incision the left internal jugular vein was isolated, 
ligated cranially and, following venotomy, the vein was canulated with p10 plastic 
tubing. Then the right common carotid artery was isolated, ligated cranially and, 
following arteriotomy a 1.4F conductance catheter (Millar) was introduced. Baseline 
aortic pressure measurements were made. Then the catheter was advanced 
retrogradely, through the aortic valve into the left ventricle. After stabilization, 
measurements at steady-state, during transient occlusion of the inferior vena cava and 
during infusion of dobutamine (5 and 10 µg/kg/min), were recorded using Powerlab 
Chart 5 software (ADInstruments, Colorado Springs) and analysed using PVAN 
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pressure–volume data analysis software package (Millar, Houston, TX). Volume was 
calculated using the Relative Volume Units/Cuvette method and parallel conductance 
was estimated by the hypersaline method (Pacher et al., 2008; Cingolani and Kass). 
Measurements made are described in table 2.2. 
 
Table 2.2 Haemodynamic indices obtained from cardiac conductance catheter experiments. 
Parameter Definition 
Aortic SBP (mmHg) Aortic systolic blood pressure 
Aortic DBP (mmHg) Aortic diastolic blood pressure 
MAP (mmHg) Mean arterial pressure 
Heart rate (bpm) Heart rate 
LV EDV (µl) Left ventricular end diastolic volume 
LV ESV (µl) Left ventricular end systolic volume 
LV SV (µl) Left ventricular stroke volume 
CO (ml/min) Cardiac output 
EF (%) Ejection fraction 
LV EDP (mmHg) Left ventricular end diastolic pressure 
LV ESP (mmHg) Left ventricular end systolic pressure 
Stroke work (mmHg.µl) Work performed by left ventricle 
Ea (mmHg/µl) Arterial elastance, a measure of  ventricular afterload 
dP/dtmax (mmHg/s) Peak rate of pressure rise 
dP/dtmin (mmHg/s) Peak rate of pressure decline 
Tau (ms) Isovolumetric relaxation time constant 
Total SVR (mmHg/ml/min) Total systemic vascular resistance 
PRSW (mmHg) 
Preload recruited stroke work, a measure of cardiac 
contractility 
Ees (mmHg/µl) End-systolic elastance, an index of myocardial contractility 
dP/dtmax-EDV (mmHg/s/µl) 
maximum rate of left ventricular pressure rise-end-diastolic 
volume relation, a measure of cardiac contractility. 
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2.6 Primary cardiac fibroblast culture. 
2.6.1 Reagents. 
Phosphate Buffered Saline (PBS) pH 7.4 stored at 4°C (Gibco #10010-023). 
Dulbecco's Modified Eagle Medium (DMEM), stored at 4°C (Gibco #41965-039). 
Foetal Calf Serum (FCS) (Gibco #10106-169). This was heat inactivated by 
incubating at 56°C for 1 hour and stored in 50ml aliquots at -20°C. 
Penicillin-Streptomycin (P/S) (Gibco #15070-063). This was stored in 10ml 
aliquots at-20°C 
0.25% Trypsin/EDTA (Gibco #25200-056). This was stored at -20°C in 5 ml 
aliquots. 
Type 2 Collagenase (Worthington Biochemical #CLS-2). A fresh 1mg/ml solution 
was obtained by diluting 50mg type 2 collagenase in 50ml DMEM and was kept on 
ice during the isolation procedure. 
4-hydroxytamoxifen (4-OHT) (Sigma #H7904). 
Recombinant Human TGFβ1 (PeproTech #100-21). 
Methylthiazolyldiphenyl-tetrazolium bromide (MTT) (Sigma #M2128). A 5mg/ml 
solution was obtained by dissolving 5mg MTT in 1 ml of filter sterilised dH2O. 
Dimethylsulphoxide (DMSO) spectrophotometric grade (Sigma #154938) 
 
2.6.2 Isolation of primary cardiac fibroblasts. 
Three mice were used for each isolation. Following humane euthanasia by cervical 
dislocation, hearts were rapidly dissected by lifting at the apex and cutting across the 
base of the heart thus removing atrial and great vessels and leaving left and right 
ventricle only. The hearts were then washed in sterile, ice cold PBS and transported to 
a tissue culture hood in sterile PBS on ice. Hearts were further washed in 5 changes of 
ice cold sterile PBS. They then transferred to a 35mm petri dish and 2mls of type 2 
collagenase (1mg/ml) was added and the hearts quickly minced into small pieces. A 
further 4 ml of collagenase was added and the minced hearts in collagenase were 
transferred to a 7ml bijous tube. This was then incubated in a shaking waterbath set at 
37°C and 100rpm for 10 minutes. The supernatant was removed and discarded. 5mls 
of fresh collagenase was added and a further incubation at 37°C and 100rpm for 15 
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minutes was performed. 2mls of supernatant was then removed and placed in a 50ml 
tube containing 5ml DMEM + 20% FCS. The remaining suspension was gently 
pipetted 5 to 6 times to release cells attached to the tissue fragments. The tissue 
fragments were allowed to settle and the supernatant removed and placed in the 
DMEM + 20% FCS. This was then centrifuged at 1200rpm for 8minutes. The media 
was then removed and the cells resuspended in 5-10ml pre-warmed DMEM + 10% 
FCS + 1% P/S and kept at 37°C, 5% CO2. Meanwhile, a further 5ml collagenase was 
added to the tissue fragments and digestion repeated. The above steps, pooling all the 
cells together, were repeated until all the tissue had been digested (about 5 digestions 
in total). The pooled cell suspension was centrifuged at 1200rpm for 10 minutes and 
the cells were resuspended in DMEM + 10% FCS + 1% P/S and placed in a T75 
tissue culture flask. The fibroblasts were allowed to adhere for 90minutes. After this 
period the media was removed and cells washed very gently with warm, sterile PBS 
and fresh culture media added (DMEM + 10% FCS + 1% P/S). The cells were grown 
for 4 days after which they were ready to passage. All experiments were performed 
after the second passage. 
 
2.6.3 CreERT2 activation in vitro. 
To activate the CreERT2 and enable endoglin knockdown, 4-hydroxytamoxifen was 
added to the culture media at the first passage and was refreshed in subsequent media 
changes. 
 
2.6.4 Transforming Growth Factor β1 stimulation. 
Primary cardiac fibroblasts were plated in 2ml of DMEM +10% FCS + 1% P/S onto 6 
well tissue culture plates (100,000 cells per well). They were allowed to adhere 
overnight. The media was removed and the cells gently washed in warm sterile PBS. 
2mls fresh, warmed culture media was then added and the cells stimulated with 5-
10ng/ml of TGFβ1. They were incubated at 37°C, 5% CO2 for a variable period of 
time depending on the experimental conditions. After this the culture media was 
removed, the cells washed in warm, sterile PBS. For protein analysis cells were 
harvested by the addition of 1ml Trypsin/EDTA and incubated for 3 minutes at 37°C, 
5%CO2. Once the fibroblasts had detached from the culture dish the trypsin/EDTA 
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was neutralised with 1 ml of culture medium. The detached cells were then transferred 
to a 2ml microcentrifuge tube. They were then spun down in a microcentrifuge at 
13,000rpm for 5 minutes at 4°C. The media was removed and the cell pellet was 
gently rinsed in ice cold sterile PBS. They were then centrifuged for at further 5 
minutes at the same speed settings before the PBS was completely removed and the 
cell pellets were either used directly or frozen and stored at -80°C until used for 
protein analysis. For RNA analysis the cells were harvested by the addition of 350µl 
RLT buffer (RNeasy Mini Kit, Qiagen) and then used directly or frozen and stored at 
-80°C until used for RNA analysis. 
 
2.6.5 MTT assay. 
Primary cardiac fibroblasts were seeded in 96 well, flat-bottomed tissue culture plates 
(5000 cells per well) at passage 1 and subjected to various culture conditions as 
described in chapter 4. Following treatment, 10µl MTT (5mg/ml) was added to each 
well and incubated at 37°C, 5% CO2 for 5 hours. The media was then removed and 
100µl DMSO was added to solubilise the formazan crystals. The absorbance was 
measured at 570nm on a spectrophotometric plate reader (Thermo Scientific). 
 
2.7 Histological procedures. 
2.7.1 General solutions. 
10 x Phosphate Buffered Saline (PBS). 
80g NaCl, 2g KCl, 14.4g Na2HPO4 and 2.4g KH2PO4 dissolved in 800ml of dH2O. 
pH adjusted to 7.4 with HCl then dH2O added to make volume up to 1 litre. Sterilized 
by autoclaving at 121°C for 30mins. 
LacZ Detergent Rinse. 
120ml of 0.5M Phosphate Buffer (pH7.2), 1.2ml of 1M MgCl2, 6ml of 1% 
NaDeoxycholate, 1.2ml of 10%NP40, made up to 600ml with dH2O. 
LacZ Staining Solution. 
6ml of 0.5M K3 Ferricyanide, 6ml of 0.5M K4 Ferrocyanide, 120ml of 0.5M 
Phosphate Buffer (pH7.2), 1.2ml of 1M MgCl2, 6ml of 1%NaDeoxycholate, 1.2ml of 
10% NP40, made up to 600ml with dH2O. This staining solution should be stored in 
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the dark at 4°C. 400µl of 25mg/ml XGAL solution was added to every 10ml of pre-
warmed (37oC) LacZ staining solution immediately before use. 
X-gal (25mg/ml). 
0.25g of X-gal dissolved in 10ml of dimethylformamide. Stored in the dark at -20°C. 
 
2.7.2 Tissue sampling, processing and sectioning. 
Hearts were dissected from euthanised mice and washed to ensure removal of excess 
blood. For the LV mass experiments the atria and right ventricle was dissected away 
from the left ventricle. The hearts were briefly blotted dry using filter paper and the 
left ventricular mass was measured. Hearts to be used for immunofluorescence were 
fixed overnight in 0.2% paraformaldehyde in phosphate buffered saline (PBS) at 4°C. 
They were than washed twice in PBS at 4°C followed by a further overnight 
incubation in 30% sucrose at 4°C. Following further washes in PBS hearts were 
embedded in OCT (RA Lamb) and frozen in liquid nitrogen. They were stored at -
80°C until needed for sectioning. 10µm cryosections were taken onto Histobond 
slides and allowed to air dry. These were then stored at -80°C until needed for 
histological staining. Prior to staining all tissue sections were removed from -80°C 
and allowed to reach room temperature inside their slide mailers to reduce 
condensation. They were then allowed to air dry at room temperature before being 
stained. 
 
2.7.3 Haematoxylin and Eosin histological staining. 
Sections were post fixed in cold AnalaR acetone for 10 minutes then allowed to air 
dry for 20 minutes. Sections were then rinsed in dH2O and incubated in Mayer’s 
haematoxylin (RA Lamb) for 2-3 minutes followed by a long rinse under running tap 
water. Sections were quickly immersed in Eosin (1% aqueous, RA Lamb) for a few 
seconds followed by a quick rinse in tap water. Sections were dehydrated in a graded 
alcohol series of 50%, 70%, 100% ethanol by immersing for 1 minute in each, 
followed by clearing in Histoclear (National Diagnostics, 2x5 minutes) and mounting 
under cover slips with HistoMount (Vector Laboratories). 
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2.7.4 Immunohistochemistry using Vecastain ABC kit. 
Anti-CD105 (Clone: MJ7/18, stock concentration: 0.5mg/ml, eBiosciences #14-1051) 
a rat anti-mouse monoclonal antibody was used to detect endoglin. All incubations 
were carried out in a humidified chamber. 
 
Endogenous peroxidise activity was blocked by incubating sections in 0.3% hydrogen 
peroxide in dH2O for 10 minutes. Cryosections were then washed in PBS for 5 
minutes then blocked with 5% rabbit serum (Vector Laboratories) in PBS for 30 
minutes. Endogenous biotin activity was then blocked using an Avidin/Biotin 
blocking kit (Vector Laboratories) according to manufacturer’s instructions; sections 
were incubated with Avidin D solution for 15 minutes then rinsed briefly in PBS 
followed by 15 minutes incubation with the Biotin solution. This was followed by 2x5 
minute washes with PBS. Sections were then incubated with anti-CD105 (1:200 
dilution in serum blocking solution) overnight at 4°C. Following this the sections 
were washed in PBS, 3x5 minutes. They were then incubated with biotinylated rabbit 
anti-rat secondary antibody (Vector Laboratories, BA-4001) at 1:200 dilution in 
serum blocking solution for 30 minutes. The Vectastain ABC reagent (Vector 
Laboratories) was prepared as per manufacturer’s instructions 30 minutes prior to use. 
Following 3 further 5 minute washes in PBS, tissue sections were incubated in the 
Vectastain ABC reagent for 30 minutes. After 3x5 minute washes, antibody binding 
was visualised using the liquid DAB substrate kit (Biogenex). Sections were counter 
stained with Mayer’s haematoxylin (RA Lamb) followed by rinsing in water. Finally 
the sections were dehydrated in a graded alcohol series of 50%, 70%, 100% ethanol 
by immersing for 1 minute in each, followed by clearing in Histoclear (National 
Diagnostics, 2x5 minutes) and mounting under cover slips with HistoMount (Vector 
Laboratories). 
 
2.7.5 Immunofluorescence. 
All incubations were performed in a humidified chamber which was protected from 
light. For double staining antibody combinations were limited due to the species in 
which the primary antibody was raised, and the anti-endoglin primary antibody was 
always used first (table 2.3). Cryosections were washed for 5 minutes in PBS 
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followed by incubation in the appropriate blocking solution for 2 hours (table 2.4). 
They were then incubated with the first primary antibody diluted in appropriate 
blocking solution overnight at 4°C (table 2.3). Following incubation, sections were 
washed for 3x5 minutes in PBS. They were then incubated in the appropriate 
secondary antibody (table 2.4), 1:200 dilution, in blocking solution. Following 3 
further 5 minute washes in PBS sections were blocked again in the blocking solution 
appropriate for the second primary antibody for 2 hours (table 2.4). They were then 
incubated with the second primary antibody diluted in appropriate blocking solution 
overnight at 4°C (table 2.3). Sections were then washed 3x5 minutes in PBS. They 
were then incubated in the appropriate secondary antibody for 2 hours (table 2.4). 
Finally, after 3x5 minute washes in PBS the sections were mounted under cover slips 
in hard set Vectashield with DAPI. Slides were left to dry at 4°C in the dark. 
 
Table 2.3 Order and combinations of primary antibodies used in double immunofluorescent 
staining. 
Antibody 1 Antibody 2 
Polyclonal goat anti-mouse CD105 Monoclonal rat anti-mouse CD31 
Polyclonal goat anti-mouse CD105 Monoclonal rat anti-mouse CD11b 
Monoclonal rat anti-mouse CD105 Polyclonal rabbit anti-mouse Fsp1 
Monoclonal rat anti-mouse CD105 Monoclonal mouse anti-SMA-Cy3 
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Table 2.4 Antibodies and conditions used in immunofluorescent staining of cryosections. 
Primary antibody Primary antibody 
supplier 
Working dilution Blocking solution Secondary antibody 
Polyclonal goat anti-
mouse CD105 
R&D Systems 
#AF1320 
1:25 5% donkey serum, 
1% BSA, 0.1% Tween 
Donkey anti-goat IgG-
alexa 595 conjugate 
Monoclonal rat anti-mouse 
CD105 
eBioscience 
#14-1051 
1:100 5% goat serum, 
1% BSA, 0.1% Tween 
Goat anti-rat IgG-alexa 
594 conjugate 
Monoclonal rat anti-mouse 
CD31 
BD Biosciences 
Pharmingen #550274 
1:100 5% goat serum, 
1% BSA, 0.1% Tween 
Goat anti-rat IgG-alexa 
488 conjugate 
Monoclonal rat anti-mouse 
CD11b 
BD Biosciences 
Pharmingen #550282 
1:100 5% goat serum, 
1% BSA, 0.1% Tween 
Goat anti-rat IgG-alexa 
488 conjugate 
Polyclonal rabbit anti-
mouse Fsp1 
Millipore 
#07-2274 
1:100 5% donkey serum, 
1% BSA, 0.1% Tween 
Donkey anti-rabbit IgG-
alexa 488 conjugate 
Monoclonal mouse anti-
SMA-Cy3 conjugate 
Sigma 
#6198 
1:100 5% donkey serum, 
1% BSA, 0.1% Tween 
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2.7.6 Measurement of cardiomyocyte cross sectional area. 
Cryosections of the mouse heart were washed in PBS for 5 minutes. They were then 
incubated with Fluorescein conjugated Wheat Germ Agglutinin (20µg/ml in PBS, 
Vector Laboratories, #FL-1021) for 1 hour at room temperature. Sections were then 
washed 3x5 minutes in PBS and mounted under cover slips in hard set Vectashield 
with DAPI. Slides were left to dry at 4°C in the dark. Digital images were captured 
using epifluorescent microscopy (see below) and cardiomyocyte area was measured 
using ImageJ (NIH) by tracing around cardiomyocytes in short axis. Approximately 
70 to 100 cardiomyocytes were traced for each ventricle and the average 
cardiomyocyte area calculated. 
 
2.7.7 Immunocytochemistry. 
Cells (e.g. fibroblasts) were seeded into wells of an 8-well slide (Lab Tek II, Nunc) 
and cultured for 48 hours at 37°C and 5% CO2. Cells were gently washed in PBS 
followed by fixing in ice cold acetone for 5 minutes. They were then washed in twice 
in PBS. They were then blocked in serum-free protein block (Dako) for 20 minutes. 
Following this the cells were incubated with appropriate primary antibody (table 2.5), 
diluted in blocking solution, overnight at 4°C. Slides were washed 3x5 minutes in 
PBS. They were then incubated with the appropriate secondary antibody (table 2.5), 
1:200 dilution, in blocking solution for 1 hour. 3 further 5 minute washes in PBS were 
performed prior to mounting the slides under cover slips with hard set Vectashield 
with DAPI. Slides were allowed to dry at 4°C in the dark. 
 
2.7.8 LacZ staining. 
Tissue sections were post fixed in 0.2% paraformaldehyde for 30 minutes at room 
temperature followed by a 10 minute wash in PBS containing 2mM MgCl2. They 
were then placed in lacZ detergent rinse on ice for 10 minutes. Sections were 
immersed in pre-warmed (37°C) LacZ staining solution () and incubated at 37°C for 3 
hours. Following this sections were washed in PBS with 2mM MgCl2 for 2x5 minutes. 
They were then rinsed in dH2O prior to counterstaining with Eosin (1% aqueous, RA 
Lamb). 3 further 5 minute washes in dH2O were performed prior to dehydration in a 
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graded alcohol series of 50%, 70%, 100% ethanol by immersing for 1 minute in each, 
followed by clearing in Histoclear (National Diagnostics, 2x5 minutes) and mounting 
under cover slips with HistoMount (Vector Laboratories). 
 
Table 2.5 Primary and secondary antibodies used for immunofluorescent staining. 
Primary antibody Primary antibody 
supplier 
Dilution Secondary 
antibody 
Monoclonal rat 
anti-mouse CD105 
eBioscience 
#14-1051 
1:100 Goat anti-rat IgG-
alexa 594 
conjugate 
Monoclonal rat 
anti-mouse CD31 
BD Biosciences 
Pharmingen 
#550274 
1:100 Goat anti-rat IgG-
alexa 594 
conjugate 
Polyclonal goat 
anti-human 
vimentin 
Millpore 
#AT1620 
1:100 Donkey anti-goat 
IgG-alexa 595 
conjugate 
Monoclonal mouse 
anti-SMA-Cy3 
conjugate 
Sigma 
#6198 
1:100  
 
2.7.9 Microscopy. 
For light microscopy, sections were viewed using a Ziess Axioplan microscope For 
fluorescent microscopy tissue sections were imaged using either a Zeiss Axioimager 
or a Nikon A1Rconfocal microscope. Digital images were captured using an Axiocam 
camera and analysed using Axiovision or ImageJ software. 
 
2.8 Protein analysis. 
2.8.1 General solutions. 
Lysis Buffer. 
10mM Tris-HCl pH7.4, 1% Triton X-100, 1/100 dilution of protease inhibitors 
(Sigma), 1/20 dilution of 10x phosphatase inhibitor (PhosSTOP tablets, Roche). 
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2x Protein Gel Loading Buffer. 
12.5ml 0.5M Tris (pH6.8), 10ml glycerol, 20ml 10% SDS, 7ml dH2O, 0.5% β-
mercaptoethanol, 20mg bromophenol blue. 
10x Gel Running Buffer. 
30g Tris base, 144g Glycine, 10g Sodium Dodecyl Sulphate (SDS), made up to 1L 
with dH2O. 
10x Western Transfer Buffer. 
144g glycine, 30g Tris base. 
10 x Tris Buffered Saline (TBS). 
24.2g Trizma® base (C4H11NO3) and 80g NaCl dissolved in 1 litre of dH2O. Adjust 
pH to 7.6 with concentrated HCl. 
TBST Wash Buffer. 
1x TBS/0.1% Tween-20. To prepare add 100ml of 10xTBS to 900ml of dH2O then 
add 1ml Tween-20 and mix. 
Strip Buffer. 
0.1M glycine in H2O, pH<2, adjusted with HCl. 
 
2.8.2 Sample preparation. 
For primary cardiac fibroblasts 50µl of lysis buffer was added to the cell pellets 
(prepared as described in section 2.6.4). For protein analysis of whole hearts, the 
hearts were rapidly dissected and rinsed in sterile PBS to remove blood following 
humane euthanasia. They were then homogenised in lysis buffer with QIAGEN 
Tissue Ruptor with disposable probes. Following homogenisation, the samples were 
briefly vortexed, total protein estimated using Pierce BCA protein assay (Thermo 
Scientific #23227) and stored at -80°C. 20µg of total protein was added to each well 
for SDS-PAGE. 
 
2.8.3 SDS-PAGE. 
A volume of 2xGel loading buffer was added to the protein sample to achieve a 1:1 
2xGel loading buffer to sample volume ratio. The samples were then heated at 95°C 
for 10 minutes in a thermomixer. This denatures the proteins, facilitates loading of 
samples onto the gels and allows tracking of the samples during gel electrophoresis. 
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The samples were allowed to reach room temperature then spun down briefly in a 
centrifuge for 10-15 seconds before loading onto a precast 10% polyacrylamide gel 
(Mini-PROTEAN® TGX™ precast gels, BioRad # 456-1039) along with a prestained 
protein marker (Precision Plus Protein Dual Coloured Standards, BioRad # 161-0374). 
Gels were run in running buffer for 1 hour at 150 volts. 
 
For the identification of eNOS dimmer and monomers a “cold” SDS-PAGE was 
performed by modifying the above protocol as follows: β-mercaptoethanol was 
omitted from 2xGel loading buffer and samples were not heated to 95°C. After 
loading the samples and protein marker the gel was run in ice cold running buffer for 
1 hour at 150 volts. To maintain the temperature of the running buffer a frozen ice 
pack was placed in the gel tank and the whole tank placed in ice 
. 
2.8.4 Western Blotting. 
Following protein separation by SDS-PAGE, the proteins were transferred to a 
Hybond ECL (GE Healthcare) membrane at 4°C in transfer buffer for 1 hour at 100 
volts. Membranes were then blocked in appropriate blocking solution (table 2.6) for 1 
hour at room temperature. They were then incubated with appropriate primary 
antibody (table 2.6) in blocking solution overnight at 4°C with gentle rocking. 
Following this the membranes were washed in TBST, 3x10 minutes. They were then 
incubated in HRP conjugated secondary antibody directed against the species of 
origin of the primary antibody for 1 hour at room temperature. Secondary antibodies 
were also diluted in blocking solution. Membranes were then washed in TBST, 3x10 
minutes. The protein-antibody complex was visualised by chemiluminescence using 
the SuperSignal West Pico Chemiluminescent Substrate (Pierce Biotechnology). Band 
signals were detected after exposure of the Western blot membranes to X-ray film 
(GE Healthcare) and processing in a Xograph Compact X4 automatic X-ray film 
processor (Xograph Imaging Systems Ltd.). 
 
To strip the membrane of the bound antibodies, the membrane was incubated with 
strip buffer for 15 minutes at room temperature followed by 3 x 5 minute washes in 
TBST before the membrane was used again for another Western blot. 
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2.8.5 Band Intensity Quantitation. 
Western blot band intensity measurements were made by scanning the x-ray film 
using an ImageScanner III scanner (GE Healthcare). The images were saved as tiff 
files and opened in ImageJ (NIH), where band intensity was measured using the gel 
analysis tool.
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Table 2.6 Antibodies and conditions used for Western blotting. 
BSA=bovine serum albumin. 
Primary antibody 
Primary antibody 
supplier 
Concentration Blocking solution Secondary antibody 
Smad 1 
Polyclonal rabbit IgG 
Cell Signalling 
Technology #9743 
1:1000 5% BSA/TBST Anti-rabbit IgG, HRP-linked 
antibody (Dako, #P0399) 
Phospho-Smad 1,5,8 
Polyclonal rabbit IgG 
Cell Signalling 
Technology #9511 
1:1000 5% BSA/TBST Anti-rabbit IgG, HRP-linked 
antibody (Dako, #P0399) 
Smad 2 (L16D3) 
Mouse monoclonal IgG 
Cell Signalling 
Technology #3103 
1:1000 5% Marvel/TBST Anti-mouse IgG, HRP-linked 
antibody (Dako, #P0447) 
Phospho-Smad 2 
Polyclonal rabbit IgG 
Cell Signalling 
Technology #3101 
1:1000 5% Marvel/TBST Anti-rabbit IgG, HRP-linked 
antibody (Dako, #P0399) 
eNOS 
Mouse monoclonal IgG 
BD Transduction 
Laboratories #610296 
1:1000 5% Marvel/TBST Anti-mouse IgG, HRP-linked 
antibody (Dako, #P0447) 
Type 1 collagen 
Polyclonal goat IgG 
Santa Cruz Biotechnology 
#sc-8784 
1:100 5% Marvel/TBST Anti-goat IgG, HRP-linked 
antibody (Dako, #P0449) 
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2.9 Quantative RT-PCR. 
2.9.1 RNA extraction. 
Primary cardiac fibroblasts were dissociated from the tissue culture plates by the 
addition of 350µl of RLT buffer (RNeasy Mini kit, Qiagen) and stored at -80°C until 
the sample was processed. For RNA analysis of heart tissue the experimental animals 
were euthanised and the hearts rapidly dissected under sterile conditions to reduce the 
risk of contamination. The hearts were rinsed in sterile PBS for tissue culture and the 
left ventricular apex was stored in RNAlater (Qiagen) at -80°C until the sample was 
processed. Following thawing the cardiac tissue was homogenised in 600µl RLT 
buffer (RNeasy Mini Kit, Qiagen) with a TissueRuptor with disposable probes 
(Qiagen). The RNeasy Mini kit (Qiagen) with on-column DNase digestion was used 
as per manufacturer’s instructions to generate RNA from both primary cardiac 
fibroblasts and cardiac tissue. The concentration and quality of RNA was measured 
using a NanoDrop spectrophotometer (Thermo Scientific). 
 
2.9.2 Generation of cDNA by reverse transcription. 
RNA (0.5µg of RNA from primary cardiac fibroblasts or 1µg of RNA from cardiac 
tissue) was converted to cDNA using a high capacity cDNA reverse transcription kit 
(Applied Biosystems) as per manufacturer’s instructions. .Quantative RT-PCR was 
performed immediately after cDNA generation or the cDNA was stored at -20°C until 
needed for quantative PCR. 
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2.9.3 Quantative PCR (qPCR). 
The relative gene expression of experimental samples was measured using quantative 
PCR with the DNA binding, fluorescence dye SYBR green. In these experiments all 
primers, except TGFβ1, were already in use in our laboratory and are summarised in 
table 2.7. The primers for amplifying TGFβ1 cDNA were previously published 
(Davidson et al., 2006). In order to measure the relative concentrations of each gene 
of interest, three internal reference genes (Gapdh, Hrpt and β Actin) were used. 
SYBR Green JumpStart Taq ReadyMix (Sigma #S4438) was used in all 
experiments and reagents were mixed in the following amounts: 
 
SYBR Green 5µl 
Forward Primer 0.5µl 
Reverse Primer 0.5µl 
Reference dye  0.1µl 
Sterile dH2O  2.9µl 
 
The 9µl reaction mix was then dispensed into one well of a 384 well plate. 1µl cDNA 
was then added each well. Each gene for every cDNA sample was run in triplicate. 
No template controls were included by the substitution of cDNA with 1µl for sterile 
water. The plate was then covered with an optical adhesive cover and placed in an 
Applied Biosystems 7900HT Fast Real-Time PCR system. Quantative PCR was then 
performed using the following thermal cycling protocol: 
 
Initial denaturing step  95°C  10 minutes 
Denaturing step  95°C  15 seconds 
Annealing step  60°C  1 minute  40 cycles 
Extension step   70°C  30 seconds 
 
For all reactions a thermal dissociation curve was generated at the end of the qPCR 
reaction to ensure that a single PCR product was produced, see chapter 4. 
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Table 2.7 Primer pairs used for quantative RT-PCR experiments. 
# calculated by LinReg. 
Gene Accession No Forward primer (5’-3’) Exon Reverse Primer (5’-3’) Exon 
Amplicon 
size (bp) 
PCR 
efficiency# 
Gapdh NM_008084 AACTTTGGCATTGTGGAAGG 4 GGATGCAGGGATGATGTTCT 5 132 1.8 
Hprt NM_013556 TCAGTCAACGGGGGACATAAA 4 GGGGCTGTACTGCTTAACCAG 6 124 1.8 
β Actin NM_007393 GGCTGTATTCCCCTCCATCG 2 CCAGTTGGTAACAATGCCATGT 3 154 1.8 
Alk1 NM_009612 GGGCCTTTTGATGCTGTCG 3 TGGCAGAATGGTCTCTTGCAG 4 114 1.9 
Alk5 NM_009370 TCCCAACTACAGACCTTTTTCA 2/3 GCAGTGGTAAACCTGATCCAGA 3/4 266 1.7 
Tgfbr2 NM_029575 CCGCTGCATATCGTCCTGTG 1 AGTGGATGGATGGTCCTATTACA 2 131 1.9 
Endoglin NM_007932 CTGCCAATGCTGTGCGTGAA 3 GCTGGAGTCGTAGGCCAAGT 4/5 191 1.8 
TGFβ1 NM_011577 GCAGTGGCTGAACCAAGGA 3 AAGAGCAGTGAGCGCTGAATC 4 59 1.8 
Id1 NM_010495 CCTAGCTGTTCGCTGAAGGC 1 CTTTGCTCCGACAGACCAAGTACCAC 2 65 1.9 
Id2 NM_010496 ACTCGCATCCCACTATCGTCAG 1 TGCTATCATTCGACATAAGCTCAGA 2 150 1.9 
Pai-1 NM_008871 AGTCTTTCCGACCAAGAGCA 6/7 ATCACTTGGCCCATGAAGAG 9 209 1.9 
Col1A1 NM_007742 GCTCCTCTTAGGGGCCACT 1 CCACGTCTCACCATTGGGG 2 103 1.9 
Col3A1 NM_009930 ACGTAGATGAATTGGGATGCAG 1/2 GGGTTGGGGCAGTCTAGTG 2 154 1.8 
Ctgf NM_010217 CCGCCAACCGCAAGATC 2 ACCGACCCACCGAAGACA 3 67 1.8 
αSMA NM_007392 GTCCCAGACATCAGGGAGTAA 2/3 TCGGATACTTCAGCGTCAGGA 3 102 1.9 
Mmp2 NM_008610 CAAGTTCCCCGGCGATGTC 1 TTCTGGTCAAGGTCACCTGTC 2 171 1.8 
Mmp9 NM_013599 TGCCCATTTCGACGACGAC 4 GTGCAGGCCGAATAGGAGC 5 132 1.9 
Timp1 NM_011593 TACACCCCAGTCATGGAAAGC 4 CGGCCCGTGATGAGAAACT 4/5 74 1.9 
Timp2 NM_011594 TCAGAGCCAAAGCAGTGAGC 2 GCCGTGTAGATAAACTCGATGTC 3 114 1.8 
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2.9.4 Data analysis. 
Raw data generated from the qPCR reaction was loaded into LinReg (Ramakers et al., 
2003) and the cycle threshold (Ct) was calculated for each gene of interest. As 
samples were run in triplicate the mean Ct for each sample was used. Mean PCR 
efficiency of each primer pair was determined from the slopes of the qPCR 
amplification curve using the LinReg method (Ramakers et al., 2003; Karlen et al., 
2007). 
 
To calculate the relative gene expression the comparative Ct method was used 
(Schmittgen and Livak, 2008). Briefly the mean Ct of the three internal reference 
genes was calculated. The difference between the Ct of the gene of interest and the 
reference gene was calculated by: 
∆Ct = Ct(gene of interest) - mean Ct(reference genes) 
 
In experiments were there was a direct biological comparator, for example in the 
TGFβ1 stimulated primary cardiac fibroblasts where the same cells acted as controls, 
then the relative gene expression between the control and treated sample was 
calculated by: 
Relative gene expression = 2-∆∆Ct   
where ∆∆Ct = ∆Ct(treated sample) – ∆Ct(control sample) 
 
In experiments where there was an indirect biological comparator, for example the in 
vivo endoglin knockdown experiments then the gene expression relative to the 
internal reference genes was calculated by: 
Relative gene expression = 2-∆Ct   
2.10 Statistical analysis. 
Statistical analysis was performed using Minitab 15 statistical software. All graphs 
were drawn either in Minitab or using Microsoft Excel. For direct comparison 
between two experimental conditions an unpaired student’s t-test was performed. For 
comparison of three or more groups, analysis of variance (ANOVA) was performed. 
For multiple comparisons over time, repeat measure ANOVA was used and post hoc 
comparisons were made using Tukey-Kramer method. Agreement between methods 
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of measuring left ventricular mass was assessed using a Bland Altman analysis (Bland 
and Altman, 1999). 
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Chapter 3  Establishing mouse cardiac magnetic resonance imaging 
 
3.1 Introduction 
Advances in transgenic techniques have led to the increased use of genetically 
modified mouse models in the study of cardiovascular disease. Integral to this study is 
the assessment of myocardial structure and function. In vivo cardiac magnetic 
resonance imaging (MRI) is ideal for this assessment as it is non-invasive, has good 
spatial and temporal resolution and allows for longitudinal study. This spatial and 
temporal resolution allows for accurate assessment of cardiac function (Ruff et al., 
1998) and means that, compared to other methods for assessing cardiac function, 
fewer animals are required to provide adequate statistical power (Stuckey et al., 2008; 
Winter et al., 2008). This is in keeping with the need to reduce the numbers of 
animals used in research. Additionally, by altering tissue characteristics with contrast 
agents or using different pulse sequences further information about cardiac 
physiology and function can be gained. For example the T1 contrast agent gadolinium 
can be used to assess myocardial perfusion and infarct size (Chapon et al., 2008; 
Protti et al., 2010). Manganese enhanced MRI (MEMRI) can be used to investigate 
alterations in calcium homeostasis in vivo (Hu et al., 2001; Waghorn et al., 2008; 
Blain et al., 2013; Greally et al., 2013). The application of myocardial tag lines during 
cardiac MRI can reveal information about regional cardiac function and myocardial 
strain (Epstein et al., 2002; Liu et al., 2006; Alistair A. Young et al., 2006; Zhong et 
al., 2008).   
 
The acquisition of a 7T horizontal bore magnetic resonance system gave the ideal 
opportunity to introduce and develop preclinical CMR. The aims of these experiments 
were to set up preclinical mouse cardiac MRI at Newcastle University, to demonstrate 
that we could reliably obtain images with good spatial and temporal resolution, to 
demonstrate that we could use these images to accurately and reproducibly measure 
cardiac mass and function and finally to use this technique to investigate changes in 
cardiac function in mouse models of heart disease. This work was done in 
collaboration with Miss Elizabeth Greally, a research technician within the Institute of 
Genetic Medicine, and also involved a series of short visits to the laboratory of Dr 
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Jurgen Schneider at the University of Oxford, who has considerable expertise in this 
technique. 
 
In this chapter I will discuss the rationale of the approach we took to optimise the 
acquisition of cine cardiac images. Secondly, I will present the experimental 
validation of cardiac MRI. Finally, I will demonstrate the use of cardiac MRI to 
measure cardiac function in three different experimental models of heart disease. The 
work done in developing mouse CMR has led to a number of publications using this 
technique (Jorgensen et al., 2011; Blain et al., 2013; Greally et al., 2013). 
 
3.2 Methods and Results 
3.2.1 Optimising mouse cardiac MRI 
The aim of optimising mouse cardiac MRI was to produce reproducible, good quality 
images that could be manually segmented to provide accurate measurements of 
cardiac mass and function in mouse models of cardiovascular disease. So when 
establishing this technique there were several factors we needed to take into 
consideration to achieve this. 
 
3.2.1.1 Anaesthetic 
Mice were to be anaesthetised for the duration of the MRI scan using isoflurane (the 
choice of anaesthetic agent is discussed in section 1.8.2.3) using a facemask (as 
described in section 2.3). During MRI experiments, which took approximately 45 
minutes, I observed no significant variability in heart rate over the course of the scans 
(ANOVA p=0.98), figure 3.1. 
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Figure 3.1 Heart rate variability during cardiac MRI. 
The heart rate for each mouse (n=10) under isoflurane anaesthesia was recorded at the start of 
acquisition of each short axis image taken. Typically 9 short axis images were obtained to cover the 
whole left ventricle. Each short axis image took approximately 2 minutes to aquire and so the data 
represents the heart rate stability over 18 minutes. There was no significant difference in mean heart 
rate over the duration of the scan (ANOVA p=0.98). Data expressed as individual value plots with 
mean value (○).  
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3.2.1.2 Image planning 
To be able to accurately assess cardiac function using MRI the imaging planes need to 
correspond to the axes of the heart. These axes are short axis (figure 3.2D), horizontal 
long axis (also known as 4 chamber view, figure 3.2E) and vertical long axis (also 
known as 2 chamber view, figure 3.2F). However, these planes lie at a double oblique 
angle to the normal scanner coordinate system (axial, coronal and sagittal). In order to 
correctly plan these planes we followed the method described by Schneider et al. 
(Schneider et al., 2006) as shown in figure 3.2. An axial scout scan is taken (figure 
3.2A) followed by a single, longitudinal slice (s1, figure 3.2B) orientated through both 
ventricles as shown in figure 3.2A. A second, single slice scan (s2, figure 3.2C), 
perpendicular to s1 and orientated through the apex of the left ventricle (figure 3.2B), 
is obtained. By orientating a slice (s3) perpendicular to both s1 and s2 a true short axis 
image can be obtained (figure 3.2D). The horizontal long axis (s4, figure 3.2D) is 
planned by orientating a slice through the left and right ventricle, as shown in figure 
3.2D, and orthogonal to s3 (figure 3.2C). Finally, the vertical long axis (s5, figure 
3.2F) is planned by an image plane which is orthogonal to both the short and 
horizontal long axes (figure 3.2D and E). Figure 3.3 shows these image planes in both 
diastole (A-C) and systole (D-F). To calculate left ventricular mass and function a 
series of multi frame (cine) images are obtained covering the whole of the left 
ventricle from base to apex (figure 3.4).
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Figure 3.2 Planning the cardiac planes. 
As described in Schneider at al I took an axial scout image (A). Then a single, longitudinal slice (s1) 
orthogonal to the axial image and orientated through both ventricles was obtained (B). A second 
longitudinal slice (s2) orthogonal to s1 and orientated through the apex of the left ventricle was 
acquired (C). Finally, the cardiac short axis (s3, D), horizontal long axis (s4, E) and vertical long axis 
(s5, F) were generated (Schneider et al., 2006). 
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Figure 3.3 The cardiac axes. 
Representative cardiac MRI images of the mouse heart in short axis (A, D), horizontal long axis (B, E) 
and vertical long axis (C, F) in both diastole (A-C) and systole (D-F). 
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Figure 3.4 Cardiac MRI of the mouse heart from base to apex. 
A contiguous stack of 1mm short axis slices in end diastole from the base (A) to apex (I) of the mouse 
heart. 
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3.2.1.3 Image parameters 
When performing mouse cine cardiac MRI using a FLASH pulse sequence it is 
recommended that the echo time is short, approximately 1-2ms and the repetition time 
is 5ms or less (Schneider et al., 2006), as this allows good temporal resolution of the 
moving myocardium. We chose the minimum echo time possible, which was 1.43ms, 
and a repetition time of 5ms. However, there are no such recommendations for other 
imaging parameters such as the field of view, the size of the data matrix or the use of 
signal averaging. When deciding on these parameters it is important to balance the 
quality of the image against the time taken to acquire the image. For example, 
increasing the data matrix from 128x128 to 256x256 will increase the resolution of 
the image but it will reduce the signal to noise ratio by a factor of 4 and take twice as 
long to acquire. To improve the image signal averaging can also be used but again this 
increases the acquisition time and the signal is only increased by the square root of the 
number of averages. So four signal averages will increase the scan time four fold but 
will only improve the signal to noise ratio two fold. So the decision as to which image 
parameters to use is a compromise between image resolution, signal to noise ratio and 
total scan time. 
 
I took a heuristic approach to investigate what these parameters should be. As the 
accuracy of LV measurements was dependent on the image resolution, the criteria I 
chose were that the images should demonstrate sufficient endocardial and epicardial 
definition to enable manual segmentation of the left ventricular myocardium. The 
same short axis slice, at the level of the mid left ventricle, was obtained with varying 
parameters as shown in figure 3.5. There is improved resolution in the images using 
the 256x256 matrix but there is also the expected reduction in signal to noise ratio 
(figure 3.5B&D). The use of four signal averages improves the image quality (figure 
3.5 C, D) with both these images having good endocardial and epicardial definition, 
equally enabling left ventricular segmentation. However, the times taken to obtain 
these images were approximately 1minute (figure 3.1A), 2 minutes (figure 3.1B & C) 
and 4 minutes (figure 3.1D).  So, using a 128x128 data matrix and 4 signal averages 
(figure 3.5C), the time taken to acquire a stack of short axis slices would be about 20 
minutes. Whereas, using a 256x256 data matrix and four signal averages (figure 3.5D), 
would double the total scan time. Therefore, I chose a data matrix of 128x128 with 
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four signal averages (figure 3.5C) as the best compromise between image resolution, 
signal to noise and total imaging time. To enhance the ease of manual segmentation of 
the left ventricle the data was zero filled by a factor of 2 to give a final matrix size of 
256 x 256 and an in plane reconstructed pixel resolution of 100 x 100 µm2. 
 
 
 
 
Figure 3.5 The effect of data matrix size and signal averaging on image quality. 
Increasing the matrix size (B and D) increases the resolution of the image but at the expense of signal 
to noise ratio and increased scan time. Increasing the number of signal averages (C and D) improves 
the signal to noise ratio but at the expense of increased scan time. I chose a data matrix of 128x128 
with four signal averages (C) as the best compromise between image resolution, signal to noise and 
total imaging time. FOV=25.6×25.6 mm.
Imaging time = 1 minute 
Resolution 200×200µm 
Imaging time = 4 minutes 
Resolution 100×100µm 
 
Imaging time = 2 minutes 
Resolution 100×100µm 
 
Imaging time = 2 minutes 
Resolution 200×200µm 
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3.2.1.4 Physiological gating 
Cardiac MR is severely affected by cardiac and respiratory motion artefacts. I used 
prospective cardiac gating which is needed to synchronise the pulse sequence to the 
cardiac cycle and at 7T respiratory gating improves image quality. The maintenance 
of a steady state level of magnetisation during respiration without acquiring image 
data has also been shown to improve image quality (Cassidy et al., 2004). 
 
With our hardware set up we had the following options: 
1. No gating. 
2. Cardiac gating alone. 
3. Cardiac and conventional respiratory gating whereby the pulse sequence is not 
triggered during respiration. The result of this is a stop/start acquisition and 
can lead to modulation of signal strength affecting contrast and image clarity 
(Cassidy et al., 2004). The cause of this modulation is T1 recovery of 
magnetisation during respiration and can be improved by the maintenance of a 
steady state of magnetisation (Cassidy et al., 2004).  
4. Cardiac and respiratory gating with maintenance of a steady state level of 
magnetisation, whereby the pulse sequence is triggered by every heart beat but 
the data is not collected during respiration. 
 
In order to determine the preferred gating strategy I first acquired a single frame short 
axis image, using each of the 4 strategies in turn. To ensure that the effects of image 
quality were only due to the gating strategy, the images were acquired without any 
signal averaging. The imaging parameters used were: field of view 25.6 x 25.6mm, 
data matrix 128 x 128, echo time = 1.43ms, repetition time = R-R interval 
(approximately 140ms), flip angle 60° and number of averages = 1. Then to 
demonstrate the effects on the cine images I acquired multi frame, short axis images 
using my standard cine imaging parameters: field of view 25.6 x 25.6mm, data matrix 
128 x 128, echo time = 1.43ms, repetition time = 5ms, flip angle = 15° and number of 
averages = 4. Figure 3.6 confirms that cardiac gating (option 2) is essential to generate 
quality images and demonstrates that, at 7T, respiratory gating (option 3) improves 
the image quality with further improvements following maintenance of a steady state 
of magnetisation (option 4). This improvement appears to be less obvious in cine 
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images most likely due to the use of signal averaging in the acquisition of these 
images. 
 
In summary, the experiments described in this section demonstrated that I was able to 
orientate the imaging plane to the correct axes of the heart and obtain cine images of 
the heart. For all experiments described in this thesis I used cardiac and respiratory 
gating and the following parameters: echo time 1.43ms, repetition time 5ms, flip angle 
15°, number of signal averages 4, field of view 25.6 x 25.6mm, data matrix 128 x 128 
(zerofilled to 256 x 256, giving an in plane resolution of 100 x 100µm2), slice 
thickness 1mm. Once I had established this setup I proceeded to validate the data 
obtained from cardiac MRI. 
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Figure 3.6 The effect of physiological gating on image quality. 
A-D. A single frame short axis image was acquired at the level of the papillary muscles with no gating (A), cardiac gating only (B), cardiac and conventional respiratory 
gating (C) and cardiac and respiratory gating with steady state (D). The imaging parameters were TE = 1.43ms, TR = one heart beat (approx 140ms), flip angle = 60° and 
number of averages = 1. E-F. Multi frame (cine) short axis images were obtained at the level of the papillary muscle. End diastolic frames are shown with no gating (E), 
cardiac gating only (F), cardiac and conventional respiratory gating (G) and cardiac and respiratory gating with steady state (H Imaging parameters: FOV 25.6x2 5.6mm, 
matrix 128x128 (zerofilled to 256x256), TE = 1.43ms, TR = 5ms, flip angle 15°, NA= 4. 
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3.2.2 Validation of MRI for the measurement of cardiac mass and function. 
To validate cardiac MRI it was necessary to show that I could accurately and 
reproducibly measure left ventricular mass and function. To achieve this I repeated an 
experiment performed by Ruff et al. (Ruff et al., 1998). Cine cardiac MRI was 
performed on nine C57BL/6 (7 male, 2 female) mice between 8 and 12 weeks old. A 
stack of short axis cine images covering the whole left ventricle was obtained. 
Following acquisition of the images the mice were euthanized, the hearts were 
dissected and the left ventricle isolated, washed in PBS to remove excess blood and 
blotted dry. The autopsy left ventricular mass was then recorded. Analysis of the MRI 
images was performed using ImageJ software. The parameters measured were left 
ventricular myocardial volumes in diastole and systole, end diastolic volume (EDV) 
and end systolic volume (ESV). From these measurements left ventricular mass, 
stroke volume (SV), ejection fraction (EF) and cardiac output (CO) were calculated. 
To compare the agreement between the LV mass measured at autopsy and by MRI, a 
Bland Altman analysis was performed (Bland and Altman, 1986). Intra-observer 
variability was assessed by analysing the MRI images on two separate occasions. 
 
The autopsy and MRI results are shown in table 3.1. They reveal no significant 
differences between autopsy mass (90.4 ± 5.7mg) and either MRI mass calculated at 
end diastole (88.7 ± 5.0mg, p=0.50) or MRI mass calculated at end systole (89.3 ± 
7.1mg, p=0.73). There was significant correlation between autopsy mass and MRI 
mass calculated at end diastole (r=0.92 p<0.001) and end systole (r=0.91, p=0.001). 
Bland Altman analysis demonstrated good agreement between autopsy and MRI 
myocardial mass with a mean difference (autopsy minus MRI) of 1.4 ± 2.6mg with 
limits of agreement -3.7mg to 6.5mg (figure 3.7). The left ventricular functional 
parameters (mean ± SD) were heart rate 504 ± 55 beats per minute, end diastolic 
volume 48.3 ± 4.8µl, end systolic volume 12.5 ± 4.5µl, stroke volume 35.8 ± 5.0µl, 
ejection fraction 74 ± 8%, and cardiac output 18 ± 2.8ml/min. The results 
demonstrated low intra-observer variability with an intra-observer variability for LV 
mass of 2.5 ± 1.8% at end diastole and 2.9 ± 1.9% at end systole. Intra-observer 
variability for functional parameters were: end diastolic volume 2.5 ± 1.0%, end 
systolic volume 6.4 ± 3.5%, stroke volume 3.8 ± 2.0%, ejection fraction was 2.2 ± 
1.7% and cardiac output 3.8 ± 2.0% (table 3.2). 
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These results demonstrate that I was able to accurately measure left ventricular mass 
and function using cardiac MRI. This provides a powerful, in vivo tool to accurately 
phenotype heart structure and function in cardiac disease models.  
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Table 3.1 Autopsy and MRI analysis of left ventricular mass, volumes and function in normal C57Bl/6 mice. 
(LV=left ventricle, bpm=beats per minute, EDV=end diastolic volume, ESV=end systolic volume, SV=stroke volume, EF=ejection fraction and CO=cardiac output) 
Mouse 
(gender) 
Age 
(weeks) 
LV mass (autopsy) 
(mg) 
LV mass (diastole) 
(mg) 
LV mass (systole) 
(mg) 
Heart rate 
(bpm) 
EDV 
(µl) 
ESV 
(µl) 
SV 
(µl) 
EF 
(%) 
CO 
(ml/min) 
1 (M) 
2 (M) 
3 (M) 
4 (F) 
5 (F) 
6 (M) 
7 (M) 
8 (M) 
9 (M) 
10 
10 
10 
9 
9 
10 
10 
11 
13 
100 
92.3 
95.5 
86.3 
83.0 
86.7 
94.0 
92.0 
84.0 
97.5 
86.7 
93.7 
83.9 
84.1 
85.4 
93.6 
88.1 
85.2 
98.9 
86.6 
97.6 
84.4 
78 
88.6 
96.7 
89.1 
84.2 
590 
550 
470 
490 
560 
515 
490 
420 
450 
44.7 
47 
46.2 
52.8 
41.2 
45.3 
57.0 
50.1 
50.5 
10.5 
14.9 
15.2 
21.2 
8.0 
6.3 
10.1 
14.1 
12.1 
34.2 
32.1 
31.0 
31.7 
33.2 
39.0 
46.9 
36.0 
38.4 
76 
68 
67 
60 
80 
86 
82 
71 
76 
20.2 
17.6 
14.6 
15.5 
18.6 
20.1 
23.0 
15.1 
17.3 
Mean 
± SD 
10 
± 1.2 
90.4 
± 5.7 
88.7 
± 5.0 
89.3 
± 7.1 
504 
± 55 
48.3 
± 4.8 
12.5 
± 4.5 
35.8 
± 5.0 
74 
± 8 
18.0 
± 2.8 
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Figure 3.7 Bland-Altman plot (difference versus mean) of left ventricular mass at autopsy 
compared to MRI (n=9). 
The mean difference between these two methods was 1.4mg and the limits of agreement -3.7 to 6.5mg, 
demonstrating good agreement between these methods. 
 
 
  
Table 3.2 Intra-observer variability in measurements of left ventricular volumes and mass. 
I analysed the raw MRI data from 9 hearts on 2 independent occasions to determine the reproducibility 
of the calculated measurements. Data expressed as mean ± SD. 
Measurement Intra-observer variability (%) 
Diastolic mass 
Systolic mass 
End diastolic volume 
End systolic volume 
Stroke volume 
Ejection fraction 
Cardiac output 
2.5 ± 1.8 
3.0 ± 1.9 
2.5 ± 1.0 
6.3 ± 3.5 
3.8 ± 2.0 
2.2 ± 1.7 
3.8 ± 2.0 
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3.2.3 Cardiac MRI in mouse models of cardiac disease 
To test whether we could use MRI to investigate differences in cardiac structure and 
function in models of cardiac disease I performed cardiac MRI in three mouse 
models: 
1. Myocardial infarction model. 
2. Adult stem cell mediated cardiac repair post MI model. 
3. Muscular dystrophy related cardiomyopathy in the delta sarcoglycan deficient 
mouse (a model of limb girdle muscular dystrophy type 2F). 
3.2.3.1 Mouse myocardial infarction model 
To evaluate the use of MRI as a means of tracking heart function following 
myocardial infarction, I performed cardiac MRI 4 weeks following permanent LAD 
ligation (as described in chapter 2). Controls were mice that had undergone a sham 
operation (a thoracotomy without LAD ligation). The surgical operations for this 
experiment were performed by Dr Rachael Redgrave. 
 
The MRI images in figure 3.8 clearly demonstrate increased sphericity of the left 
ventricle with myocardial wall thinning and akinesis in the anterolateral and apical 
walls of the infarcted left ventricle. Comparison of cardiac function can be seen in 
table 3.3. These data reveal that compared to sham operated mice there are significant 
increases in myocardial mass (122.29 ± 9.18mg vs. 111.93 ± 4.87mg, p =0.01), end 
diastolic volume (116.65 ± 36.24µl vs. 66.35 ± 5.51µl, p=0.001) and end systolic 
volume (85.08 ± 39.62µl vs. 21.79 ± 2.41µl, p<0.001) in the mice that had undergone 
LAD ligation. In addition, there are also significant reductions in stroke volume 
(30.39 ± 4.12µl vs. 44.55 ± 4.12 µl, p<0.001), ejection fraction (26.63 ± 8.84% vs. 
67.14 ± 2.59%, p<0.001) and cardiac output (12.57 ± 2.27ml/min vs. 18.22 ± 
2.25ml/min, p<0.001) following LAD ligation. There were no significant differences 
in mean heart rate (416 ± 38bpm vs. 409 ± 27bpm, p=0.6). 
 
There is a significant difference in pre surgery weights between the groups (25.46 ± 
2.73 in the infarct group vs. 29.01 ± 3.56 in the sham group, p=0.03). This is most 
likely due to the different numbers of each sex in this experiment. There were 5 males 
and 3 females in the sham group and 3 males and 7 females in the infarct group. To 
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account for this difference I indexed the measurements made to the body weight of 
the animal (table 3.3). I chose the pre-operative weight of the animal to index the 
measurement to in order to eliminate any effect of the operative procedure or 
subsequent heart failure on body weight. In agreement with the non-indexed 
measurement there was a significant increase in myocardial mass index (4.95 ± 
0.65mg/g vs. 3.89 ± 0.51mg/g, p=0.002), end diastolic volume index (4.79 ± 1.75 µl/g 
vs. 2.32 ± 0.43µl/g, p=0.001) and end systolic volume index (3.52 ± 1.80µl/g vs. 0.76 
± 0.15µl/g, p< 0.001) in the mice with LAD ligation compared to sham controls. 
There was also a significant reduction in stroke volume index (1.27 ± 0.16µl/g vs. 
1.56 ± 0.30µl/g, p=0.02) and a trend towards a reduction in cardiac index (0.53 ± 
0.08ml/min/g vs. 0.64 ± 0.15ml/min/g, p=0.06) in the LAD ligation group. 
 
The mean infarct size in the LAD ligation group was 34.29 ± 7.94%. There was an 
inverse linear relationship (slope = -1.296) and strong inverse correlation between 
infarct size and ejection fraction (figure 3.9, r=-0.96, p<0.001). This confirms that the 
larger myocardial infarction the greater reduction in left ventricular systolic function. 
 
These data confirm left ventricular hypertrophy with dilatation and a reduction in 
systolic function occurred in mice by 4 weeks following permanent LAD ligation, and 
agrees with expected outcomes (Wiesmann et al., 2001b; Ross et al., 2002; Yang et 
al., 2004). 
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Table 3.3 Cardiac function post MI. 
Cardiac functional parameters in mice 4 weeks following coronary artery ligation (n=10) or sham 
operation (n=8). Data expressed as mean ± standard deviation, statistical comparisons made using 
unpaired Student’s ttest. 
 Sham Infarct p value 
Sex 5M 3F 3M 7F n/a 
Body weight – pre surgery (g) 29.20 ± 4.07 24.96 ± 2.83 0.02 
Body weight – pre MRI (g) 29.01 ± 3.6 25.03 ± 2.91 0.02 
Age at infarct (wks) 12.38 ± 1.33 12.00 ± 1.27 0.55 
Time to MRI (days) 26 ± 2.45 27.70 ± 3.89 0.3 
Mean heart rate (bpm) 409 ± 27 416 ± 38 0.6 
Mean myocardial mass (mg) 111.93 ± 4.87 122.29 ± 9.18 0.01 
Myocardial mass index (mg/g) 3.89 ± 0.51 4.95 ± 0.65 0.002 
End diastolic volume (µl) 66.35 ± 5.51 116.65 ± 36.24 0.001 
End diastolic volume index (µl/g) 2.32 ± 0.43 4.79 ± 1.75 0.001 
End systolic volume (µl) 21.79 ± 2.41 85.08 ± 39.62 <0.001 
End systolic volume index (µl/g) 0.76 ± 0.15 3.52 ± 1.80 <0.001 
Stroke volume (µl) 44.55 ± 4.12 30.39 ± 4.12 <0.001 
Stroke volume index (µl/g) 1.56 ± 0.30 1.27 ± 0.16 0.02 
Ejection fraction (%) 67.14 ± 2.59 26.63 ± 8.84 <0.001 
Cardiac output (ml/min) 18.22 ± 2.25 12.57 ± 2.27 <0.001 
Cardiac index (ml/min/g) 0.64 ± 0.15 0.53 ± 0.08 0.06 
Infarct size (%LV) n/a 34.29 ± 7.94 n/a 
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Figure 3.8 MRI images of a representative mouse hearts 4 weeks following sham operation (A-F) or LAD ligation (G-L). 
The arrows identify the thinned, akinetic area of the myocardial infarct. Imaging parameters: FOV 25.6x2 5.6mm, matrix 128x128 (zerofilled to 256x256), TE = 1.43ms, TR 
= 5ms, flip angle 15°, NA= 4.
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Figure 3.9 Relationship between infarct size and ejection fraction. 
There is an inverse linear relationship between infarct size and ejection fraction (slope = -1.296) and a 
strong inverse correlation (r=-0.96, p<0.001). 
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3.2.3.2 Adult stem cell mediated cardiac repair model 
The aim of this project was to investigate the effect of endoglin depletion on the 
ability of an adult stem cell to mediate cardiac repair following myocardial infarction. 
Cardiosphere derived cells (CDCs) are grown from myocardial tissue and have been 
shown to have stem cell properties, are able to mediate cardiac repair following 
myocardial infarction and express endoglin (Messina et al., 2004; Smith et al., 2007). 
CDCs were isolated and expanded from murine hearts. Cre-lox technology (see 
chapter 4 for further information) was used to knockdown endoglin in these cells. 
Following permanent LAD ligation, CDCs (with or without endoglin knockdown) or 
sterile PBS was injected in the peri-infarct myocardium. They were then imaged by 
cardiac MRI at 1 and 4 weeks following LAD ligation. The CDC culture and surgical 
procedures were performed by Dr Rachael Redgrave in my host laboratory. I 
performed and analysed the cardiac MRI. 
 
Representative short and long axis cardiac MR images for sham operated, infarct 
alone group, infarct with CDCs group and infarct with endoglin knockdown (Eng 
iKOu) CDCs 4 weeks following surgery are shown in figure 3.10 A to D respectively. 
These images clearly demonstrate that there is left ventricular enlargement following 
myocardial infarction but that this is attenuated by cell transplantation. The results of 
analysis of the cardiac MRI data are shown in table 3.4 and figure 3.11. These 
demonstrate a difference between the sham operated and all infarct groups and that 
the mean left ventricular volumes were smaller in the CDC treated groups compared 
to the infarct only group but this difference is not statistically significant. The main 
effect of cell transplantation is the significant attenuation adverse remodelling 
compared to the infarct alone group table 3.5 (ANOVA p<0.05). These results 
demonstrate that CDC transplantation have a beneficial effect on cardiac function. 
However, both CDCs with and without endoglin appear to be equally beneficial in 
reducing the adverse remodelling seen following myocardial infarction.  
 
This study demonstrates that cardiac MRI is able to longitudinally measure 
ventricular function and assess the effects of different therapies on cardiac function.
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Figure 3.10 Cardiac MRI of representative mice 4 weeks following coronary artery ligation and cell therapy. 
A. sham operated control. B. Coronary artery ligation alone. C. Coronary artery ligation with endoglin positive CDCs. D. Coronary artery ligation with endoglin knockdown 
CDCs. Imaging parameters: FOV 25.6x2 5.6mm, matrix 128x128 (zerofilled to 256x256), TE = 1.43ms, TR = 5ms, flip angle 15°, NA= 4.
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Table 3.4 Cardiac function 1 and 4 weeks following coronary artery ligation with or without cell therapy. 
Left ventricular volumes were smaller and ejection fraction greater in the infarct with CDC transplantation groups compared to the infarct and PBS treated group but these 
differences were not significant using parametric ANOVA. Data expressed as mean ± SE. 
 1 week 4 weeks 
 Sham operation 
(n=4) 
MI + PBS 
(n=3) 
MI + CDCs (n=6) MI + Eng iKOu 
CDCs (n=4) 
Sham operation 
(n=4) 
MI + saline (n=3) MI + CDCs (n=6) MI + Eng iKOu 
CDCs (n=4) 
Weight 
(g) 23.8 ± 2.3 23.2 ± 1.5 25.5 ± 0.9 25.5 ± 3.2 26.3 ± 2.4 25.5 ± 2.0 28.3 ± 1 28.9 ± 2.8 
Mean HR 
(bpm) 423 ± 15 429 ± 28 448 ± 24 432 ± 9 425 ± 11 420 ± 7.9 456 ± 15 440 ± 15 
Mean mass 
(mg) 113 ± 6.1 146 ± 18 136 ± 4.3 146 ± 7.5 121 ± 8.7 167 ± 22 144 ± 4.7 159 ± 9.3 
Mass index 
(mg/g) 4.4 ± 0.2 5.8 ± 0.6 4.6 ± 0.2 5.18 ± 0.6 4.7 ± 0.3 6.6 ± 0.9 4.9 ± 0.2 5.7 ± 0.8 
EDV 
(µl) 66.3 ± 3.6 146.3 ± 24.6 125.8 ± 14.8 124.9 ± 20.8 72.9 ± 4.1 210.5 ±27.3 153.1 ± 17.2 153.9 ± 30.1 
EDVI 
(µl/g) 2.6 ± 0.2 5.8 ± 0.9 4.2 ± 0.5 4.6 ± 1.2 2.9 ± 0.2 8.4 ± 1.1 5.2 ± 0.6 5.7 ± 1.6 
ESV 
(µl) 20.5 ± 1.5 119.4 ± 20.7 87.7 ±15.4 87.4 ± 25.6 23.3 ± 2.2 171.3 ± 20.4 110.6 ± 20.7 111.7 ± 37.7 
ESVI 
(µl/g) 0.81 ± 0.08 4.7 ± 0.7 3.0 ± 0.5 3.3 ± 1.3 0.9 ± 0.04 6.8 ± 0.9 3.9 ± 0.7 4.28 ± 1.8 
SV 
(µl) 45.7 ± 2.3 26.9 ± 4.0 36.7 ± 4.2 37.5 ± 6.6 44.7 ± 6.1 39.2 ± 7.6 41.2 ± 4.9 42.2 ± 8.0 
SVI 
(µl/g) 1.79 ± 0.1 1.1 ± 0.1 1.2 ± 0.1 1.3 ± 0.1 1.97 ± 0.2 1.6 ± 0.3 1.43 ± 0.1 1.4 ± 0.2 
EF 
(%) 69.1 ± 1.0 18.6 ± 0.8 32.0 ± 6.3 33.4 ± 7.9 67.9 ± 3.0 18.4 ± 1.7 30.8 ± 6.1 35.1 ± 10.6 
CO 
(ml/min) 19.4 ± 1.3 11.7 ± 2.2 16.1 ± 1.4 16.1 ± 2.6 21.2 ± 2.2 16.5 ± 3.3 19.2 ± 1.9 18.3 ± 3.2 
CI 
(ml/min/g) 0.76 ± 0.03 0.5 ± 0.08 0.5 ± 0.04 0.5 ± 0.04 0.84  ± 0.1 0.7 ± 0.1 0.7 ± 0.06 0.6 ± 0.07 
Infarct size 
(%) n/a 50.2 ± 4.73 40.1 ± 3.69 38.2 ± 6.5 n/a 51.8 ± 1.9 42.1 ± 4.7 38.3 ± 6.8 
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Table 3.5 Change in cardiac functional parameters between 1 and 4 weeks following coronary 
artery ligation with or without cell therapy. 
Using ANOVA there was a significant attenuation in the increase in EDV (and EDVI) between the 
groups. The difference was significant between the MI+PBS and endoglin positive CDC groups, but 
not between MI+PBS and endoglin knockdown CDC groups (this was likely due to smaller numbers in 
the endoglin knockdown CDC group). Data expressed as mean ± SE, *p<0.05 compared to MI+PBS 
 
Sham 
operation 
(n=4) 
MI + PBS 
(n=3) 
MI + CDCs 
(n=6) 
MI + Eng 
iKOu CDCs 
(n=4) 
p value 
(ANOVA) 
∆Mean HR 
(bpm) 
1.5 ± 25 -8.3 ± 32 8.5 ± 19.7 7.8 ± 13.7 0.9 
∆Mean mass 
(mg) 
7.9 ± 2.7 21.7 ± 7.0 8.5 ± 1.7 12.8 ± 4.5 0.1 
∆Mass index 
(mg/g) 
0.3 ± 0.1 0.9 ± 0.3 0.3 ± 0.05 0.5 ± 0.2 0.1 
∆EDV 
(µl) 
6.7 ± 1.1 64.2 ± 12.8 27.3 ± 5.5* 29.0 ± 11.2 0.041 
∆EDVI 
(µl/g) 
0.3 ± 0.06 2.6 ± 0.6 1.0 ± 0.2* 1.1 ± 0.5 0.048 
∆ESV 
(µl) 
2.7 ± 2.7 51.9 ± 12.0 23.0 ± 7.6 24.3 ± 12.8 0.2 
∆ESVI 
(µl/g) 
0.1 ± 0.1 2.1 ± 0.6 0.9 ± 0.3 1.0 ± 0.6 0.17 
∆SV 
(µl) 
-1.3 ± 6.8 12.4 ± 3.9 4.5 ± 4.8 4.7 ± 0.1 0.5 
∆SVI 
(µl/g) 
0.2 ± 0.2 0.5 ± 0.2 0.2 ± 0.2 0.2 ± 0.08 0.3 
∆EF 
(%) 
-1.2 ± 7.8 -0.2 ± 2.1 -1.26 ± 3.4 1.8 ± 3.8 0.8 
∆CO 
(ml/min) 
1.9 ± 2.2 4.86 ± 1.1 3.1 ± 2.4 2.3 ± 1.1 0.7 
∆CI 
(ml/min/g) 
-0.004 ± 0.07 0.2 ± 0.04 0.1 ± 0.08 0.08 ± 0.04 0.6 
∆Infarct size 
(%) 
n/a 1.6 ± 3.5 2.1 ± 1.7 0.08 ± 0.9 0.2 
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Figure 3.11 Cardiac volumes and function 1 and 4 weeks following coronary artery ligation with or without cell therapy. 
*p<0.05. 
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3.2.3.3 Muscular dystrophy related cardiomyopathy. 
In order to evaluate another independent mouse model of cardiomyopathy by cardiac 
MRI, I turned to a model of muscular dystrophy that was being used for studies within 
my host Institute. Muscular dystrophies are frequently associated with 
cardiomyopathies (Bushby et al., 2003). The δ-sarcoglycan deficient mouse (Scgd-/-) 
is a model for limb girdle muscular dystrophy type 2F. Patients with this type of 
muscular dystrophy can develop a progressive and potentially fatal cardiomyopathy 
(Politano et al., 2001). The Scgd-/- mouse develops cardiac pathology from about 16 
weeks of age (Coral-Vazquez et al., 1999) and in vivo studies have demonstrated 
alterations in cardiac function at 16 (Bauer et al., 2008) and 32 (Wansapura et al., 
2011) weeks of age. The effects of a number of treatments used clinically for the 
treatment of both muscular dystrophies and heart failure have been assessed by 
colleagues in my host Institute (Bauer et al., 2008; Bauer et al., 2010a; Bauer et al., 
2010b). However, longitudinal studies using cardiac MRI in these mice would enable 
investigation of the onset and progression of the cardiomyopathy, as well as gaining 
understanding into alterations in calcium homeostasis by using manganese enhanced 
MRI, as discussed in chapter 1 (Hu et al., 2001).  
 
32 week old, male Sgcd-/- and 40 week old, control male C57BL/10 mice underwent 
cine cardiac MRI (n=16 and 9 respectively) as described in section 2.3. The results 
(table 3.6) show that the Sgcd-/- mice had higher heart rates (487 ± 30bpm vs. 385 ± 
41 bpm, p<0.001) and an increased left ventricular mass (126.19 ± 11.62mg vs. 112 ± 
8.37mg, p=0.004) than the control mice. However, there is a trend towards a reduced 
left ventricular end diastolic volume (63.25 ± 14.46µl vs. 74.11 ± 9.18µl, p=0.055) 
and a significantly smaller end systolic volume (21.25 ± 7.16µl vs. 27.67 ± 5.34µl, 
p=0.028) in the Sgcd-/- mice. There is no significant difference in stroke volume 
(42.06 ± 8.49µl vs. 46.46 ± 5.77µl, p=0.17), ejection fraction (67.19 ± 5.91% vs. 
63.00 ± 4.97%, p=0.086) or cardiac output (20.39 ± 4.17ml/min vs. 17.79 ± 
2.53ml/min, p=0.10). These data suggest that at this age Sgcd-/- mice had developed 
left ventricular hypertrophy but had preserved systolic function. 
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Table 3.6 Cardiac function in Sgcd-/- mice. 
Cardiac functional parameters in 32 week old male Sgcd-/- mice (n=16) and 40 week old, male 
C57Bl/10 mice (n=9). Data expressed as mean ± standard deviation, statistical com parison was made 
using unpaired Student’s ttest. 
 C57BL/10 Sgcd-/- p value 
Mean heart rate (bpm) 385 ± 41 487 ± 30 <0.001 
Mean myocardial mass (mg) 112.00 ± 8.37 126.19 ± 11.62 0.004 
End diastolic volume (µl) 74.11 ± 9.18 63.25 ± 14.46 0.055 
End systolic volume (µl) 27.67 ± 5.34 21.25 ± 7.16 0.028 
Stroke volume (µl) 46.46 ± 5.77 42.06 ± 8.49 0.17 
Ejection fraction (%) 63.00 ± 4.97 67.19 ± 5.91 0.086 
Cardiac output (ml/min) 17.79 ± 2.53 20.39 ± 4.17 0.10 
 
3.3 Discussion 
The ability to measure in vivo cardiac function is important in cardiovascular research. 
Cine cardiac MRI is a widely used technique to do this. The aim of this study was to 
establish cardiac MRI to allow its use in the study of models of cardiac disease. Using 
a heuristic approach I was able to quickly define optimal imaging parameters. These 
parameters are similar to previously published studies that used a gradient echo 
FLASH pulse sequence (table 3.7). I validated this technique and demonstrated that I 
was able to accurately and reproducibly measure myocardial mass and cardiac 
function in mice. 
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Table 3.7 Summary of MRI imaging parameters in a selection of studies using a FLASH pulse 
sequence in murine cardiac MRI. 
(TE – echo time, TR – repetition time, FOV – field of view, NA – number of signal averages, ns – not 
stated) 
Study 
TE 
(ms) 
TR 
(ms) 
Flip 
angle 
(°) 
FOV 
(mm) 
Matrix 
size 
NA 
Field 
strength 
(T) 
This thesis 1.43 5 15 
25.6 x 
25.6 
128 x 
128 
4 7 
(Ruff et al., 1998) 1.6 4-11 40 30 x 30 
256 x 
256 
2 7 
(Schneider et al., 
2003) 
1.43 4.6 15 
25.6 x 
25.6 
256 x 
256 
2 11.7 
(Hu et al., 2004) 2.3 11.0 ns 25 x 25 
128 x 
128 
4 9.4 
(Winter et al., 
2008) 
1.9 7 15 
25.6 x 
25.6 
256 x 
256 
4 9.4 
(Wansapura et al., 
2011) 
3 5.2 20 
25.6 x 
25.6 
256 x 
256 
ns ns 
(Amundsen et al., 
2011) 
3 6 15 35 x 35 
128 x 
128 
ns 7 
(Smart et al., 
2011) 
1.18 4.5 20 
25.6 x 
25.6 
128 x 
128 
2 9.4 
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The earliest described multi-frame cardiac MRI used a spin echo pulse sequence and 
was able to achieve an in plane resolution of 117 x117 µm2 and a temporal resolution 
of approximately 24ms resulting in 8 frames being acquired to cover the cardiac cycle 
(Kubota et al., 1997). They demonstrated that LV mass measured gravimetrically and 
by MRI were linearly related with a mean error between the methods of 0.28±2.70 mg 
(Kubota et al., 1997). However, the nature of their spin echo pulse sequence meant 
they had to rotate the acquisition order of their multi-slice set in order to obtain multi-
frame images. The limiting factor with this method is the R-R interval as this 
determines how many slices can be obtained within one heart beat. They used sodium 
phenobarbital as the anaesthetic agent, which resulted in markedly lower heart rates (~ 
220 beats per minute, R-R interval ~270ms) in their mice (Kubota et al., 1997). 
Higher heart rates, such as those in our study (~500 beats per minute, R-R interval 
~120ms), would reduce the number of slices and time frames that could be obtained. 
 
The use of fast gradient echo pulse sequences (FLASH) enabled the use of shorter TE 
and TR without sacrificing special resolution (Haase et al., 1986).  Initial experiments, 
in mice, using a FLASH pulse sequence on a clinical MRI scanner at 1.5T had an in 
plane resolution of 195 x 195 µm2 and a temporal resolution of 39ms (Franco et al., 
1998). However, they used a slice thickness of 1.6mm, which would have been 
required to increase the signal as their magnetic field strength is lower. However, they 
still reported strong correlation and good agreement between gravimetric mass and 
MRI mass (Franco et al., 1998). At high field strength (7T), Ruff et al. were able to 
achieve an in plane resolution of 117 x117 µm2 (slice thickness 1mm) and a temporal 
resolution of between 4 and 11 ms. They altered the TR, depending on the heart rate, 
to achieve 12 frames per cardiac cycle, which resulted in the variable temporal 
resolution (Ruff et al., 1998). They validated their ability to measure small volumes 
with a water filled, glass phantom. However, it was 190µl, which is 4 times the mean 
end diastolic volume (45.2 ± 9.3µl). They demonstrate good agreement between 
gravimetric and MRI mass. Measurements of myocardial mass and function were 
reproducible (Ruff et al., 1998). Schneider et al. also demonstrated good agreement 
(mean difference 0.04mg and coefficient of variation ± 7.2) and reproducibility 
between cardiac mass and function using an 11.5T vertical magnet. They also 
demonstrate that the use of respiratory gating improved image quality (Schneider et 
al., 2003). 
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The results of my validation experiment are comparable to these previously published 
studies. However, the intra-observer variability for end systolic volume was higher in 
my study. This is likely due to my use of manual, rather than automatic (Ruff et al., 
1998; Schneider et al., 2003), segmentation to measure ventricular volumes. 
Interestingly, in the work described in this chapter the mean difference between the 2 
independent measurements of end diastolic and end systolic volumes were similar 
(1.7 ± 0.7µl vs. 1.1 ± 0.8µl respectively). However, as the end systolic volume is very 
small (12.5 ± 4.5µl) a small difference in volume results in greater percentage 
variability. Consequently, it is essential to ensure careful, accurate segmentation of 
the left ventricular cavity, particularly at end systole. To ensure this I routinely 
calculated the left ventricular mass in both systole and diastole and only accepted the 
measurements if there was less than 5% difference between the two measurements. 
 
Following myocardial infarction, cardiac function is impaired and left ventricular 
remodelling occurs. In mice undergoing infarct reperfusion injury there is a 
significant increase in ventricular volumes and reduced function by the first day 
following surgery (Yang et al., 2004). This reduction in function was not simply due 
to the size of the infarct as it was not strongly correlated with ejection fraction 
(r=0.53). Also Yang et al were able to demonstrate a reduction in regional function in 
myocardium remote from the infarct. This suggests that the early reduction in cardiac 
function is due to loss of viable myocardium and contractile dysfunction in non-
infarcted regions (Yang et al., 2004). In another study, Wiesmann et al. (Wiesmann et 
al., 2001b) demonstrated a reduction in cardiac function in mice two weeks following 
permanent LAD ligation but no difference in LV mass. A longitudinal study 
investigating left ventricular remodelling in mice following infarct reperfusion injury 
documented that most LV remodelling occurs in the first 4 weeks following injury 
(Ross et al., 2002). They also documented a 50% increase in LV mass 1 day 
following infarction with a trend towards further increases at later time points (Ross et 
al., 2002). However, inspection of their data gives the impression that there may be an 
increase in LV mass, peaking at one week post infarct followed by a slight reduction 
at two and four weeks post MI before an increased mass from six weeks onwards. 
This may reflect the resolution of initial myocardial oedema along side the left 
ventricular hypertrophy seen in ventricular remodelling. This might also account for 
the fact that Wiesmann did not see a difference in LV mass at 2 weeks post infarction. 
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The data presented in this chapter is consistent with these studies as I saw significant 
increases in ventricular volumes and myocardial mass and a significant reduction in 
cardiac function four weeks following permanent LAD ligation when compared to 
sham operated controls (summarised in table 5.8). In contrast to Yang et al. (Yang et 
al., 2004), at four weeks post infarct I demonstrated a significant correlation between 
infarct size and ejection fraction (r=-0.96, p<0.001). This is in agreement with a study 
by Schneider et al. which demonstrated significant correlation between infarct size 
and ejection fraction in their data (r=-0.91, p<0.01) and in that of Wiesmann et al 
(Wiesmann et al., 2001b) following a retrospective analysis (r=-0.95, p<0.01) 
(Schneider et al., 2003).  
 
One of the challenges of assessing cardiac function following myocardial infarction is 
the fact that the infarction results in myocardial deformation. An advantage of MRI is 
that it does not rely on geometric assumption when calculating myocardial mass and 
ventricular volumes and is considered to be the gold standard for these measurements 
(Siri et al., 1997; Ruff et al., 1998). However, other techniques such as 
echocardiography and cardiac conductance catheters are commonly used in published 
studies and are vulnerable to misinterpretation.  Two-dimensional echocardiography 
depends on geometric assumptions which may not be valid following myocardial 
infarction given the alterations in left ventricular geometry. A study comparing two-
dimensional echocardiography with MRI in both normal and chronically infarcted rat 
hearts demonstrated that measurements made by the two methods were correlated. 
However, cine-MRI measurements of ejection fraction were 12 ± 6% higher when 
compared to 2D echocardiography, which they attributed to the differences in 
temporal resolution (4.6ms for MRI and 8.3ms for echocardiography). A higher 
temporal resolution results in more images obtained per cardiac cycle meaning you 
would be more likely to image true end diastole and end systole. They also found that 
MRI was more reproducible in repeated studies (Stuckey et al., 2008). This study was 
performed in rats and it is not known how these two techniques compare in mice. 
However, given that mice have smaller hearts and faster heart rates, the higher spatial 
and temporal resolutions of cine MRI are likely to be in its favour. Unlike two-
dimensional echocardiography, three-dimensional echocardiography does not rely on 
geometric assumptions and has been used to try to overcome this limitation (Dawson 
et al., 2004). That study demonstrated excellent correlations for measurements of 
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ventricular volumes, function, mass and infarct size. They also found good agreement 
in myocardial mass and infarct size when measured using three-dimensional 
echocardiography and at necropsy. The advantage of the three dimensional 
echocardiography in this study was that it took  4 minutes to obtain the three 
dimensional data set with the whole study taking 10 minutes in contrast to MRI which 
took 40 to 60 minutes (Dawson et al., 2004). However, they used a bespoke imaging 
platform and data reconstruction software for the three-dimensional echocardiography 
study which would limit transferability to other research groups. 
 
Following peri-infarct transplantation of human CDCs into immunodeficient mice, 
Smith and colleagues demonstrated a significant decline in LV function within 2 days. 
Moreover, the further decline in LV function seen in control mice at 3 weeks was not 
seen in CDC treated mice (Smith et al., 2007). This suggests that the main action of 
CDCs is in the prevention of adverse left ventricular remodelling. The results 
described in this chapter are in agreement and also demonstrate that there is a 
reduction in adverse remodelling following delivery of CDCs. This beneficial effect 
was also seen in endoglin depleted CDCs suggesting that endoglin plays no role in 
this process. However, the numbers of animals per group was low (n=4) and this 
experiment is being repeated to validate this finding. 
 
The in vivo cardiac function in the δ-sarcoglycan deficient mouse (Sgcd-/-) was first 
described in our institution by Bauer et al. using cardiac conductance catheters. He 
demonstrated that at 16 weeks of age there was no difference in ventricular volumes, 
but there were significant differences in systolic and contractile function in these mice 
compared to controls. However, due to alterations on preload and afterload these mice 
maintained their stroke volume and cardiac output, resulting in a compensated 
cardiomyopathy (Bauer et al., 2008). At the time of our initial experiments MRI had 
not been used to measure cardiac structure and function in the Sgcd-/- mouse. 
However, Wansapura et al. have subsequently used MRI to assess these mice at 32 
weeks of age. They demonstrated that these mice have an increased left ventricular 
mass. There was no difference in left ventricular end diastolic volume but right 
ventricular end diastolic volume was significantly increased. Also both left and right 
ventricular ejection fractions were significantly reduced (Wansapura et al., 2011). We 
measured left ventricular mass, volumes and function at 32 weeks. In agreement with 
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Wansapura we also demonstrated an increased LV mass with no difference in left 
ventricular end diastolic volume. In contrast to their results we did not demonstrate 
any change in left ventricular ejection fraction. The reasons for this difference are 
unclear but I used only male mice and Wansapura do not comment on gender in their 
paper, so it is possible that there are gender difference in the Sgcd-/- mouse but this 
has not been investigated. 
 
In conclusion, the work described in this chapter demonstrates that cardiac MRI can 
be used as an accurate, non-invasive method of measuring cardiac structure and 
function in various mouse models of cardiac disease, with methods and data being 
comparable to those in the published literature. Establishing this valuable technique 
has enabled me to use cardiac MRI in my studies investigating the role of endoglin in 
the cells of the heart in vivo as will be described in chapter 5. However, I first 
evaluated the role of endoglin in the cardiac fibroblast using an in vitro approach and 
this is described in the next chapter.
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Chapter 4 The effect of endoglin depletion on primary mouse cardiac 
fibroblasts. 
 
4.1 Introduction 
In contrast to the human heart, cardiac fibroblasts compromise approximately 30% of 
the adult murine heart (Banerjee et al., 2007). As discussed in chapter 1, cardiac 
fibroblasts play an integral part in the structure and function of the heart. However, 
they also play an important role in cardiac diseases with fibrosis an important factor in 
the development and progression of cardiac disease (Leask, 2007; Krenning et al., 
2010; Leask, 2010). Endoglin appears to be involved in the regulation of fibrosis in a 
number of organ systems. However, studies examining the role of endogen in the 
fibrotic response in vitro suggest a conflicting role for endoglin, with some studies 
suggesting it negatively regulates fibrosis (Diez-Marques et al., 2002; Leask et al., 
2002; Burke et al., 2010; Holmes et al., 2011), whereas others suggest it is a positive 
regulator (K. Chen et al., 2004; Meurer et al., 2010; Shyu et al., 2010; Morris et al., 
2011; Kapur et al., 2012). A number of methods were used in these studies, including 
over expression of endoglin (Leask et al., 2002; Holmes et al., 2011), inhibition of 
endoglin with siRNA (Burke et al., 2010) or antibodies directed against endoglin (K. 
Chen et al., 2004). However, in vivo data from endoglin heterozygous mice 
demonstrate that endoglin haploinsufficiency results in reduced fibrosis following 
tissue injury, suggesting that endoglin positively regulates the fibrotic response 
(Docherty et al., 2006; Scharpfenecker et al., 2009; Kapur et al., 2012). 
 
My hypothesis was that endoglin was a regulator of cardiac fibrosis, most likely a 
positive regulator, and that a novel approach was needed to elucidate its role. 
Therefore, I chose to develop an in vitro, inducible endoglin knockdown model to 
further investigate the role of endoglin in the regulation of cardiac fibrosis. 
 
The aims of these experiments was to establish primary cultures of mouse cardiac 
fibroblasts, identify whether these cells express endoglin, establish the conditional 
knockdown of endoglin and to investigate the effect of endoglin knockdown on the 
fibroblast response to TGFβ1. 
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4.2 Results 
4.2.1 Establishing mouse primary cardiac fibroblast culture 
To achieve the aims of this study I first needed to establish primary cultures of murine 
cardiac fibroblasts. One of the commonest methods in the literature is enzymatic 
digestion of the heart, followed by a short period of attachment, after which the non-
adherent cells are discarded. The majority of these adherent cells are fibroblasts and 
are cultured until confluent and then passaged (Eghbali et al., 1991b; Peng Li et al., 
2008; Y. Chen et al., 2009; Shyu et al., 2010). In fact a similar method was used in 
our laboratory to deplete fibroblasts from primary rat cardiomyocyte cultures. I 
adapted these methods to develop the final protocol described in chapter 2. In initial 
experiments I used a single heart to obtain fibroblasts. However, although these cells 
attached to the culture dish they were sparsely distributed and did not proliferate. In 
order to increase the seeding density I pooled 3 hearts during the digestion period. 
Again these cells rapidly adhered to the culture dish (figure 4.1A) and reached 
confluence after 4 days (figure 4.1E). Figure 4.1 shows these fibroblasts in the first 4 
days of culture. It demonstrates how the small round cells that adhere to the culture 
dish develop the morphological characteristics of fibroblasts, which are a flat, spindle 
shaped cell with multiple processes emanating from the cell body (Souders et al., 
2009). 
 
It is necessary to characterise these cells to ensure that they are fibroblasts and there is 
minimal contamination with other cell types. Cardiac fibroblasts are of mesenchymal 
origin, so in order to confirm that the isolated cells are indeed fibroblasts I performed 
immunocytochemistry with an antibody against vimentin. Vimentin is a type III 
intermediate filament protein expressed in mesenchymal cells. Figure 4.2 
demonstrates that on the first day after isolation (figure 4.2A), the majority of cells 
express vimentin confirming them as fibroblasts. The number of cells expressing 
vimentin remains high at passage 2 (figure 4.2E). The vimentin staining pattern seen 
in figure 4.2E clearly demonstrates the morphological characteristics of fibroblasts. 
These cells do not express the endothelial cell marker CD31 (figure 4.2B&F) and nor 
do they express α-smooth muscle actin immediately after isolation (figure 4.2C). 
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However, by passage 2 some cells do express α-smooth muscle actin suggesting 
conversion from a fibroblast to a myofibroblast phenotype (figure 4.2G). 
 
As two previous studies demonstrating that endoglin is expressed in cardiac 
fibroblasts used rat primary cardiac fibroblasts (K. Chen et al., 2004; Shyu et al., 
2010), it was important to demonstrate that endoglin is also expressed on mouse 
primary cardiac fibroblasts in culture. To do this I performed immunocytochemistry 
using an antibody against endoglin. Figure 4.3 demonstrates that mouse primary 
cardiac fibroblasts express endoglin at passage 1 and 2. 
 
Now that I had established the culture of mouse primary cardiac fibroblasts it was 
necessary to develop an in vitro model to investigate the effects of endoglin 
knockdown on these fibroblasts. 
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Figure 4.1 Primary mouse cardiac fibroblasts in culture.  
Following enzymatic digestion of adult heart tissue, the digested cells were plated into a T75 flask. Following 90 minutes the flasks were rinsed with PBS to remove non-
adherent cells. Adherent cells (A) were then cultured in DMEM with 10% FCS and 1% penicillin/streptomycin. The cells were then cultured for 4 days (B-E) until confluent 
(E). They were then passaged and fibroblasts from passage 2 were used for subsequent experiments. 
(A=day 0, B=day1, C=day 2, D=day 3 and E=day 4. Scale bar=100µm). 
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Figure 4.2 Characterisation of primary cardiac fibroblasts in culture.  
Primary cardiac fibroblasts at passage 0 (A-D) and passage 2 (E-H) were immunostained with antibodies to vimentin (A & E), CD31 (B & F) and α smooth muscle actin (C 
& G). Representative no primary controls are shown in D & H. (Scale bar 100µm). 
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Figure 4.3 Endoglin expression in mouse primary cardiac fibroblasts.  
Endoglin is expressed in mouse primary cardiac fibroblasts at passage 1 (A) and passage 2(B). No 
primary control, C. Scale bar 100 µm. 
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4.2.2 Endoglin depletion in mouse primary cardiac fibroblasts. 
I next aimed to generate cardiac fibroblasts in which knockdown of endoglin could be 
achieved in a time specific manner using Cre-Lox genetics. As we did not have a 
fibroblast specific inducible Cre recombinase at this time I chose to use the 
ubiquitously expressed, tamoxifen inducible Rosa26-CreERT2 transgenic mouse line 
(Cheng et al.). This line drives expression of a mutated oestrogen receptor (ERT2) 
fused to Cre recombinase in most cell types. Binding of 4-hydroxytamoxifen to the 
receptor results in activation of the Cre recombinase (Feil et al., 1997). This mouse 
line was crossed with our floxed endoglin line to give Engfl/fl;Rosa26-CreERT2 mice 
enabling temporal regulation of endoglin knockdown in vitro using 4-
hydroxytamoxifen.  
 
4.2.2.1 Rosa26-CreERT2 is expressed in primary cardiac fibroblasts 
Although the Rosa26 promoter drives ubiquitous gene expression and therefore 
Rosa26-CreERT2 should express CreERT2 in all cell types it was important to 
demonstrate that it was expressed in my cultured fibroblasts. To investigate this I used 
the Rosa26R reporter, which monitors Cre expression (Soriano, 1999). In this line, the 
lacZ gene is inserted into the ubiquitously expressed Rosa26 locus. However, a PGK 
neo cassette flanked by loxP sites is present that blocks transcription of the lacZ gene 
(figure 4.4A). In the presence of Cre recombinase this PGK neo cassette is excised 
following Cre/lox recombination and allows the transcription of the lacZ 
gene(Soriano, 1999). When stained with X-gal the beta galactosidase enzyme encoded 
by lacZ converts the colourless X-gal to a blue precipitate that is easily visible in 
white light. So those cells in which the Cre recombinase was activated, and hence the 
lac Z gene expressed, will appear blue. 
 
Engfl/fl; Rosa26-CreERT2 mice were crossed with Rosa26R mice to produce 
Engfl/fl;Rosa26-CreERT2;R26R mice. Cardiac fibroblasts were isolated and cultured 
from the hearts of these mice. Culture medium containing various concentrations of 4-
hydroxytamoxifen (1, 2 and 5 µM) was added to the cardiac fibroblasts at passage 1 
or 2 to activate the Cre recombinase. They were then cultured for a further 72 hours 
following which they were fixed and stained with X-gal. Figure 4.4 demonstrates 
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widespread blue staining of fibroblasts at all concentrations of 4-hydroxytamoxifen 
used. There are a small number of unstained cells and these represent cell that don’t 
express either Rosa26-CreERT2 or the Rosa26 reporter, demonstrating that the Rosa 
locus is not 100% ubiquitous.  
 
These data clearly demonstrate that Rosa26-CreERT2 is expressed in primary cardiac 
fibroblasts. However, the efficiency of endoglin knockdown in these cells is of greater 
importance for this study and this was tested as follows. 
 
4.2.2.2 Endoglin is efficiently depleted in Engfl/fl; Rosa26-CreERT2 primary cardiac 
fibroblasts. 
Although Cre activation is required for Cre/lox recombination and the knockdown of 
endoglin (figure 4.5A), it is essential to demonstrate efficient knockdown and identify 
the concentration of 4-hydroxytamoxifen needed to achieve this. Primary cardiac 
fibroblasts isolated from Engfl/f;Rosa26-CreERT2;R26R mice were exposed to 4-
hydroxytamoxifen at varying concentrations as described above. First, I confirmed 
that exons 5 and 6 of the endoglin gene had been deleted using genomic PCR (figure 
4.5B). Second, I performed immunocytochemistry using an antibody against endoglin 
to confirm endoglin protein had also been depleted. Figure 4.6 demonstrates that at all 
concentrations of 4-hydroxytamoxifen used, endoglin is efficiently depleted from the 
primary cardiac fibroblasts. In order to quantify the efficiency of endoglin knockdown, 
four random fields of view were obtained and the total number of cells and the 
number of cells expressing endoglin were counted. Efficiency of knockdown was then 
calculated which demonstrates that in cells at passage 1 and 2, and all concentrations 
of 4-hydroxytamoxifen used, there is greater than 95% depletion of endoglin (figure 
4.6I). These cells will be termed endoglin knockdown (Eng-IKOu) fibroblasts for the 
remainder of this chapter. 
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Figure 4.4 Cre activation in primary cardiac fibroblasts isolated from Engfl/fl;Rosa26-
CreERT;Rosa26R mice.  
A, schematic showing Cre/lox recombination of the Rosa26R allele in the presence a tamoxifen 
inducible Cre recombinase resulting in the expression of β-galactocidase. B – E, X-gal staining, for β-
galactosidase, demonstrating Cre activation in primary cardiac fibroblasts isolated from Engfl/fl;Rosa26-
CreERT;Rosa26R mice following incubation with various concentrations of 4-hydroxytamoxifen. (B = 
no 4-hydroxytamoxifen, C = 1µM 4-hydroxytamoxifen, D = 2µM 4-hydroxytamoxifen and E = 5µM 4-
hydroxytamoxifen). Cells were counterstained with eosin. Scale bar = 100 µm. 
 
The Importance of Endoglin for Cardiac Structure and Function 
 
 103 
Rosa 
CreERT2
Tamoxifen
Exon 4 Exon 7
loxP
EngΔEx5&6/ΔEx5&6
Engfl/fl
Exon 4 Exon 5 Exon 6 Exon 7
loxP loxP
CF CF+4OHT Water Eng +/∆
F4/R7
F6/R7
603bp
430bp
F6 R7A
B
F4 R7
 
Figure 4.5 Treatment of Engfl/fl; Rosa26-CreERT2 primary cardiac fibroblast with 4-
hydroxytamoxifen resulted in excision of exons 5 and 6.  
A. Schematic showing the position of the primers in the endoglin gene before and after Cre mediated 
excision of exons 5 and 6. B. Agarose gel showing the PCR products amplified from genomic DNA 
isolated from Engfl/fl;Rosa26-CreERT2 cardiac fibroblasts (CF) with and without treatment with 1µM 4-
hydroxytamoxifen (4-OHT) for 72 hours. The gain of the 603bp F4/R7 PCR product and loss of the 
430bp F6/R7 PCR product demonstrates the presence of the endoglin deleted allele in fibroblast cells 
only after exposure to 4-OHT. (Note that the size of the F4/R7 PCR product from the floxed endoglin 
allele prior to recombination is too large to be amplified by standard PCR methods.) 
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Figure 4.6 Endoglin expression in Engfl/fl; Rosa26-CreERT2 primary cardiac fibroblasts is depleted following treatment with 4-hydroxytamoxifen. 
Primary cardiac fibroblasts at passage 1 (A-D) and passage 2(E-H) were treated with different concentrations of 4-hydroxytamoxifen for 72 hours. A & E – no 4-
hydroxytamoxifen, B & F, 1µM, C & G, 2µM and D &H, 5µM. The table in I shows the efficiency of endoglin knock down in passage 1 and 2 fibroblasts with the different 
concentrations of 4-hydroxytamoxifen. Scale bars 100µm. 
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4.2.2.3 4-hydroxytamoxifen has no effect on the viability of primary cardiac 
fibroblasts. 
In order to knockdown endoglin in vitro, 4-hydroxytamoxifen needs to be added to 
the cells. Consequently I needed to ensure that it is not toxic to the fibroblasts at the 
concentration required to knockdown endoglin. I addressed this by performing a MTT 
assay on my primary cardiac fibroblasts prepared from Engfl/fl mice. 
 
MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) is a yellow 
tetrazole, that enters the cell and passes into the mitochondria. Once there it is reduced 
by mitochondrial succinate dehydrogenase to a water-insoluble, purple formazan 
product. Following incubation with MTT, an organic solvent (dimethyl sulphoxide, 
DMSO) is added to the cells to dissolve the formazan and produce a purple coloured 
solution. The absorbance of this solution can be measured spectrophotometrically. As 
the reduction reaction can only occur in metabolically active cells the absorbance is 
proportional to the viability of the cells (Mosmann, 1983). 
 
In this experiment primary cardiac fibroblasts at passage 1 were seeded into a 96 well 
plate (5000 cells per well) and incubated with 4-hydroxytamoxifen (0, 1, 2, 5 µM, 
using 3 technical replicates at each concentration) for 4 days. The MTT assay was 
then performed as described in chapter 2. Figure 4.7 confirms that 4-
hydroxytamoxifen has no effect on primary cardiac fibroblast viability at any of the 
concentrations examined (ANOVA, p=0.642) 
 
As a result of these experiments I chose to use 1µM 4-hydroxytamoxifen in all 
subsequent experiments as it efficiently knocks down endoglin and is not toxic to the 
fibroblasts. 
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Figure 4.7 MTT assay of primary cardiac fibroblasts from Engfl/fl mice following incubation with 
various concentrations of 4-hydroxytamoxifen.  
Absorbance of the solubilised formazan product was measured at 570nM. There was no significant 
difference in absorbance at any of the concentrations used (ANOVA, p=0.642) demonstrating that 4-
hydroxytamoxifen does not effect cell viability. Data expressed as mean ± SE. 
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4.2.3 The effect of endoglin knockdown on TGFβ signalling pathways in response 
to TGFβ1 stimulation 
The aim of these experiments was to investigate the effect endoglin knockdown had 
on components of the TGFβ signalling pathway, including Smad phosphorylation and 
of selected downstream genes that were related to the cardiac fibrotic response.  
 
4.2.3.1 TGFβ1 stimulation of primary cardiac fibroblasts results in Smad2 
phosphorylation. 
The initial aim of this experiment was to establish whether serum starvation was 
necessary for the Smad phosphorylation experiments, to determine the optimum dose 
of TGFβ1 required and the duration of stimulation. 
 
It is common to serum starve fibroblasts prior to TGFβ1 stimulation experiments, 
because TGFβ1 and related growth factors are present in the serum used in complete 
growth media (Goustin et al., 1986). However, when the fibroblasts are serum starved 
there can be cell death (Leicht et al., 2001). This is dependent on the conditions used 
so it was important to assess the viability of these cells over the potential time course 
of the experiment. This was achieved using the MTT assay to monitor cell viability, 
as described above. Again primary cardiac fibroblasts from Engfl/fl mice, at passage 1, 
were seeded into 96 well plates (5000 cells per well, 8 replicates per time point) and 
allowed to adhere overnight before serum starvation (0.2% foetal calf serum) for 16, 
24 and 40 hours. Following this period of starvation an MTT assay was performed. 
For the control sample the MTT assay was performed after overnight adherence only 
and represents the viability of the cells prior to serum starvation. Figure 4.8 shows the 
absorbance of the solubilised formazan product at the different time points. It 
demonstrates a significant reduction in absorbance with the serum starved cells 
compared to control (ANOVA, p<0.001). This likely represents a reduction in both 
cell viability and metabolic activity as the MTT assay does not distinguish between 
the two. However, there is no difference between absorbance over the course of serum 
starvation (ANOVA, p=0.318) suggesting that no further cell death occurs but the 
cells remain quiescent. 
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Figure 4.8 MTT assay of primary cardiac fibroblasts from Engfl/fl mice following serum 
starvation.  
Absorbance of the solubilised formazan product was measured at 570nM. There was a significant 
reduction in absorbance of the control sample compared to the serum starved samples at all time points 
(ANOVA, p<0.001) but no difference between the different durations of serum starvation (ANOVA, 
p=0.318). This demonstrates that there is a reduction in cell viability/metabolic activity by 16 hours 
following serum starvation, but the cells remained quiescent without a reduction in viability for the 
duration of the experiment. Data expressed as mean ± SE. 
 
To determine the optimal dose and incubation time to investigate the effect of 
endoglin depletion on Smad phosphorylation following TGFβ1 stimulation I 
performed 2 experiments. The first addressed the effect of serum starvation and 
concentration of TGFβ1 on the primary cardiac fibroblasts. In this experiment 
primary cardiac fibroblasts were seeded onto 6 well plates (100,000 cells per well). 
Following overnight adherence the cells were cultured for a further 24 hours in either 
normal media or low serum media (0.2% FCS). The cells were then stimulated with 
TGFβ1, at concentrations of 0, 5 and 10ng/ml, for 30 minutes. Following this the cells 
were collected for western blot analysis using antibodies to phospho-Smad2 and total 
Smad2. Figure 4.9A demonstrates that in the absence of TGFβ1 there is minimal 
phosphorylation of Smad2. Following stimulation with both doses of TGFβ1 Smad2 
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becomes phosphorylated. This phosphorylation appears to be greater in the cells that 
were serum starved prior to stimulation. 
 
The second experiment aimed to establish the optimal duration of TGFβ1 stimulation. 
In this experiment following seeding and adherence in 6 well plates the primary 
cardiac fibroblasts were serum starved for 24 hours followed by stimulation with 
5ng/ml of TGFβ1 for 15, 30 and 60 minutes. Again the cells were collected for 
western blot analysis as described above. Figure 4.9B demonstrates that Smad 2 
phosphorylation occurs with in 15 minutes and remains for at least 60 minutes. 
 
Following these results I decided that in all subsequent western blot experiments, the 
primary cardiac fibroblasts would be serum starved in 0.2% FCS for 24 hours prior to 
stimulation with 5ng/ml TGFβ1 for 30 minutes. 
 
 
Figure 4.9 Phosphorylation of Smad2 following TGFβ1 stimulation of primary cardiac 
fibroblasts from Engfl/fl mice.  
A, phosphorylation of Smad2 in primary cardiac fibroblasts with and without serum starvation (0.2% 
FCE for 24 hours), in response to TGFβ1 at 5 and 10ng/ml. B, phosphorylation of Smad2 over time 
following stimulation with 5ng/ml TGFβ1 in serum starved primary cardiac fibroblasts. Total Smad2 
levels were similar in all samples. These experiments were repeated 3 times with similar results. 
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4.2.3.2 Endoglin knockdown in primary cardiac fibroblasts does not affect Smad 
phosphorylation following TGFβ1 stimulation. 
To investigate the effect of endoglin knockdown on Smad phosphorylation in 
response to TGFβ1, primary cardiac fibroblasts from Engfl/fl;Rosa26-CreERT2 and 
Engfl/fl mice were cultured. All cells were treated with 4-hydroxytamoxifen and 
cardiac fibroblasts from Engfl/fl mice were used as controls. The primary cardiac 
fibroblasts were treated with 4-hydroxytamoxifen at passage 1 and grown to 
confluence. They were then passaged and seeded to 6 well plates (100,000 cells per 
well). Following overnight adherence, they were serum starved for 24 hours followed 
by stimulation with 5ng/ml TGFβ1 for 30 minutes. The cells were then collected for 
western blot analysis. To investigate the effects of endoglin knockdown on 
TGFβ1/Alk5 signalling and TGFβ1/Alk1 signalling pathways, phospho-Smad 
2/Smad2 ratio and phospho-Smad 1,5,8/Smad 1 ratio, respectively, were calculated. 
Figure 4.10 demonstrates that TGFβ1 stimulation results in phosphorylation of Smad2 
in both control and endoglin knockdown (Eng-iKOu) fibroblasts (p=0.005 and 
p=0.001, respectively). Although following TGFβ1 stimulation mean phopho-
Smad2/Smad2 ratio appears lower in the fibroblasts with endoglin knockdown, the 
difference is not statistically significant (p=0.247). Figure 4.11 shows that there is a 
reduction in phospho-Smad 1/5/8/Smad 1 ratio in endoglin depleted fibroblasts with 
an increase following TGFβ1 stimulation compared to control fibroblasts. However, 
these changes are not statistically significant. These results demonstrate that the 
response to TGFβ1 stimulation may be different between control and endoglin 
depleted fibroblasts. Any small change in Smad phosphorylation is likely to lead to 
larger changes in downstream gene expression and so I chose to investigate effect of 
TGFβ1 on gene expression of TGFβ receptors, as well as the downstream genes Id1 
and Pai-1. 
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Figure 4.10 Effect of endoglin knockdown on Smad2 phosphorylation following TGFβ1 
stimulation.  
A. Endoglin knockdown resulted in a small, non-significant reduction in Smad2 phosphorylation in 
response to TGFβ1. Data from three biological replicates are presented as mean ± SD, n=3. 
B. A representative western blot experiment shows TGFβ1stimulates phosphorylation of Smad2 in 
the absence of endoglin.  
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Figure 4.11 The effect of TGFβ1 stimulation on Smad1/5/8 phosphorylation in control and 
endoglin depleted fibroblasts.  
A. Smad 1/5/8 was already phosphorylated in serum starved, unstimulated fibroblasts and was not 
induced by TGFβ1. Endoglin knockdown had no significant effect. Data from three biological 
replicates are presented as mean ± SD, n=3. 
B. A representative western blot experiment shows phosphorylation of Smad1/5/8 in the absence of 
endoglin, with and without TGFβ1 stimulation (5ng/ml for 30 minutes).  
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4.2.3.3 The effect of endoglin knockdown on expression of TGFβ receptor genes 
and downstream signalling genes. 
To investigate the effect of endoglin depletion on the expression of TGFβ receptors 
genes and downstream signalling genes, quantitive real time PCR (qPCR) was 
performed on primary cardiac fibroblasts with and without endoglin knockdown. 
 
In these experiments all primers, except TGFβ1, were already in use in our laboratory 
and are summarised in table 2.7. The primers for amplifying TGFβ1 cDNA were 
previously published (Davidson et al., 2006). The TGFβ receptor genes I investigated 
were the type I receptors, Alk1 and Alk5, the type II receptor (Tgfbr2) and endoglin 
on the basis that endoglin regulates the balance between Alk1 and Alk5 signalling 
(figure 1.2). To demonstrate differences in target gene activation I investigated Id1 
and Id2 (inhibitor of DNA binding 1 and 2), expressed following activation of the 
Alk1/Smad1/5/8 pathway, and Pai-1 (plasminogen activator inhibitor 1, also known as 
Serpine1), expressed following Alk5/Smad2/3 activation. I also investigated any 
effect on transcription of TGFβ1 ligand. I used three housekeeping genes 
(glyceraldehyde-3-phosphate dehydrogenase (Gapdh), hypoxanthine-guanine 
phosphoribosyltransferase (Hprt) and β-actin) for data normalisation (see chapter 2). 
Table 2.7 gives details of the primers used to identify the expression of these genes 
and the PCR efficiency. All qPCR reactions used the SYBR green quantitative 
method (described in chapter 2). Figure 4.12 shows the dissociation curves for these 
primers used during typical qPCR reactions. This demonstrates a single melting peak 
for all PCR products, except for Alk5 (this will be discussed further below), 
confirming primer specificity. Mean PCR efficiency of each primer pair was 
determined from the slopes of the qPCR amplification curve using the LinReg method 
(table 2.7) (Ramakers et al., 2003; Karlen et al., 2007). 
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Figure 4.12 Dissociation curves of the qPCR product for each primer pair.  
The single peak confirms that the primers are specific and give a single PCR product, with the exception of Alk5, which has a shape indicating more than one PCR product. 
 
Gapdh Hrpt β-actin Alk1 
Pai-1 Id1 Eng 
Alk5 
Tgfβ1 Tgfbr2 
The Importance of Endoglin for Cardiac Structure and Function 
 
 115 
These experiments were performed with primary cardiac fibroblasts isolated from 
hearts of Engfl/fl and Engfl/fl;Rosa26-CreERT2 mice. All cells were treated with 4-
hydroxytamoxifen (1µM) at passage 1. Once they had reached confluence the 
fibroblasts were passaged and seeded onto 6 well plates (100,000 cells per well). They 
were then cultured in normal media for 24 hours. In order to assess the effect of 
endoglin depletion on primary cardiac fibroblasts under normal conditions, serum 
starvation was not used in these experiments. However, subsequent experiments 
assessing the effect of endoglin depletion on TGFβ1 stimulation, serum starvation 
was performed as for the western blot experiments above. The fibroblasts were lysed 
using RLT buffer (Qiagen) and stored at -80°C. Following RNA extraction and 
reverse transcription, as described in chapter 2, qPCR was performed using the above 
primers. Gene expression in endoglin depleted fibroblasts (Eng-iKOU) relative to 
control fibroblasts was calculated using the comparative Ct method, described in 
chapter 2. 
 
The relative gene expression levels are given in table 4.1. As the relative gene 
expression data is exponential the data was log transformed prior to graphical 
representation as shown in figure 4.14 and figure 4.15. As would be expected there is 
a significant, 14.7 fold reduction in endoglin expression (p<0.0001) following 
endoglin knockdown. There is no difference in Alk1 gene expression but there 
appears to be a significant, 14.7 fold increase in Alk5 expression (p=0.001) following 
endoglin knockdown. However, as mentioned above the dissociation curve for Alk5 
shows the presence of 2 peaks. This indicates more than one PCR product is present 
but is unlikely to be due to genomic DNA contamination as the both primers span 
exon boundaries. Therefore, this suggests that there is primer dimer formation 
resulting in a false positive result.  
 
To further clarify the effect of endoglin knock down on Alk5 gene expression I used 
commercially available primers (Qiagen Quantitect primers) to repeat the experiment. 
These primers amplified a 120bp amplicon in exons 4 and 5. The dissociation curves 
for these primers shows a single peak confirming specificity (figure 4.13). The qPCR 
results are shown in table 4.1 and demonstrate that endoglin knock down has no effect 
on Alk5 gene expression (p=0.88). 
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Following endoglin knockdown there is no difference in expression of Pai-1 (p=0.49) 
or Tgfβ1. There is a small (1.2 fold), but statistically significant, increase in Id1 
expression (p=0.047) following endoglin knockdown, suggesting that the 
Alk1/Smad1/5/8 pathway is activated following endoglin knockdown. 
 
 
Figure 4.13 Dissociation curve for qPCR products using Qiagen Quantitect primers for Alk5.  
This demonstrates a single peak confirming primer specificity. 
 
 
 
Table 4.1 Relative gene expression of TGFβ receptor and downstream signalling genes in 
primary cardiac fibroblasts with endoglin knockdown compared to control.  
Compared to control fibroblasts, endoglin knockdown results in no difference in Alk1, Pai-1 or Tgfβ1 
gene expression. As would be expected there is 14.7 fold reduction in endoglin gene expression in 
fibroblasts following endoglin knockdown compared to control. There is a small but significant 
increase (1.2 fold difference) in Id1 gene expression in fibroblasts with endoglin knockdown compared 
to control. Data presented a mean ± SD, n=3 biological replicates per group. 
 Alk1 Alk5 
(Quantitect) 
Endoglin Id1 Pai-1 Tgfβ1 
Control 1.0 ± 
0.27 
1.0 ±  
0.26 
1.0 ±  
0.03 
1.0 ± 
0.04 
1.0 ± 
0.07 
1.0 ± 
0.05 
Eng-
iKOu 
1.3 ± 
0.67 
1.0 ±  
0.39 
0.068 ± 
0.03 
1.2 ± 
0.14 
1.1 ± 
0.34 
0.9 ± 
0.34 
p value 0.58 0.88 <0.0001 0.047 0.49 0.23 
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Figure 4.14 The effect of endoglin knockdown on the relative gene expression of TGFβ receptors 
in primary cardiac fibroblasts.  
Following endoglin knockdown there is a significant (14.7 fold) decrease in endoglin expression. There 
is no significant difference in the expression of the type I receptors, Alk1 or Alk5. Data expressed as 
mean ± SD, n=3 per group, *p<0.001. 
 
 
 
Figure 4.15 The effect of endoglin knockdown on the relative gene expression of TGFβ target 
genes in primary cardiac fibroblasts.  
There is no significant difference in Pai-1 or TGFβ1 gene expression following endoglin knockdown. 
There is a small (1.2 fold) increase in Id1 expression. Data expressed as mean ± SD, n=3 biological 
replicates per group, *p=0.047. 
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4.2.3.4 The effect of endoglin knockdown on the expression of TGFβ receptors 
genes and downstream signalling genes in response to TGFβ1. 
TGFβ1 is a major fibrogenic cytokine, and cardiac fibroblasts are primarily 
responsible for generating scar tissue following heart injury. I therefore investigated 
whether endoglin knockdown had any effect on collagen synthesis in cardiac 
fibroblasts following TGFβ1 stimulation. To do this, primary cardiac fibroblasts were 
isolated from hearts of Engfl/fl and Engfl/fl;Rosa26-CreERT2 mice. All cells were treated 
with 4-hydroxytamoxifen (1µM) at passage 1. Once they had reached confluence the 
fibroblasts were passaged and seeded onto 6 well plates (100,000 cells per well). They 
were allowed to adhere overnight in normal media followed by serum starvation 
(0.2% FCS) for 24 hours prior to TGFβ1 stimulation. Fibroblasts were treated with 
5ng/ml TGFβ1 or left untreated for 24 hours prior to harvest. The fibroblasts were 
lysed using RLT buffer (Qiagen) and stored at -80°C. Following RNA extraction and 
reverse transcription, as described in chapter 2, qPCR was performed using the 
primers in table 2.7. Gene expression in TGFβ1 treated fibroblasts relative to 
untreated fibroblasts, for both control and Eng-iKOU fibroblasts, was calculated using 
the comparative Ct method as described in chapter 2 (table 4.2 and table 4.3). 
 
In control fibroblasts (table 4.2 and figure 4.16) TGFβ1 stimulation resulted in down 
regulation of Alk1 (1.5 fold reduction, p=0.011) and a very small reduction in Tgfbr2 
expression (1.1 fold reduction, p=0.018). In some (n=2) control fibroblast cultures 
there was very little change in endoglin expression in response to TGFβ1 stimulation. 
However, in one experiment there was an 8 fold increase in endoglin expression. As 
this response was not consistent between biological replicates it was not considered 
statistically significant, but should be monitored in future work. As expected, TGFβ1 
stimulation in control fibroblasts resulted in significant up regulation of Pai-1 (2.3 
fold increase, p=0.005) confirming activation of the Alk5/Smad2/3 pathway. There 
was also down regulation of the Alk1/Smad1/5/8 pathway with a significant down 
regulation of both Id1 (2.0 fold reduction, p=0.038) and Id2 (2.1 fold reduction, 
p=0.003). Finally, there was also a small increase in Tgfβ1 expression (1.2 fold 
increase, p=0.002). 
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Overall, TGFβ1 stimulation of fibroblasts following endoglin knockdown resulted in 
a similar change in gene expression to control fibroblasts. As with control fibroblasts, 
both Alk1 (1.5 fold reduction, p=0.024) and Tgfbr2 (1.2 fold reduction, p=0.009) 
were down regulated. Endoglin was up regulated following TGFβ1 stimulation (2.2 
fold increase, p=0.028). The Alk5/Smad2/3 pathway is activated as shown by the 2.9 
fold increase in Pai-1 expression (p=0.002) and Alk1/Smad1/5/8 pathway down 
regulated (3 fold reduction in Id1 expression (p<0.0001) and 2.3 fold reduction in Id2 
expression (p=0.004)). Interestingly, in endoglin depleted fibroblasts, there is no 
increase in TGFβ1 expression following TGFβ1 stimulation (p=0.8), suggesting this 
response was endoglin dependent. 
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Table 4.2 Relative gene expression of TGFβ signalling pathway genes in control primary cardiac 
fibroblasts following TGFβ1 stimulation.  
Compared to untreated fibroblasts, TGFβ1
 
stimulation resulted in up regulation of Pai-1 and Tgfβ1 and 
down regulation of Alk1, Tgfbr2 and Id1 and 2. Data expressed as mean ± SD, n=3 biological 
replicates per group. 
Control fibroblasts 
 
Alk1 Tgfbr2 Eng Pai-1 Id1 Id2 Tgfβ1 
Untreated 
1.0 ± 
0.01 
1.0 ± 
0.002 
1.0 ± 
0.008 
1.0 ± 
0.033 
1.0 ± 
0.003 
1.0 ± 
0.001 
1.0 ± 
0.003 
TGFβ1 
treated 
0.65 ± 
0.14 
0.89 ± 
0.05 
3.6 ± 
4.35 
2.3 ± 
0.4 
0.50 ± 
0.3 
0.47 ± 
0.1 
1.2 ± 
0.04 
p value 0.011 0.018 0.361 0.005 0.038 0.003 0.002 
 
 
Table 4.3 Relative gene expression of TGFβ signalling pathway genes in endoglin depleted 
primary cardiac fibroblasts following TGFβ1 stimulation.  
Compared to untreated fibroblasts, TGFβ1
 
stimulation resulted in up regulation of endoglin and Pai-1 
and down regulation of Alk1, Tgfbr2 and Id1 and 2. There was no effect on Tgfβ1 expression. Data 
expressed as mean ± SD, n=3 biological replicates per group. 
Eng-iKOu fibroblasts 
 
Alk1 Tgfbr2 Eng Pai-1 Id1 Id2 Tgfβ1 
Untreated 
1.0 ± 
0.001 
1.0 ± 
0.001 
1.2 ± 
0.17 
1.0 ± 
0.06 
1.0 ± 
0.009 
1.0 ± 
0.01 
1.0 ± 
0.008 
TGFβ1 
treated 
0.58 ± 
0.21 
0.85 ± 
0.06 
2.2 ± 
0.48 
2.9 ± 
0.43 
0.33 ± 
0.02 
0.43 ± 
0.17 
1.0 ± 
0.12 
p value 0.024 0.009 0.028 0.002 <0.0001 0.004 0.80 
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Figure 4.16 The effect of TGFβ1 stimulation on TGFβ signalling pathway gene expression in 
control fibroblasts.  
Data expressed as mean ± SD, n=3 per group, *p<0.05 
 
 
 
Figure 4.17 The effect of TGFβ1 stimulation on TGFβ signalling pathway gene expression in 
endoglin depleted fibroblasts.  
Data expressed as mean ± SD, n=3 per group,*p<0.05 
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4.2.4 The effect of endoglin knockdown on expression of selected genes expressed 
in the extracellular matrix  
To investigate the effect of endoglin knockdown on extracellular matrix gene 
expression qPCR was performed using primers to a number of genes involve in 
extracellular matrix remodelling (table 1.1). These were, type I collagen (Col1A1), 
type III collagen (Col3A1), connective tissue growth factor (Ctgf, also known as 
Ccn2), alpha smooth muscle actin (α-SMA, a marker of fibroblast to myofibroblast 
transformation), matrix metalloproteinases (Mmp) 2 and 9 and tissue inhibitors of 
metalloproteinases (Timp) 1 and 2. The details of the primers used in the qPCR 
experiments are given in table 2.7. These primers were taken from the online 
resource; primer bank (http://pga.mgh.harvard.edu/primerbank/), except for the 
primers for Ctgf which have been previously published (Davidson et al., 2006). All 
these primers were specific as only a single peak was seen on their respective 
dissociation curves (figure 4.18). 
4.2.4.1 The effect of endoglin knockdown on expression of extracellular matrix 
genes in unstimulated cells 
The expression of ECM genes in control and endoglin depleted cardiac fibroblasts 
were compared under normal culture conditions as described in section 4.2.3.3 above. 
There were no significant differences in expression of these ECM genes between the 
control and endoglin depleted fibroblasts (table 4.4 and figure 4.19) 
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Figure 4.18 Dissociation curves of the qPCR product for each primer pair. 
The single peak confirms that the primers are specific. 
 
α-sma Col1A1 Col3A1 
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Table 4.4 Relative gene expression of extracellular matrix genes in primary cardiac fibroblasts 
with endoglin knockdown compared to control.  
There was no difference in baseline expression of extracellular matrix genes in endoglin depleted 
fibroblasts compared to controls. Data expressed as mean ± SD, n=3 biological replicates for each 
group. 
 Col1A1 Col3A1 Ctgf Mmp2 Mmp9 Timp1 Timp2 
α-
SMA 
Control 
1.0 ± 
0.06 
1.0 ± 
0.30 
1.0 ± 
0.12 
1.0 ± 
0.25 
1.0 ± 
0.63 
1.0 ± 
0.28 
1.0 ± 
0.23 
1.0 
±0.11 
Eng-iKOU 
1.0 ± 
0.17 
1.0 ± 
0.19 
0.88 ± 
0.29 
1.0 ± 
0.067 
0.79 ± 
0.63 
0.91 ± 
0.28 
0.94 
±0.30 
0.89 ± 
0.14 
p value 0.93 0.88 0.54 0.84 0.70 0.72 0.80 0.36 
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Figure 4.19 The effect of endoglin knockdown on the relative expression of extracellular matrix 
genes in primary cardiac fibroblasts.  
There was no difference in expression of extracellular matrix genes in endoglin depleted fibroblasts 
compared to controls. Data expressed as mean ± SD, n=3 biological replicates for each group. 
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4.2.4.2 The effect of endoglin knockdown on the expression of extracellular 
matrix genes in response to TGFβ1. 
The effect of TGFβ1 stimulation on fibroblasts with and without endoglin was 
examined as described in section 4.2.3.4 above. 
 
Contrary to my expectations, collagen I expression was not increased in control 
fibroblasts following 24 hours of TGFβ1 stimulation (table 4.5 and figure 4.20). There 
was a significant down regulation of collagen III induction following TGFβ1 
stimulation (2.3 fold reduction, p=0.007) whereas Ctgf was up regulated by 2.2 fold 
(p<0.0001) and αSMA by 2.5 fold (p=0.025). There was no significant change in 
either Mmp2 (p=0.18) or Mmmp9 (p=0.13) expression in response to TGFβ1. Timp1 
gene expression was also unaffected (p=0.29) but Timp 2 was down regulated 1.8 fold 
(p=0.023).  
 
TGFβ1 stimulation of endoglin depleted fibroblasts resulted in a significant down 
regulation of collagen III (3.2 fold reduction, p=0.0001) with an up regulation of both 
Ctgf (2.6 fold increase, p=0.007) and α-SMA (3.1 fold increase, p=0.029), similar to 
control fibroblasts. However, in contrast to control fibroblasts, endoglin depletion 
resulted in a 1.25 fold reduction in collagen I expression (p=0.02) and a 3.7 fold 
reduction in Mmp2 (p<0.0001) expression, following TGFβ1 stimulation. There 
appeared to be an increase in Mmp9 expression but this was not significant (1.64 fold 
increase, p=0.065), and was similar to the response in control fibroblasts. Timp1 
expression remained unchanged (p=0.14) and Timp2 expression was reduced 2.8 fold 
(p=0.0009) in keeping with the response of control fibroblasts. 
 
Overall, the results demonstrate that in contrast to control fibroblasts, endoglin 
knockdown results in down regulation of both type I collagen and Mmp2 gene 
expression in response to TGFβ1 stimulation suggesting that endoglin positively 
regulates their expression. Also, endoglin knockdown has little effect on the other 
extracellular matrix genes tested. However, changes in gene expression are dynamic 
and so further experiments would be needed to define the optimal conditions. 
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Table 4.5 Relative gene expression of extracellular matrix genes in control primary cardiac 
fibroblasts following TGFβ1 stimulation.  
Compared to untreated fibroblasts, TGFβ1
 
resulted in up regulation of Ctgf and αSMA. There is down 
regulation of type III collagen and Timp1. There was no effect on type I collagen, Mmp2, Mmp9 and 
Timp2 gene expression. Data expressed as mean ± SD, n=3 biological replicates per group. 
Control fibroblasts 
 
Col1A1 Col3A1 Ctgf Mmp2 Mmp9 Timp1 Timp2 
α-
SMA 
Untreated 
1.0 ± 
0.0004 
1.0 ± 
0.008 
1.0 ± 
0.004 
1.0 ± 
0.013 
1.0 ± 
0.036 
1.0 ± 
0.026 
1.0 ± 
0.003 
1.0 ± 
0.0009 
TGFβ1 
treated 
1.0 ± 
0.093 
0.44 ± 
0.19 
2.2 ± 
0.065 
0.72 ± 
0.32 
1.6 ± 
0.56 
1.5 ± 
0.71 
0.55 ± 
0.21 
2.5 ± 
0.73 
p value 0.78 0.007 <0.0001 0.18 0.13 0.29 0.023 0.025 
 
 
Table 4.6 Relative gene expression of extracellular matrix genes in endoglin depleted primary 
cardiac fibroblasts following TGFβ1 stimulation.  
In contrast to control fibroblasts there is a significant down regulation of type I collagen and Mmp2. In 
keeping with control fibroblasts, TGFβ1 stimulation resulted in up regulation of Ctgf and αSMA, and 
down regulation of type III collagen and Timp2. There was no difference in expression of Mmp9 and 
Timp1. Data expressed as mean ± SD, n=3 biological replicates per group. 
Eng-iKOU fibroblasts 
 
Col1A1 Col3A1 Ctgf Mmp2 Mmp9 Timp1 Timp2 
α-
SMA 
Untreated 
1.0 ± 
0.006 
1.0 
±0.046 
1.0 ± 
0.016 
1.0 ± 
0.008 
1.0 ± 
0.0005 
1.0 ± 
0.002 
1.0 ± 
0.033 
1.0 ± 
0.0005 
TGFβ1 
treated 
0.78 ± 
0.10 
0.31 ± 
0.063 
2.6 ± 
0.55 
0.27 ± 
0.066 
1.64 ± 
0.44 
1.1 ± 
0.14 
0.36 ± 
0.12 
3.1 ± 
1.1 
p value 0.02 0.0001 0.007 <0.0001 0.065 0.14 0.0009 0.029 
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Figure 4.20 The effect of TGFβ1 stimulation on extracellular matrix gene expression in control 
fibroblasts.  
Data expressed as mean ± SD, n=3 biological replicates per group, *p<0.05 
 
 
 
Figure 4.21 The effect of TGFβ1 stimulation on extracellular matrix gene expression in endoglin 
depleted fibroblasts.  
Data expressed as mean ± SD, n=3 biological replicates per group, *p<0.05 
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4.2.4.3 TGFβ1 stimulation results in increased expression of α smooth muscle 
actin. 
 
The change from fibroblast to myofibroblast is an important one during fibrosis (see 
chapter1) and this is associated with increased αSMA expression. Although induction 
of αSMA expression by TGFβ1 stimulation did not appear to be dependent on 
endoglin (figure 4.20 and figure 4.21), it was important to determine whether the 
frequency of myofibroblast differentiation was endoglin dependent. To do this, 
control and endoglin depleted primary cardiac fibroblast were serum starved for 24 
hours followed by incubation with 5ng/ml TGFβ1 or normal media for a further 24 
hours. Following this they were fixed and immunostained with an antibody to αSMA. 
 
TGFβ1 stimulation of control primary cardiac fibroblasts resulted in an increased 
expression of αSMA protein (figure 4.22A and B). There was a similar increase in the 
expression of αSMA in endoglin depleted fibroblasts suggesting a similar level of 
differentiation to the myofibroblast phenotype and that this differentiation process 
was not endoglin dependent. 
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Figure 4.22 Expression of α smooth muscle actin following TGFβ1 stimulation.  
Primary cardiac fibroblasts were stimulated with TGFβ1 for 24 hours. They were then immunostained 
with antibodies against αSMA. A and B, control primary cardiac fibroblasts with (B) and without (A) 
TGFβ1 stimulation. C and D, endoglin depleted primary cardiac fibroblasts with (D) and without (C) 
TGFβ1 stimulation. TGFβ1 stimulation results in an increased expression of αSMA in both groups. 
Scale bar 50µm. 
A 
C D 
B 
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4.3 Discussion 
These experiments were designed to investigate the effect of endoglin knockdown on 
cardiac fibroblasts and their response to TGFβ1 in the context of fibrosis. Fibroblasts 
were readily cultured from adult mouse hearts, and were characterised by their 
morphological properties and by immunocytochemical analysis. With subsequent 
passages (greater than passage2) these cardiac fibroblasts become positive for αSMA, 
suggesting a shift to a myofibroblast phenotype (Gabbiani, 1998; Hinz, 2010). 
Cardiac fibroblasts appear to be predisposed to convert to a myofibroblast phenotype 
in culture. Porter et al found that fibroblasts cultured from normal human atrial 
explants expressed αSMA from the first passage suggesting an early activation of the 
myofibroblast phenotype. These cells remained positive for αSMA with subsequent 
passage (Porter et al., 2004). However, initial immunophenotyping of rat cardiac 
fibroblasts demonstrated that they were negative for αSMA. It is not known if they 
develop a myofibroblast phenotype with subsequent passaging (K. Chen et al., 2004; 
Shyu et al., 2010). TGFβ is an important cytokine in mediating this phenotypic 
transformation (Eghbali et al., 1991b; Leask, 2007).However, culture conditions are 
also important. For example, Masur and colleagues demonstrated that at low seeding 
density the proportion of myofibroblasts was 70 to 80% in rabbit corneal fibroblasts, 
whereas at high seeding density it was 5 to 10% (Masur et al., 1996). In addition to 
seeding density the specific culture medium appears to influence this phenotypic 
change. Rossini et al. demonstrated that human primary cardiac fibroblasts cultured in 
Dulbecco’s modified Eagles medium converted spontaneously to a myofibroblast 
phenotype but those cultured in endothelial growth medium retained a fibroblast 
phenotype (Rossini et al., 2008). In my study, primary mouse cardiac fibroblasts were 
initially negative for αSMA but spontaneously developed a myofibroblast phenotype 
after passage two. As a consequence they likely represent a mixed 
fibroblast/myofibroblast population. Equally, fibroblasts and myofibroblasts are 
present in the healing myocardial infarct and so the presence of these two phenotypes 
in vitro may be more representative of the in vivo situation. 
 
As discussed in chapter 1, endoglin is expressed in fibroblasts isolated from numerous 
tissues. It is also up-regulated in fibroblasts in a number of diseases where fibrosis is a 
feature, such as scleroderma (Leask et al., 2002), Crohn’s disease (Burke et al., 2010) 
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and following myocardial infarction (van Laake et al., 2006). The mouse primary 
cardiac fibroblasts described in this thesis were no exception- with endoglin being 
expressed at all passages. A number of methods have been used to regulate endoglin 
expression in fibroblasts. Endoglin has been targeted using antibodies specific for 
endoglin (K. Chen et al., 2004) or small interfering (si) RNA (Burke et al., 2010; 
Shyu et al., 2010; Morris et al.). Endoglin overexpression studies have been 
performed in rat myoblasts (Obreo et al., 2004), NIH3T3 and dermal fibroblasts 
(Leask et al., 2002) and an intestinal fibroblast cell line (CCD-18Co) (Burke et al., 
2010) and are discussed in chapter 1. In my study I used Cre/lox technology to 
achieve endoglin knockdown. The floxed endoglin mouse line was developed in our 
laboratory (Allinson et al., 2007) and has been used to investigate the role of endoglin 
in retinal angiogenesis (Mahmoud et al., 2010) and tumour angiogenesis (Anderberg 
et al., 2013). I have demonstrated that Rosa26-CreERT2 expression can be induced and 
endoglin efficiently depleted in primary mouse cardiac fibroblasts cultured from the 
Engfl/fl;Rosa26-CreERT2 mouse. Its use in these experiments represents a novel 
approach to investigate the role of endoglin in fibrosis. 
 
The experiments described in this chapter demonstrate that TGFβ1 stimulation of 
control mouse primary cardiac fibroblasts results in phosphorylation of Smad2 and 
induction of Pai-1 expression. There was no detectable effect on Smad1/5/8 
phosphorylation after 30 minutes exposure to TGFβ1, but the baseline level of 
Smad1/5/8 activation was already high. Nevertheless, TGFβ1 stimulation did lead to a 
reduction in Id1 transcription at 24 hours, indicating reduced activation of the 
Smad1/5/8 pathway, perhaps below the level of detection in the western blot 
experiments. The increase in Tgfb1 transcription following TGFβ1stimulation 
demonstrates autocrine induction of Tgfb1 expression. TGFβ1 stimulation also led to 
increased expression of Ctgf and αSMA. Interestingly there was no alteration in 
collagen 1 transcription in response TGFβ1 stimulation, most likely due to the 
activation of this pathway by serum starvation (Leicht et al., 2001) and consequently 
it was not further activated following TGFβ1 stimulation. There was a reduction in 
collagen 3 and Timp2 transcription. Overall, these results are consistent with TGFβ1 
signalling via the Alk5/Smad2/3 pathway in control cardiac fibroblasts, however, 
there was no increased expression of collagen 1 following TGFβ1 stimulation. 
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As expected, endoglin depleted primary cardiac fibroblasts have significantly reduced 
expression of endoglin, which was seen at both protein and mRNA level. There is also 
a small, but significant increase in Id1 transcription under normal culture conditions 
suggesting that endoglin may inhibit the Alk1/Smad 1/5/8 signalling pathway in 
normal fibroblasts. In my studies there was no difference in Alk5 expression between 
control and endoglin depleted cardiac fibroblasts. This differs from endothelial cells 
where Alk5 is reduced in endothelial cells from HHT1 patients (Fernandez et al., 
2005) and endoglin heterozygous mice (Lebrin et al., 2004). One possible explanation 
for this difference is that cells may require time to undergo this adaptation. However, 
endoglin depletion has no effect on the expression of the majority of extracellular 
matrix genes examined in this chapter under the culture conditions used in this chapter. 
 
As with control fibroblasts, TGFβ1 stimulation of endoglin depleted fibroblasts 
results in phosphorylation of Smad2. Again, there is no effect on Smad1/5/8 
phosphorylation but similar reductions in Alk1 and Id1 expression. There is an 
increase in Pai-1 transcription but no increase in Tgfβ1 transcription suggesting that 
endoglin may be important in the autocrine regulation of Tgfβ1. Ctgf and αSMA 
transcription are both up regulated by TGFβ1 in endoglin deficient fibroblasts. 
However, unlike in control fibroblasts, collagen 1 and Mmp2 are both down regulated 
following TGFβ1 stimulation, suggesting that endoglin positively regulates collagen 1 
and Mmp2 gene expression. There is also down regulation of collagen 3 and Timp2 
gene expression. These results suggest that endoglin is involved in the autocrine 
regulation of Tgfβ1 and a positive regulator of collagen 1 and Mmp2 gene expression. 
I observed no differences between control and endoglin deplete fibroblasts in the 
activation of canonical TGFβ signalling pathways. This points to the possibility that 
endoglin is involved in regulation of the non-canonical signalling pathways such as 
MAP kinase (K. Chen et al., 2004) or ERK 1/2 (Kapur et al., 2012). Further work is 
needed to examine the effects of endoglin depletion on collagen protein production in 
response to TGFβ1 and non-canonical TGFβ signalling. 
 
Quantative PCR (qPCR) is a widely used technique to measure gene expression 
(Schmittgen and Livak, 2008). However, there are a number of steps, from isolation 
and purification of RNA through reverse transcription PCR (to generate cDNA) to 
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qPCR and detection chemistry used, prior to achieving a result. All these steps need to 
be performed accurately as there is the possibility of error being introduced at any 
point. The experiments described in this thesis used SYBR green chemistry where the 
fluorescent dye binds to double stranded DNA (dsDNA) in the reaction mix. The 
advantages of this method are that it can be used to monitor the amplication of any 
dsDNA and so multiple genes can be investigated at relatively low cost. However, it 
relies on good primer design and optimisation of the PCR reaction as it can produce 
false positive results with binding to non specific DNA products. This was 
demonstrated during my experiments when quantifying Alk5 expression. The melting 
curve (figure 4.12) for Alk5 demonstrates 2 peaks suggesting the presence of more 
than one DNA product, most likely primer dimer in this case. Taqman chemistry uses 
a flurogenic probe which is released from the quencher dye as the target sequence is 
transcribed. The flurogenic probe is specific to the target sequence and different 
reporter dyes are available which allows amplification of more than one gene in a 
single reaction. Due to this specificity Taqman qPCR is more sensitive than SYBR 
green (Matsenko et al., 2008; Cao and Shockey, 2012) which is of importance when 
dealing with small amounts of isolated RNA. However, it requires the synthesis of 
different probes for each target sequence and as a consequence the cost is greater. 
  
The results described in this chapter have shown that the depletion of endoglin in 
cardiac fibroblasts potentially inhibits the autocrine regulation of TGFβ1 and reduces 
collagen 1 gene expression, suggesting that endoglin positively regulates extracellular 
matrix production. This is in keeping with other studies using rat cardiac fibroblasts 
and in vivo models of organ fibrosis. The effects of endoglin depletion in vivo will be 
investigated in the next chapter. 
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Chapter 5 The Effect of Endoglin on Cardiac Structure and 
Function. 
 
5.1 Introduction 
There is a significantly greater reduction in cardiac function following surgical LAD 
ligation in endoglin heterozygous mice compared to controls, possibly due to 
impaired neovascularisation of the infarct border zone following MI (van Laake et al., 
2006). However, inflammation and fibrosis also play an important role in the healing 
process following myocardial infarction but the role of endoglin in this process is not 
clearly defined. In a renal ischaemia/reperfusion injury model endoglin 
haploinsufficiency was protective (Docherty et al., 2006) with reduced macrophage 
infiltration and activation in endoglin heterozygous mice. The authors concluded that 
it was the reduction in inflammation that resulted in this protection (Docherty et al., 
2006). In the irradiated mouse kidney, endoglin haploinsufficiency was also 
associated with reduced inflammation and a reduction in levels of the inflammatory 
cytokines IL-1β and IL-6 (Scharpfenecker et al., 2012). The attenuation of 
inflammatory response in endoglin heterozygous mice is likely to explain the reduced 
fibrosis seen in this model (Scharpfenecker et al., 2009). Although endoglin is 
expressed on activated macrophages (Lastres et al., 1992), endothelial endoglin has 
been shown to be involved in the adhesion and transmigration of inflammatory cells 
(Elisa Rossi et al., 2013). There is also impaired homing of mononuclear cells isolated 
from patients with HHT type 1 to infarcted myocardium in mouse models (Post et al., 
2010) which may be mediated through the SDF1/CXCR4 axis (Post et al., 2010; K. 
Young et al., 2012).  It is unclear if the effects of endoglin in inflammation are due to 
direct effects on inflammatory cells, particularly macrophages, or on the adhesion and 
transmigration of these cells into injured tissue. It has also been demonstrated that 
endoglin is expressed in cardiac fibroblasts (K. Chen et al., 2004; Shyu et al., 2010; 
Kapur et al., 2012), in myofibroblasts during wound healing in skin (Torsney et al., 
2002) and modulates fibrosis in a cardiac pressure overload model (Kapur et al., 
2012). All of these are important in healing following myocardial infarction but I was 
particularly interested in the effect of endoglin on fibrosis following myocardial 
infarction. I initially hypothesised that a reduction in fibrosis in the early period 
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following myocardial infarction resulted in a reduced tensile strength of the infarct 
leads to infarct expansion, as described in chapter 1, and accounted for the difference 
in cardiac function following MI in endoglin heterozygous mice. Whilst testing this 
hypothesis I discovered a novel phenotype in the Eng-iKOu mouse, which is described 
in this chapter, so the focus of my studies changed during the course of my PhD. The 
work form this chapter has not yet been published as there are ongoing experiments to 
characterise this novel phenotype further.  
 
5.2 Results 
5.2.1 The expression of endoglin in normal mouse myocardium 
To investigate the role of endoglin following myocardial infarction it was important to 
first establish its expression pattern in normal myocardium. Immunohistochemistry, 
using a monoclonal antibody against endoglin, was performed on 10µm cryosections, 
sectioned in the short axis of control (Engfl/fl) mice hearts. This demonstrated that 
endoglin is highly expressed in the mouse heart, particularly in the endocardium and 
cells surrounding cardiomyocytes but not in the cardiomyocytes themselves (figure 
5.1A & B). To establish in which non-cardiomyocytes endoglin was expressed I 
performed co-immunofluorescence of endothelial cells (CD31), smooth muscle cells 
(α-smooth muscle actin (SMA)) and fibroblasts (fibroblast specific protein (Fsp1)). 
Figure 5.1C to E demonstrates that endoglin is co-expressed with CD31 in endothelial 
cells, as expected. Endoglin does not co-express with vessel associated αSMA in the 
vascular smooth muscle cells. Most Fsp1 positive cells do not co-localise with 
endoglin, but a small number do, which likely represents endothelial cells and 
fibroblasts in close proximity. This demonstrates that in mouse hearts, endoglin is 
expressed in endothelial cells but not in cardiomyocytes, smooth muscle cells or 
fibroblasts. 
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Figure 5.1 The expression pattern of endoglin in normal mouse myocardium. 
10µm cryosection of mouse myocardium were cut in the short axis of the heart. A&B. Low and high 
power images of DAB stained sections demonstrating endoglin expression in the endocardium (black 
arrow) and non-cardiomyocyte cells in the myocardium (white arrow). Scale bar 50µm. 
 
5.2.2 The expression of endoglin in the heart following myocardial infarction 
In order to investigate the expression of endoglin within the myocardium following 
myocardial infarction I performed permanent coronary artery ligation of the left 
anterior descending artery (LAD) or sham operation on control (Engfl/fl) mice. 
Animals were euthanised 1, 3, and 5 days post infarct and the heart processed to 
prepare cryosections. Immunohistochemistry and immunofluorescence was performed 
on 10µm cryosections. Figure 5.2 shows an overview of the early changes in the 
infarcted myocardium. The infarcted myocardium was identified anatomically using 
low power to determine the anterior wall of the left ventricle which is supplied by the 
LAD artery. There is an infiltration of what appear to be inflammatory cells into the 
infarcted myocardium on day 1 post infarct (figure 5.2B & F). By day 3 post infarct 
the number of infiltrated cells has increased (figure 5.2C & G) and by day 5 post 
infarct there is heavy infiltration of cells into the infarcted myocardium, figure 5.2D 
& F. These changes represent the inflammatory and proliferative phases of infarct 
healing and were further examined using immunofluorescence microscopy. 
 
Over the same time period (day 1 to day 5 post MI) there is a large increase in 
expression of endoglin within the infarcted myocardium (figure 5.3). In order to 
investigate which cells expressed endoglin, cryosections were co-stained with 
antibodies to endoglin as well as CD31 (for endothelial cells), CD11b (for 
macrophages), Fsp1 (for fibroblasts) and αSMA (for myofibroblasts and vascular 
smooth muscle cells). Figure 5.4 shows that there is an increase in endothelial cells in 
A B 
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the infarcted myocardium and that they all co-express endoglin and CD31. There is an 
increase in macrophages over time following myocardial infarction but these cells do 
not co-express endoglin (figure 5.5). Within the first day following infarction there 
are no myofibroblasts present, with only vessel associated smooth muscle staining 
positive for αSMA (figure 5.6A). By day 3 post infarct, myofibroblasts start to be 
seen but the expression of αSMA is low (figure 5.6B). There is a significant increase 
in myofibroblast infiltration by day 5 (figure 5.6C). At day 3 and 5 these 
myofibroblasts do co-localise with endoglin (figure 5.6, arrows). However, the 
expression of endoglin is lower in myofibroblasts than in endothelial cells. Figure 5.7 
demonstrates fibroblast infiltration into the infarcted myocardium over time. However, 
Fsp1 expression is not co-localised with endoglin, suggesting that the endoglin 
becomes expressed as the phenotype changes from fibroblast to myofibroblast. 
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Figure 5.2 Histological changes in the myocardium following coronary artery ligation. 
H&E staining at low (A-D) and high (E-F) power of the normal myocardium from control mice (A&E) and myocardium in the infarcted region 1 day (B&F) 3 days (C&G) 
and 5 days (D&H) following coronary artery ligation. There is infiltration of cells into the infarcted myocardium by day one (F) that increase in number at day 3 (G) a 
process that is more marked by day 5 (H). Scale bars: 500µm A-D and 50µm E-H. 
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Figure 5.3 Expression of endoglin post MI. 
Immunohistochemical staining with a monoclonal antibody to endoglin in the infarcted myocardium at 1 day (A), 3 days (B) and 5 days (C) following coronary artery 
ligation shows a dramatic increase in endoglin expression (brown) . No primary control (D). All sections are counter stained with haematoxylin to detect nuclei. Scale bar 
50µm. 
 
A C B D 
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Figure 5.4 Co-immunofluorescence of endoglin (red) and CD31 (green) in the infarcted 
myocardium at 1 day (A) 3 days (B) and 5 days (C) following coronary artery ligation. 
Normal myocardium (D) and no primary control (D inset). These images show that an infiltration and 
proliferation of endothelial cells in the infarct zone and they are all endoglin positive. Dapi (blue) was 
used to stain nuclei. Scale bar 50µm.  
A 
D 
B 
C 
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Figure 5.5 Double immunofluorescent staining of endoglin (red) and CD11b (green)  in the 
myocardium of the infarcted myocardium at 1 day (A) 3 days (B) and 5 days (C) following 
coronary artery ligation. 
Normal myocardium (D) and no primary control (D inset) are shown for comparison. These images 
show that there are an increasing number of CD11b-positive macrophages in the infarcted myocardium 
after day 1. The macrophages do not appear to co-express endoglin. Dapi (blue) was used to stain 
nuclei. Scale bar 50µm. 
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Figure 5.6 Double immunofluorescent staining of endoglin (red) and α SMA (green) in the 
myocardium of the infarcted myocardium at 1 day (A) 3 days (B) and 5 days (C) following 
coronary artery ligation. 
Normal myocardium (D) and no primary control (D inset). These images show that by day 3 there is an 
infiltration of αSMA positive cells, which likely represent myofibroblasts. These have significantly 
increased in number by day 5. Some of these cells co-express endoglin (white arrows). Dapi (blue) was 
used to stain nuclei. Scale bar 50µm. 
D 
C 
B A 
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Figure 5.7 Double immunofluorescent staining of endoglin (red) and fibroblast specific protein 1 
(Fsp1, green) in the myocardium of the infarcted myocardium 1 day (A) 3 days (B) and 5 days 
(C) following coronary artery ligation. 
Normal myocardium (D) and no primary control (D inset). These images show that there are an 
increased number of fibroblasts in the infarcted myocardium at days 3 and 5 compared with day 1. 
There is no detectable co-expression with endoglin. Dapi (blue) was used to stain nuclei. Scale bar 
50µm. 
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5.2.3 Endoglin depletion in adult myocardium 
Having demonstrated that endoglin expression is increased following myocardial 
infarction, in both endothelial cells and myofibroblasts, I next aimed to evaluate the 
role of endoglin in these cells following myocardial infarction. In order to address the 
role of endoglin I needed to evaluate whether endoglin can be efficiently knocked 
down in both these cell types in an inducible endoglin knockout mouse. As endoglin 
is expressed in both myofibroblasts and endothelial cells in the infarcted tissue I 
aimed to knock down endoglin in all cell types to test my hypothesis. For this reason I 
used the tamoxifen inducible Rosa26;CreERT2 line crossed with the Engfl/fl line, to 
provide the option of ubiquitous knockdown of endoglin. To assess the expression of 
Rosa26;CreERT2 in the myocardium, Engfl/+; Rosa26;CreERT2;Rosa26R mice 
(described in chapter 4) were treated with an intra-peritoneal injection of 2mg 
tamoxifen once a day for 5 days. Myocardial cryosections were then stained with X-
gal, which demonstrated that Rosa26;CreERT2 is expressed in the myocardium (figure 
5.8). This illustrated widespread but not absolutely ubiquitous expression and/or 
activation of the Rosa26 lacZ Cre reporter. However although known to be imperfect, 
the Rosa26 promoter is widely used to drive ubiquitous gene expression and was the 
best available mouse line for this study. 
 
 
Figure 5.8 Rosa26;CreERT2 is expressed in the majority of  myocardial cells  as judged by the 
activation of lacZ expression (blue) in the heart tissue from Rosa26;CreERT2;Rosa26R  mice after 
tamoxifen treatment 
(A). Control image (B). Scale bar 50µm. 
 
As we did not know the optimum duration of tamoxifen treatment that would result in 
endoglin knockdown, the next experiment was designed to assess this. 
Engfl/fl;Rosa26;CreERT2 mice (n=3 per group) were treated with tamoxifen (ip 
A B 
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injection of 2mg per day) according to the following different protocols. Group 1 
were treated for 3 consecutive days, group 2 were treated for 5 consecutive days and 
group 3 were treated for 5 consecutive days followed by 2 further 2mg tamoxifen 
doses on days 7 and 9. All animals were euthanised 3 days after the last dose. 
Untreated control animals (n=2) showed a normal pattern of endoglin expression 
(figure 5.9 A & B). Mice (Engfl/fl;Rosa26;CreERT2) in group 1 showed a reduction in 
endoglin expression, but knockdown was not complete (figure 5.9 D-F). There is 
significant knockdown of endoglin after 5 days of tamoxifen treatment (group 2, 
figure 5.9 G-H). In group 3 there is also significant knockdown of endoglin but no 
greater than that seen in group 2 (figure 5.9 J-L). Surprisingly, in 2 of the mice from 
group 3 (both littermates) the knockdown was not as efficient (figure 5.9 J &K). 
Consequently in all subsequent experiments endoglin knockdown was achieved by 5 
daily doses of 2mg tamoxifen. 
 
As I proposed to assess cardiac function at 4 weeks post infarct it was important to 
ensure that endoglin expression did not return and remained depleted for the duration 
of the study. To investigate this Engfl/fl;Rosa26;CreERT2 mice were treated with 
tamoxifen (2mg daily for 5 days, as for group 2 above). They were then euthanised 10 
weeks following the first dose of tamoxifen. Figure 5.10 demonstrates that 10 weeks 
following tamoxifen treatment endoglin remains depleted in the heart. 
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Figure 5.9 Evaluating endoglin knockdown in the Engfl/fl;Rosa26;CreERT2 mouse following CreERT2 activation with different doses of tamoxifen. 
Represenative cryosections of the left ventricle of control mice (A&B) show normal levels of endoglin, which is only slightly reduced following the 3 dose protocol (D-F), 
whereas there is a considerable reduction following the 5 dose protocol (G-I) and in some of the mice given the 7 dose protocol (J-L). A no primary control image 
demonstrates staining specificity. (C). Together these images demonstrate knock down of endoglin following 5 and 7 doses of tamoxifen. Scale bar 50µm.
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Figure 5.10 Sustained knock down of endoglin expression  after 10 weeks following Cre-ERT2 
activation. 
Endoglin expression in Engfl/fl control (A-C), and in Engfl/fl;Rosa26;CreERT2 mice 10 weeks following 
tamoxifen treatment using the 5 dose regimen(D-F). This demonstrated a sustained depletion of 
endoglin at the10 week time point. Scale bar 50µm.
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5.2.4 The effect of endoglin knockdown on cardiac function following myocardial 
infarction 
 
Having established a reproducible and stable level of endoglin knockdown in the 
Engfl/fl;Rosa26;CreERT2 mice I proceeded to test the hypothesis that endoglin is 
required for efficient tissue repair following myocardial infarction. Initially a pilot 
group of Engfl/fl;Rosa26;CreERT2 mice were treated with tamoxifen (i.p. 2mg daily, for 
five days) to generate “ubiquitous” endoglin knockdown mice, from here on termed 
Eng-iKOu  mice. In parallel, Engfl/fl mice (termed control mice) were treated with 
tamoxifen in the same way and served as controls. Three days following the last dose 
of tamoxifen all mice underwent permanent LAD ligation or sham operation, thus 
giving four groups (control mice with sham operation, control mice with LAD 
ligation, Eng-iKOu  mice with sham operation and Eng-iKOu  mice with LAD ligation). 
Four weeks following MI, cardiac MRI was performed to evaluate cardiac function in 
vivo. 
 
Analysis of left ventricular mass and function in the different treatment groups are 
given in table 5.1 and figure 5.11. The data indicate that compared to control mice 
following MI, Eng-iKOu mice  have greater LV mass (205.0 ± 10.6mg vs. 123.0 ± 
3.6mg) and volumes (end diastolic volume 169.7 ± 3.5µl vs. 83.2 ± 3.1µl and end 
systolic volume 104.8 ± 3.7µl vs. 40.0 ± 2.7µl), with reduced cardiac function 
(ejection fraction 38.3 ± 0.9% vs. 52.1 ± 1.6%). Infarct size, as a percentage of the left 
ventricle, was similar in both groups (20.5 ± 0.8% vs. 18.9 ± 2.1%). These results 
suggest that there is greater left ventricular adverse remodelling in mice following 
endoglin knockdown. However, in the sham operated, Eng-iKOu mouse there 
appeared to be a similar increase in left ventricular mass (208.1mg) and volumes (end 
diastolic volume 148.0µl and end systolic volume 66.8µl), but with only slightly 
reduced function (ejection fraction 54.9%). This led me to consider whether endoglin 
depletion alone, without cardiac injury, resulted in left ventricular remodelling. 
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Table 5.1 Analysis of MRI data to show cardiac function 4 weeks following coronary artery 
ligation in control and Eng-iKOu mice. 
Data expressed as mean (± SE  when n>2) 
Control Eng-iKOU 
 Sham (n=1) MI (n=4) Sham (n=1) MI (n=2) 
Age at infarct 
(wks) 8.1 9.2 ± 0.3 9.7 9.3  
Sex 
 
F 2M 2F M 2M 
Weight 
(g) 22.6 24.6 ± 1.7 30.6 30.4 
Heart rate 
(bpm) 420 337 ± 6.2 414 378 
LV mass 
(mg) 108.3 123.0 ± 3.6 208.1 205.0 
LV mass index 
(mg/g) 4.8 5.1 ± 0.3 6.8 6.8 
EDV 
(µl) 61.9 83.2 ± 3.1 148.0 169.7 
EDVI 
(µl/g) 2.7 3.4 ± 0.2 4.8 5.6 
ESV 
(µl) 22.3 40.0 ± 2.7 66.8 104.8 
ESVI 
(µl/g) 1.0 1.6 ± 0.1 2.2 3.46 
SV 
(µl) 39.5 43.2 ± 0.9 81.2 64.9 
SVI 
(µl/g) 1.8 1.8 ± 0.1 2.7 2.1 
Ejection fraction 
(%) 63.9 52.1 ± 1.6 54.9 38.3 
CO 
(ml/min) 16.61 14.6 ± 0.4 33.6 24.5 
CI 
(ml/min/g) 0.73 0.6 ± 0.1 1.1 0.8 
Infarct size 
(%LV) n/a 18.9 ± 2.1 n/a 20.5 
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Figure 5.11 Cardiac volumes and function 4 weeks following coronary artery ligation in control 
and Eng-iKOu mice. 
Data suggests loss of endoglin alone leads to an increase in LV volume and an increase in cardiac 
output. Small group sizes prohibits statistical analysis. 
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5.2.5 Endoglin depletion results in significant ventricular remodelling 
To study the effect of endoglin depletion without cardiac injury on the mouse heart, 
Engfl/fl;Rosa26;CreERT2 and control (Engfl/fl) mice were treated with tamoxifen, 
2mg/day for 5 days. MRI was performed at 5 weeks following the first dose of 
tamoxifen. This is equivalent to the analysis time point used in the experiment 
described in section 5.2.4, where the timing of MRI was 4 weeks after MI, but 5 
weeks after the first dose of tamoxifen. 
 
It is clear from the MRI images (figure 5.12) and the autopsy specimens (figure 5.13) 
that the hearts are significantly larger in the endoglin knockdown group. MRI analysis 
of cardiac size and function are given in table 5.2 and shown in figure 5.14 and figure 
5.15. It demonstrates that there is a significant increase in left ventricular mass (157.4 
± 12.9mg vs. 102.5 ± 13.3mg, p=0.03) and biventricular dilatation (LVEDV = 113.1 ± 
8.8µl vs. 60.4 ± 2.5µl, p=0.004 and RVEDV = 93.4 ± 6.4µl vs. 52.3 ± 4.0µl, p=0.004) 
following endoglin knockdown. End systolic volumes were also significantly 
increased in the endoglin knockdown group (LVESV = 39.2 ± 4.0µl vs. 18.3 ± 0.6µl, 
p=0.007 and RVESV = 28.7 ± 2.6µl vs. 13.3 ± 2.3µl, p=0.009). As a result, in the 
endoglin knockdown group there was a significant increase in stroke volumes (LVSV 
= 73.9 ± 5.6µl vs. 42.1 ± 2.8µl, p=0.006 and RVSV = 64.7 ± 4.2µl vs. 39.0 ± 1.7µl, 
p=0.004) and consequently cardiac output (LVCO = 30.3 ± 2.8µl vs. 19.3 ± 1.6µl, 
p=0.03 and RVCO = 26.4 ± 1.7µl vs. 17.9 ± 1.1µl, p=0.01). However, ejection 
fraction was not significantly altered (LVEF = 65.5 ± 1.6% vs. 69.5 ± 2.0%, p=0.2 
and RVEF = 69.4 ± 1.3% vs. 74.9 ± 2.4%, p=0.08). These differences all remained 
significant following indexing to body weight, with the exception of right ventricular 
stroke volume index and cardiac index. Interestingly the heart rate was significantly 
lower in the endoglin knockdown group compared to control (408 ± 8bpm vs. 458 ± 
10bpm, p=0.01). 
 
To confirm that the observed increase in left ventricular mass was secondary to 
myocyte hypertrophy, paraffin section from hearts of endoglin knockdown and 
control mice were stained with fluorescein conjugated wheat germ agglutinin, which 
binds carbohydrate residues on the cell membrane. Cross sectional area of the 
cardiomyocytes was then measured as described previously. Figure 5.16 demonstrates 
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that there was a significant increase in cardiomyocyte cross sectional area in the 
endoglin knockdown mice (154 ± 5.9µm2 vs. 202 ± 5.8µm2, p<0.0001). This confirms 
that the increase in left ventricular mass was indeed due to cardiomyocyte 
hypertrophy. 
 
These data demonstrate that endoglin knockdown results in biventricular remodelling 
even in the absence of cardiac injury. However, stroke volume and cardiac output 
were both increased, with no difference in ejection fraction, suggesting that cardiac 
function is not impaired. It is unclear from these data why this remodelling occurs. 
Ventricular remodelling was not seen in the endoglin heterozygous mouse in the 
absence of cardiac injury (van Laake et al., 2006) and so perhaps suggests that there is 
a “dose” effect whereby these changes are only seen following >50% endoglin 
depletion. There are also reports of myocardial toxicity from Cre recombinase 
(Buerger et al., 2006; Koitabashi et al., 2009) and so it is important to exclude this as 
a possible cause of the ventricular remodelling. Finally, are these changes due to the 
effect of endoglin depletion within the heart or are they secondary effects from 
endoglin depletion in the vascular system, such as the development of arteriovenous 
malformations leading to a high output cardiac failure? The following experiments 
aim to address some of these possibilities. 
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Figure 5.12 Cardiac MRI of control (Engfl/fl) and Eng-iKOu mice. 
This demonstrates significant left and right ventricular remodelling in the Eng-iKOu mice 5 weeks after initiating endoglin knockdown, even in the absence of myocardial 
injury. 
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Figure 5.13 Macroscopic images of hearts from control (A-C) and endoglin iKOu (D-F) adult 
mice. 
There is an increase in heart size in Eng-iKOu mice, 5 weeks after initiating depletion of endoglin. 
A&D, B&E and C&F are the same sex and littermates. Scale bar 5mm. 
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Table 5.2 Cardiac mass, volumes and function in control and Eng-iKOu adult mice 5 weeks after 
the first tamoxifen dose. 
This shows a significant change in the majority of these criteria in Eng-iKOu mice.  Data expressed as 
mean ± SE 
 
Control 
(n=3) Eng-iKO
U
 (n=4) p value 
Mouse Weight (g) 24.1 ± 3.2 29.0 ± 1.6 0.2 
Sex 2M 1F 3M 1F n/a 
Heart rate (bpm) 458 ± 10 408 ± 8 0.01 
Left Ventricle 
LV mass (mg) 102.5 ± 13.3 157.4 ± 12.9 0.03 
LV mass index (mg/g) 4.3 ± 0.1 5.4 ± 0.2 0.004 
EDV (µl) 60.4 ± 2.5 113.1 ± 8.8 0.004 
EDVI (µl/g) 2.6 ± 0.3 3.9 ± 0.1 0.005 
ESV (µl) 18.3 ± 0.6 39.2 ± 4.0 0.007 
ESVI (µl/g) 0.8 ± 0.1 1.4 ± 0.1 0.01 
SV (µl) 42.1 ± 2.8 73.9 ± 5.6 0.006 
SVI (µl/g) 1.8 ± 0.2 2.5 ± 0.1 0.01 
Ejection fraction (%) 69.5 ± 2.0 65.5 ± 1.6 0.2 
CO (ml/min) 19.3 ± 1.6 30.3 ± 2.8 0.03 
CI (ml/min/g) 0.8 ± 0.1 1.0 ± 0.04 0.05 
Right Ventricle 
EDV (µl) 52.3 ± 4.0 93.4 ± 6.4 0.004 
EDVI (µl/g) 2.2 ± 0.1 3.2 ± 0.2 0.02 
ESV (µl) 13.3 ± 2.3 28.7 ± 2.6 0.009 
ESVI (µl/g) 0.6 ± 0.02 1.0 ± 0.1 0.004 
SV (µl) 39.0 ± 1.7 64.7 ± 4.2 0.004 
SVI (µl/g) 1.7 ± 0.1 2.3 ± 0.2 0.055 
Ejection fraction (%) 74.9 ± 2.4 69.4 ± 1.3 0.08 
CO (ml/min) 17.9 ± 1.1 26.4 ± 1.7 0.01 
CI (ml/min/g) 0.8 ± 0.05 0.9 ± 0.06 0.1 
.
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Figure 5.14 Left ventricular volumes and function in control and Eng-iKOu mice. 
Analysis of MRI data shows a significant increase in LV volume and LV mass and LV cardiac output, 
but no change in LV ejection fraction at 5 weeks following initiation of endoglin depletion.  Data 
expressed as mean ± SE. * p<0.03 
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Figure 5.15 Right ventricular volumes and function in control and Eng-iKOu mice. 
This shows that there is a significant increase in RV volume and cardiac output, but no change in RV 
ejection fraction at 5 weeks following initiation of endoglin depletion. Data expressed as mean ± SE; * 
p<0.01. 
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Figure 5.16 Cardiomyocyte size of control and Eng-iKOu mice. 
Wheat germ agglutinin staining of left ventricular cardiomyocytes of control (A) and Eng-iKOu (B) 
mice. C. Analysis of average cardiomyocyte area demonstrating cardiomyocyte hypertrophy in Eng-
iKOu mice. Data expressed as mean ± SE; * p<0.05. 
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an endoglin dose effect as only a single floxed allele is present. Heterozygosity for a 
null mutation in endoglin leads to a significant reduction of endoglin expression 
compared with wild type (Mahmoud et al., 2008) but does not lead to complete loss 
of endoglin. Therefore tamoxifen treatment of the Engfl/+;Rosa26;CreERT2 line is 
expected to generate a mouse that is equivalent to the heterozygous Eng+/- mouse and 
to have residual endoglin expression driven by the wild type endoglin allele. Engfl/fl 
mice were used as controls. All animals were treated with tamoxifen as described 
above and cardiac MRI was performed 5 weeks following the first dose. 
 
The results are shown in table 5.3. They demonstrate that there is no difference in LV 
mass, volumes or function in Engfl/+;Rosa26;CreERT2 or Rosa26;CreERT2 mice when 
compared to controls. The LV mass index and cardiac index is significantly lower in 
Rosa26;CreERT2 mice compared to control mice (p=0.01 for both LV mass index and 
cardiac index) but there is no significant difference between control and 
Engfl/+;Rosa26;CreERT2 mice (LV mass index p= 0.07 and LV cardiac index p=0.06) 
or between Engfl/+;Rosa26;CreERT2 and Rosa26;CreERT2 mice (LV mass index p=0.5 
and LV cardiac index p=0.7). 
 
These results clearly demonstrate that there is an endoglin ‘dose’ effect as no cardiac 
remodelling was seen with partial endoglin knockdown. This is consistent with the 
lack of reported generalised cardiac function defects in HHT1 patients, who are 
heterozygous for loss of function mutations in endoglin. Equally, Cre recombinase 
activation alone also does not result in ventricular remodelling thus excluding a direct 
myocardial toxicity effect of Cre activity. 
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Table 5.3 Cardiac mass, volumes and function calculated from MRI analysis of control (Engfl/fl), 
Engfl/+;Rosa26;CreERT2 and Rosa26;CreERT2 mice at 5 weeks following initiation of tamoxifen 
treatment. 
 
Control 
(n=4) 
Eng fl/+ Rosa 
Cre-ERT2  
(n=6) 
Rosa Cre-ERT2 
(n=7) 
p value 
(ANOVA) 
Weight 
(g) 26.5 ± 2.4 26.0 ± 1.6 29.0 ± 1.5 0.4 
Heart rate 
(bpm) 445 ± 27 400 ± 26 417 ± 16 0.4 
Sex 
 
2M 2F 3M 3F 5M 2F n/a 
Left Ventricle 
LV mass 
(mg) 105 ± 6 91.1 ± 2.3 98.6 ± 3.2 0.07 
LV mass index 
(mg/g) 4.1 ± 0.2 3.6 ± 0.2 3.4 ± 0.1 0.02 
EDV 
(µl) 65.2 ± 3.2 60.0 ± 2.2 62.7 ± 1.9 0.4 
EDVI 
(µl/g) 2.6 ± 0.2 2.4 ± 0.2 2.2 ± 0.1 0.3 
ESV 
(µl) 21.0 ± 1.1 18.3 ± 2.0 19.3 ± 0.7 0.5 
ESVI 
(µl/g) 0.8 ± 0.1 0.7 ± 0.1 0.7 ± 0.04 0.5 
SV 
(µl) 44.2 ± 2.7 41.7 ± 0.6 43.4 ± 1.7 0.6 
SVI 
(µl/g) 1.7 ± 0.1 1.6 ± 0.1 1.5 ± 0.03 0.2 
EF 
(%) 67.7 ± 1.5 69.9 ± 2.1 69.2 ± 1.0 0.7 
CO 
(ml/min) 19.7 ± 1.9 16.6 ± 0.9 18.2 ± 1.2 0.3 
CI 
(ml/min/g) 0.8 ± 0.04 0.6 ± 0.03 0.6 ± 0.02 0.03 
Right Ventricle 
EDV 
(µl) 51.6 ± 3.4 49.9 ± 2.2 54.9 ± 1.3 0.2 
EDVI 
(µl/g) 2.0 ± 0.2 2.0 ± 0.2 2.2 ± 0.1 0.9 
ESV 
(µl) 15.8 ± 1.8 13.1 ± 1.0 16.2 ± 0.9 0.1 
ESVI 
(µl/g) 0.6 ± 0.1 0.5 ± 0.05 0.6 ± 0.03 0.4 
SV 
(µl) 35.8 ± 1.9 36.8 ± 1.7 38.7 ± 1.0 0.6 
SVI 
(µl/g) 1.4 ± 0.1 1.5 ± 0.1 1.4 ± 0.1 0.8 
EF 
(%) 69.7 ± 1.7 73.8 ± 1.6 70.6 ± 1.3 0.2 
CO 
(ml/min) 15.9 ± 0.8 14.5 ± 1.6 16.2 ± 0.9 0.3 
CI 
(ml/min/g) 0.6 ± 0.02 0.6 ± 0.04 0.6 ± 0.02 0.4 
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5.2.7 Progression of ventricular remodelling following endoglin depletion 
Five weeks following the first dose of tamoxifen, ubiquitous endoglin depletion in 
Eng-iKOu mice had resulted in significant ventricular remodelling (table 5.2) but there 
was no significant difference in systolic function. However, it was unknown how 
early these ventricular remodelling changes began, nor whether the remodelling 
would persist, improve or deteriorate with time and whether there would be further 
progression to systolic dysfunction. Therefore, an experiment was designed to 
investigate this progression over time. A significant advantage of cardiac MRI is the 
ability to perform serial studies in the same mice. Therefore, Eng-iKOu and control 
(Engfl/fl) mice were imaged before tamoxifen treatment and then at 1, 3, 5 and 12 
weeks following the first dose of tamoxifen. The mice were all the same age (68 days) 
at the time of the first tamoxifen dose and all subsequent MRI scans were performed 
on the same day in the same order. LV mass and cardiac functional parameters were 
than calculated as previously described. Statistical analysis was performed using 
repeated measures ANOVA and post hoc comparisons were made using Tukey-
Kramer method. 
 
Figure 5.17 shows cardiac MRI images of both control and Eng iKOu mice at the 
different time points. They show that visually there is little change in the size of the 
control hearts over time but in the hearts of Eng-iKOu mice there is obvious dilatation 
of both the left and right ventricle as would be expected from previous studies. 
Importantly these changes appear to persist at 12 weeks.  
 
Analysis of left ventriculer volume, function and mass (table 5.4 and figure 5.18) and 
right ventricular volume and function (table 5.5 and figure 5.19) reveal that there is no 
significant difference between the groups at baseline. Thus demonstrating that there is 
no difference in phenotype between the Engfl/fl and Engfl/fl;Rosa26;CreERT2 mice prior 
to CreERT2 activation. Over the course of the study both mouse weight and mean heart 
rate increased over time in both groups. However, there were no significant 
differences between the groups over time (p=0.5 and p=0.8 respectively, repeated 
measures ANOVA for group by time). However, following CreERT2 activation, there 
were progressive increases in left ventricular mass as well as left and right ventricular 
volumes in the Eng-iKOu mice, compared to control mice, that increased over the 12 
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week study period (p<0.003, repeated measures ANOVA for group by time). The 
changes in ventricular volumes resulted in significant increases in stroke volume and 
consequently cardiac output in Eng-iKOu mice (p<0.001, repeated measures ANOVA 
for group by time). However, there was no significant difference in ejection fraction 
over this time suggesting that systolic function is preserved, despite the ventricular 
remodelling that has occurred. 
 
These data confirm that, over the course of 12 weeks, ventricular remodelling occurs 
in Eng-iKOu mice but not in control mice. Post hoc analysis of the data also reveals 
that in Eng-iKOu mice there are significant differences in left ventricular mass, end 
diastolic volume, stroke volume and cardiac output at 3 weeks (p<0.05 compared to 
baseline measurements). This demonstrates that significant ventricular remodelling 
has occurred by 3 weeks post Cre activation. 
 
Interestingly, in the Eng-iKOu mice there is no difference in ejection fraction 
suggesting that systolic function is preserved in these mice. However, ejection 
fraction is just one measure of cardiac function and these data do not allow us to look 
for changes in myocardial contractility or diastolic function. Equally, cardiac output is 
increased suggesting that there may be changes in the wider cardiovascular system 
that led to the ventricular remodelling. In order to investigate some of these 
possibilities cardiac catheterisation of control and Eng-iKOu mice was performed at 5 
weeks following Cre induction to investigate cardiac pressure volume relationships. 
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Figure 5.17 Cardiac MRI of hearts in diastole in the same control and Eng-iKOu mice following tamoxifen treatment demonstrating increased right and left 
ventricular dilatation following endoglin depletion. 
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Table 5.4  Left ventricular volume and function in control (n=4, 2M 2F) and Eng-iKOu (n=6, 3M 3F) mice over time following tamoxifen treatment. 
Data analysed from MRI images and expressed as mean ± SE, p value represents repeat measures ANOVA, *=p<0.05 post hoc comparison compared to control mice at same 
time point using Tukey-Kramer method. 
Time Baseline 1 week 3 weeks 5 weeks 12 weeks 
Group Control Eng-iKOU Control Eng-iKOU Control Eng-iKOU Control Eng-KOU Control Eng-iKOU 
p value 
Weight 
(g) 23.6 ± 2.2 23.4 ± 1.4 25.0 ± 2.0 24.9 ± 1.2 26.1 ± 1.8 26.6 ± 1.7 26.5 ± 2.4 27.4 ± 1.3 31.1 ± 3.6 30.2 ± 1.6 0.5 
Heart rate 
(bpm) 408 ± 17 389 ± 14 418 ± 36 402 ± 18 469 ± 25 429 ± 11 445 ± 27 436 ± 9 442 ± 11 430 ± 21 0.8 
LV mass 
(mg) 88.8 ± 2.6 82.4 ± 1.9 96.9 ± 8.1 88.1 ± 4.3 101.8 ± 6.1 118.6 ± 6.3 105 ± 6 129 ± 5.4* 103 ± 3.2 148 ± 5.6* <0.001 
LV mass 
index 
(mg/g) 
3.9 ± 0.4 3.6 ± 0.3 3.9 ± 0.07 3.6 ± 0.16 3.9 ± 0.1 4.5 ± 0.1* 4.1 ± 0.2 4.7 ± 0.1* 3.4 ± 0.3 5.0 ± 0.2* <0.001 
LV EDV 
(µl) 60.6 ± 3.8 59.3 ± 1.6 62.2 ± 5.7 65.7 ± 3.0 65.6 ± 4.3 94.0 ± 6.0* 65.2 ± 3.2 106 ± 7.9* 70.8 ± 7.4 120 ± 9.9* <0.001 
LV EDVI 
(µl/g) 2.6 ± 0.2 2.6 ± 0.1 2.5 ± 0.03 2.7 ± 0.12 2.5 ± 0.1 3.6 ± 0.1* 2.6 ± 0.2 3.9 ± 0.2* 2.3 ± 0.08 4.0 ± 0.3* <0.001 
LV ESV 
(µl) 20.4 ± 2.3 20.0 ± 2.3 15.1 ± 2.6 15.9 ± 1.0 19.2 ± 2.3 26.9 ± 2.7 21.0 ± 1.1 36.3 ± 5.1 24.9 ± 4.0 45.3 ± 5.5* 0.002 
LV ESVI 
(µl/g) 0.9 ± 0.05 0.9 ± 0.1 0.6 ± 0.06 0.7 ± 0.06 0.7 ± 0.05 1.0 ± 0.06* 0.8 ± 0.1 1.3 ± 0.1* 0.8 ± 0.05 1.5 ± 0.2* 0.003 
LV SV 
(µl) 40.2 ± 2.5 39.3 ± 1.0 47.1 ± 3.4 49.8 ± 2.6 46.4 ± 2.2 67.0 ± 3.7* 44.2 ± 2.7 69.9 ± 2.9* 45.9 ± 3.6 75.0 ± 5.3* <0.001 
LV SVI 
(µl/g) 1.8 ± 0.2 1.7 ± 0.1 1.9 ± 0.04 2.0 ± 0.08 1.8 ± 0.09 2.5 ± 0.1* 1.7 ± 0.1 2.6 ± 0.1* 1.5 ± 0.08 2.5 ± 0.1* <0.001 
LV EF 
(%) 66.6 ± 2.8 66.5 ± 2.8 76.2 ± 2.1 75.7 ± 1.4 71.1 ± 1.7 71.7 ± 1.3 67.7 ± 1.5 66.6 ± 2.2 65.4 ± 2.3 62.9 ± 2.3 0.9 
LV CO 
(ml/min) 16.4 ± 1.1 15.3 ± 0.7 20.0 ± 3.0 20.0 ± 1.4 21.9 ± 2.1 28.8 ± 2.0* 19.7 ± 1.9 30.6 ± 1.8* 20.4 ± 2.1 32.4 ± 3.3* <0.001 
LV CI 
(ml/min/g) 0.7 ± 0.05 0.7 ± 0.05 0.8 ± 0.06 0.8 ± 0.04 0.8 ± 0.04 1.1 ± 0.06* 0.8 ± 0.04 1.1 ± 0.05* 0.7 ± 0.03 1.1 ± 0.08* <0.001 
The Importance of Endoglin for Cardiac Structure and Function 
 
 165 
 
Table 5.5 Right ventricular volume and function in control (n=4) and Eng-iKOu (n=6) mice over time following tamoxifen treatment. 
Data analysed from MRI images and expressed as mean ± SE, p value represents repeat measures ANOVA, *=p<0.05 post hoc comparison compared to control mice at same 
time point using Tukey-Kramer method. 
Time Baseline 1 week 3 weeks 5 weeks 12 weeks 
Group Control Eng-iKOU Control Eng-iKOU Control Eng-iKOU Control Eng- iKOU Control Eng-iKOU 
p value 
RV EDV 
(µl) 48.1 ± 0.8 51.9 ± 2.1 52.0 ± 4.1 57.3 ± 3.7 52.9 ± 3.6 75.6 ± 3.4* 49.9 ± 2.2 80.1 ± 3.7* 52.1 ± 4.0 97.8 ± 6.3* <0.001 
RV EDVI 
(µl/g) 2.1 ± 0.2 2.2 ± 0.1 2.1 ± 0.04 2.3 ± 0.06 2.0 ± 0.05 2.9 ± 0.05* 2.0 ± 0.2 2.9 ± 0.1* 1.7 ± 0.1 3.2 ± 0.1* <0.001 
RV ESV 
(µl) 16.3 ± 2.2 18.0 ± 2.1 12.2 ± 2.3 13.9 ± 1.8 15.0 ± 2.4 23.5 ± 2.3* 13.1 ± 1.0 31.1 ± 2.3* 18.6 ± 3.3 39.3 ± 4.1* <0.001 
RV ESVI 
(µl/g) 0.7 ± 0.04 0.8 ± 0.07 0.5 ± 0.06 0.5 ± 0.05 0.6 ± 0.06 0.9 ± 0.03* 0.5 ± 0.05 1.1 ± 0.1* 0.6 ± 0.1 1.3 ± 0.1* <0.001 
RV SV 
(µl) 31.8 ± 1.9 33.9 ± 0.7 39.8 ± 2.1 43.2 ± 2.1 37.9 ±1.7 52.1 ± 1.4* 36.8 ± 1.7 49.0 ± 1.9* 33.6 ± 1.9 58.3 ± 4.3* <0.001 
RV SVI 
(µl/g) 1.4 ± 0.2 1.5 ± 0.09 1.6 ± 0.06 1.7 ± 0.05 1.5 ±0.04 2.0 ± 0.08* 1.5 ± 0.1 1.8 ± 0.1* 1.1 ± 0.1 1.9 ± 0.1* <0.001 
RV EF 
(%) 66.2 ± 4.3 65.9 ± 2.8 77.1 ± 2.5 76.2 ± 1.6 72.1 ± 2.6 69.3 ± 1.7 73.8 ± 1.6 61.4 ± 1.6 65.1 ± 4.0 59.9 ± 2.5 0.3 
RV CO 
(ml/min) 12.9 ± 0.4 13.2 ± 0.6 16.8 ± 2.2 17.6 ± 1.5 17.9 ± 1.7 22.3 ± 0.9* 14.5 ± 1.6 21.3 ± 0.9* 14.9 ± 1.2 25.3 ± 2.5* <0.001 
RV CI 
(ml/min/g) 0.6 ± 0.06 0.6 ± 0.05 0.7 ± 0.04 0.7 ± 0.05 0.7 ± 0.03 0.9 ± 0.04* 0.6 ± 0.04 0.8 ± 0.03* 0.5 ± 0.03 0.8 ± 0.06* 0.003 
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Figure 5.18  Changes in mean left ventricular mass, volume and function in control (n=4) and 
Eng-iKOu (n=6) mice over 12 weeks following tamoxifen treatment. 
Data expressed as mean ± SE.*p<0.001 repeat measures ANOVA.  
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Figure 5.19 Right ventricular volume and function in control (n=4) and Eng-iKOu (n=6) mice 
over time following tamoxifen treatment. 
Data expressed as mean ± SE. *p<0.001 repeat measures ANOVA. 
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5.2.8 Effect of endoglin depletion on LV pressure-volume relationships. 
Cardiac catheterisation using a conductance catheter allows for examination of the 
relationship between ventricular pressure and volumes throughout the cardiac cycle. 
This procedure gives information about systolic and diastolic ventricular function and 
can be used to obtain load independent measures of ventricular contractility. 
Combining these measurements with inotropic agents allows for assessment of the 
intact heart under basal and stress conditions. The major limitations of the procedure 
are the technical skills required to obtain accurate data and, in small animals, the 
measurements are limited to a single time point; due to its invasive nature this 
procedure is performed under terminal anaesthesia. As I saw no difference in ejection 
fraction between the control and Eng-iKOu mice during the MRI experiments, these 
experiments were designed to assess if endoglin depletion resulted in more subtle 
effects on ventricular function. Equally it would allow assessment under basal and 
stress conditions and finally may give some insights into the effect of endoglin 
depletion on the wider cardiovascular system. 
 
These experiments were performed using the same protocol as the initial MRI 
experiments. Briefly, Engfl/fl and Engfl/fl;Rosa26;CreERT2  mice were treated with 
tamoxifen (2mg/day for 5 days). Five weeks following the first dose of tamoxifen 
cardiac catheterisation was performed as described in Chapter 2. Dobutamine, a 
positive inotrope and vasodilator, was infused at 5µg/kg/min and 10µg/kg/min to 
examine cardiac function under stress conditions. Analysis of the data was performed 
using the PVAN pressure-volume analysis software package (Millar). Details of the 
parameters obtained are shown in chapter 2 (table 2.2). 
 
Analysis of the pressure volume loops obtained under basal and stress conditions are 
shown in table 5.6. Under basal conditions there were no significant differences in 
aortic or left ventricular pressures between Eng-iKOu and control mice. However, 
there was a significant increase in left ventricular end systolic volume (28.7±5.9µl) in 
Eng iKOu mice compared with 15.2±2.6µl in control( p=0.04) and a trend towards 
increased end diastolic volume (52.4±5.3µl) in Eng iKOu mice compared with  
41.1±2.5µl in control (p=0.06). These increases agree with those observed from the 
MRI analysis, but the volumes measured by conductance catheter were smaller than 
The Importance of Endoglin for Cardiac Structure and Function 
 
 170 
those measured by MRI; this a recognised feature from previous studies comparing 
MRI and conductance catheter data and is discussed below. Unlike the MRI analysis 
the catheter data revealed no significant differences in stroke volume or cardiac output 
between Eng-iKOu mice and controls. There was a significant difference in maximal 
left ventricular volume (55.5±5.4µl in Eng-iKOu mice vs. 43.1±2.4µl in control, 
p=0.05) which would be consistent with an increased preload in endoglin depleted 
mice. However, there was no significant difference in arterial elastance (Ea) or 
systemic vascular resistance between the groups suggesting endoglin depletion has no 
effect on afterload under basal conditions. Measures of systolic and diastolic function 
(both load dependent and independent) did not reveal any significant differences 
under basal conditions confirming that endoglin depletion has no effect on cardiac 
function under resting conditions. 
 
Following administration of dobutamine in control animals there was an expected 
increase in cardiac output, systolic function and left ventricular contractility. These 
effects were not seen following dobutamine administration in Eng-iKOu mice with 
cardiac output, dP/dtmax and stroke work showing very little change. The load 
independent parameter dP/dt-EDV reduced with dobutamine in Eng-iKOu mice 
whereas in control mice it increased. This difference following dobutamine 
administration was not universal across the load independent parameters. The 
difference between load dependent and independent parameters is likely due to the 
increased preload on the heart in Eng-iKOu mice. This is also indicated by an increase 
LVEDV and dilated internal jugular veins (figure 5.20) in these mice. Arterial 
elastance (Ea), a measure of cardiac afterload, decreased in control mice following 
dobutamine administration at both doses. This would be expected as dobutamine is a 
vasodilator as well as an inotrope. However, in Eng-iKOu mice there was no change in 
Ea with dobutamine. These results suggest that there may be an impairment of 
contractile reserve and vasomotor function, with reduced vasodilator response to 
dobutamine in Eng-iKOu mice. 
 
The Importance of Endoglin for Cardiac Structure and Function 
 
 171 
Table 5.6 Volumetric and haemodynamic parameters from cardiac catheter analysis of control 
and Eng-iKOu mice 5 weeks following tamoxifen treatment. 
Data expressed as mean ± SE. *p<0.05 # p=0.06. 
 
 Baseline 
Dobutamine  
5µg/kg/min 
Dobutamine 
10µg/kg/min 
 
Control 
n=10 
Eng iKOu 
n=9 
Control 
n=6 
Eng iKOu 
n=6 
Control 
n=6 
Eng iKOu 
n=6 
Sex 6M 4F 9M 1F 2M 4F 5M 1F 2M 4F 5M 1F 
Aortic SBP 
(mmHg) 
96.5 ± 3.7 93.6 ± 2.9     
Aortic DBP 
(mmHg) 
66.7 ± 3.9 62.3 ± 2.8     
MAP 
(mmHg) 
76.6 ± 3.8 72.7 ± 2.8     
Heart rate (bpm) 477 ± 17 438 ± 15 477 ± 14 448 ± 9.2 479 ± 14.3 452 ± 7 
LV EDV (µl) 41.1 ± 2.5 52.4±5.3# 45.6 ± 2.9 52.7 ± 7.6 42.9 ± 1.8 52.1 ± 7.2 
LV ESV (µl) 15.2 ± 2.6 28.7±5.9* 13.0 ± 3.0 25.5 ± 8.9 10.7 ± 2.5 23.4 ± 9.0 
LV SV (µl) 28.5 ± 2.0 28.6 ±2.9 35.0 ± 1.6 31.9 ± 5.2 35.4 ± 1.0 32.7 ± 5.7 
CO (ml/min) 13.6 ± 1.1 12.6 ± 1.4 16.8 ± 1.2 14.4 ± 2.5 17.0 ± 0.9 14.9 ± 2.7 
EF (%) 67.1 ± 4.8 53.9 ± 6.0 75.9 ± 5.1 59.5 ± 8.6 78.5 ± 4.2 61.8 ± 8.9 
LV EDP (mmHg) 10.4 ± 0.9 12.5 ± 1.7 13.9 ± 1.8 11.5 ± 1.6 14.4 ±1.3 13.9 ± 1.2 
LV ESP (mmHg) 91.5 ± 2.4 97.5 ± 1.9 94.8 ± 3.1 103.3±3.9 90.1 ± 3.7 93.5 ± 4.1 
Stroke work 
(mmHg.µl) 
2255  
± 218 
2323 
± 250 
2751  
± 279 
2411 
± 386 
2718 
 ± 200 
2222 
± 365 
Ea (mmHg/µl) 3.3 ± 0.19 3.7 ± 0.4 2.7 ± 0.1 3.6 ± 0.7 2.6 ± 0.1 3.5 ± 0.8 
dP/dtmax 
(mmHg/s) 
8179  
± 742 
7516 
± 516 
9697  
± 792 
7537 
± 629# 
9896  
± 596 
7603 
± 528* 
dP/dtmin 
(mmHg/s) 
-7069  
± 455 
-6245 
± 463 
-6333  
± 402 
-5145 
± 500 
-6022  
± 364 
-4973 
± 503 
Tau (ms) 11.5 ± 1.1 13.3 ± 1.1 12.9 ± 0.6 14.6 ± 1.5 12.2 ± 0.8 15.1 ±1.9 
Total SVR 
(mmHg/ml/min) 
5.7 ± 0.3 6.3 ± 0.8  
Parameters obtained after temporary preload reduction. 
PRSW (mmHg) 62.5 ± 6.4 59 ± 10.5 62.1 ± 6.9 67.1 ± 17 65.0 ± 7.8 66.1 ± 14 
Ees (mmHg/µl) 2.92 ± 0.6 2.8 ± 0.4 2.4 ± 0.6 2.2 ± 0.5 2.7 ± 1.0 2.5 ± 0.8 
dP/dtmax-EDV 
(mmHg/s/µl) 
121.4 
± 22.8 
97.4 
± 21.0 
144.1 
± 19.9 
75.8 
± 16.8* 
152  
± 18 
82.5 
± 15.8* 
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Figure 5.20 Macroscopic images of the left internal jugular vein of control (A-C, n=3) and Eng- 
iKOu (D-F, n=3) mice. 
The internal jugular vein appears larger in Eng-iKOu mice suggesting elevated right heart pressures. 
A&D, B&E and C&F are littermates of the same gender. Scale bar 5mm. 
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5.2.9 Endothelial specific endoglin knockdown results in ventricular remodelling. 
The MRI and cardiac catheter data both clearly show that ubiquitous endoglin 
knockdown in the Eng-iKOu mice results in significant ventricular remodelling. As 
endoglin is expressed in a number of cell types, I wanted to determine whether the 
ventricular remodelling observed following ubiquitous knockdown of endoglin was 
partly or completely dependent on the role of endoglin in endothelial cells. To 
investigate this I used an endothelial specific Cre recombinase (Cdh5(PAC)-CreERT2) 
that is well established in our lab to induce an endothelial specific endoglin 
knockdown (Eng-iKOe) (Mahmoud et al., 2010). As in previous experiments Engfl/f 
land Engfl/fl;Cdh5(PAC)-CreERT2 mice were treated with tamoxifen 2mg/day for 5 days 
to induce endoglin knockdown in endothelial cells. Cardiac MRI was then performed 
5 weeks following the first dose of tamoxifen. 
 
Analysis of left ventricular mass, volume and function is shown in table 5.7 and figure 
5.21. There was a significant difference in the body weight between the 2 groups due 
to there being more male animals in the Eng-iKOe group than the control group. 
Therefore it is important to use indexed measurements to account for this difference. 
As with the ubiquitous endoglin knockdown, endothelial specific knockdown resulted 
in increased left ventricular mass index (5.2 ± 0.2mg/g for Eng-iKOe mice vs. 4.3 ± 
0.1mg/g for control mice, p=0.01). Also indexed ventricular volumes, stroke volume 
index and cardiac index were significantly greater in the Eng-iKOe group than 
controls. Interestingly, following endothelial specific endoglin knockdown there was 
a significant reduction in left ventricular ejection fraction in the Eng-iKOe group (57.6 
± 3.3%) versus  in the control group, (69.5 ± 2.0%, p=0.04). 
 
These data suggest that the ventricular remodelling seen following endoglin 
knockdown is due to depletion of endoglin from the endothelium. Consequently, the 
changes seen in the heart are likely secondary to haemodynamic changes in the wider 
cardiovascular system. 
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Table 5.7 Analysis of MRI data showing cardiac mass, volumes and function in control and Eng-
iKOe mice 5 weeks after first tamoxifen dose. 
Data expressed as mean ± SE.  
 
Control 
(n=3) Eng-iKO
e
 (n=5) p value 
Sex 1M 2Fs 5M n/a 
Weight 
(g) 24.1 ± 3.2 29.7 ± 0.3 0.05 
Heart rate 
(bpm) 458 ± 10 414 ± 20 0.2 
Left Ventricle 
LV mass 
(mg) 102.5 ± 13.3 153.2 ± 4.9 0.005 
LV mass index 
(mg/g) 4.3 ± 0.1 5.2 ± 0.2 0.01 
EDV 
(µl) 60.4 ± 2.5 135.5 ± 12.0 0.004 
EDVI 
(µl/g) 2.6 ± 0.3 4.6 ± 0.4 0.01 
ESV 
(µl) 18.3 ± 0.6 59.0 ± 10.2 0.02 
ESVI 
(µl/g) 0.8 ± 0.1 2.0 ± 0.3 0.04 
SV 
(µl) 42.1 ± 2.8 76.6 ± 2.4 0.0001 
SVI 
(µl/g) 1.8 ± 0.2 2.6 ± 0.1 0.004 
Ejection fraction 
(%) 69.5 ± 2.0 57.6 ± 3.3 0.04 
CO 
(ml/min) 19.3 ± 1.6 31.7 ± 1.9 0.004 
CI 
(ml/min/g) 0.8 ± 0.1 1.1 ± 0.1 0.05 
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Figure 5.21 Analysis of MRI data showing cardiac mass, volumes and function in control and 
Eng-iKOe mice 5 weeks after first tamoxifen dose. 
Data expressed as mean ± SE, * = p<0.04. 
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5.2.10 Changes in extracellular matrix following endoglin knockdown. 
 
In order to investigate if there were any changes in the extracellular matrix following 
endoglin knockdown, I performed a number of experiments to quantify collagen 1 
protein expression and expression of extracellular matrix genes. Three groups of mice 
Engfl/fl, Engfl/fl;Rosa26-CreERT2 and Engfl/fl;Cdh5(PAC)-CreERT2 mice were treated with 
tamoxifen 2mg/day for 5 days, to generate control, Eng-IKOu and Eng-iKOe mice as 
previously n=3 per group). 5 weeks following the first dose of tamoxifen hearts were 
dissected and processed appropriately for protein or RNA quantification (using the 
methods described in chapter 2). 
 
A Western blot was performed to quantify the expression of collagen 1, a major 
extracellular matrix protein in the heart. Quantification of this demonstrated no 
significant differences between the 3 groups (figure 5.22). 
 
Quantitive real time PCR suggested that loss of endoglin may lead to increased 
expression of collagen 3, Ctgf, Timp1, Timp2 and Tgfβ1 with reduced expression of 
Mmp9 (figure 5.23). However, none of these differences were statistically significant 
(ANOVA) and there was considerable variation between individuals so that 
verification of any results would require large sample sizes. Furthermore, it is likely 
that any changes in extracellular matrix synthesis are related to the ventricular 
remodelling process rather than being a primary consequence of endoglin depletion 
per se, and that therefore any changes will be dynamic during the cardiac remodelling 
process. Testing this would require large sample sizes at multiple time points and was 
not possible within the time constraints of my PhD studies. 
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Figure 5.22 Expression of collagen 1 protein from hearts of control, Eng-iKOu and Eng-iKOe 
mice. 
Western blot of cardiac protein from 3 mice of each group. Collagen I protein was detected using anti-
Collagen I antibody and alpha-tubulin was used as a gel loading control. There was no significant 
difference between collagen I protein levels (normalised to alpha-tubulin) between the groups. Data 
was analysed using ANOVA.  
0
0.5
1
1.5
co
lla
ge
n
 
1 
/ α
tu
bu
lin
 
ra
tio
 
(A
U)
 
Control (n=3) iKOu (n=3) iKOe (n=3)
Control iKOu iKOe 
α tubulin 
collagen 1 
The Importance of Endoglin for Cardiac Structure and Function 
 
 178 
 
Figure 5.23 Expression of fibrosis genes from hearts of control, Eng-iKOu and Eng-iKOe mice. 
There was no significant difference between the groups using ANOVA. 
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5.2.11 Endoglin depletion may result in eNOS uncoupling. 
As ventricular remodelling is seen after endothelial specific endoglin depletion it is 
important to investigate changes in endothelial specific proteins. Endoglin has been 
shown to be critical for coupling of endothelial nitric oxide synthase (eNOS) activity 
(Jerkic et al., 2004; Toporsian et al., 2005). I therefore looked at the effect of losing 
endoglin expression on eNOS uncoupling. One approach that has been widely used to 
examine eNOS uncoupling is to investigate the ratio of eNOS monomer to dimer in 
tissues using native protein gels (i.e. proteins are separated by electrophoresis in the 
absence of reducing agents to preserve any dimeric forms). A high monomer/dimer 
ratio of eNOS protein corresponds to increased uncoupling (Cai et al., 2005). 
 
Figure 5.24 is a Western blot demonstrating eNOS expression in whole heart lysates 
from control, Eng-iKOu and Eng-iKOe mice. This suggests that there is a reduction in 
the dimeric form of eNOS in both Eng-iKOu and Eng-iKOe mice, which would be 
consistent with eNOS uncoupling in these mice. However, there is still a large amount 
of monomeric eNOS in all the samples. This could be due to the fact that eNOS is 
expressed in cardiomyocytes as well as endothelial cells (Balligand et al., 1995). So it 
would be important to repeat these experiments in freshly prepared vascular 
endothelial cells, following endoglin knockdown, to determine whether there is 
endothelial specific eNOS uncoupling in Eng-iKOe mice. 
 
 
Figure 5.24 Expression of monomeric, dimeric and total eNOS protein from hearts of control, 
Eng-iKOu and Eng-iKOe mice. 
This ‘cold’ western blot of native proteins shows the levels of dimeric and monomeric eNOS protein in 
whole heart extracts. The level of dimeric eNOS is reduced in both Eng-iKOu and Eng-iKOe mice. The 
lower gel shows total eNOS run under reducing conditions at normal temperatures. 
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5.3 Discussion 
In vivo analysis of cardiac function in this chapter has shown that endoglin is essential 
in endothelial cells to maintain normal adult cardiovascular function. Using the 
inducible endoglin knockdown models, developed in our lab, I have demonstrated that 
endoglin is expressed in the normal mouse heart and that it can be efficiently depleted 
following Cre-ERT2 activation. The majority of endoglin protein is expressed in 
endothelial cells of the endocardium and blood vessels. This is consistent with 
previously published data demonstrating that endoglin and the endothelial cell maker, 
CD31, are expressed in similar patterns in the normal myocardium (van Laake et al., 
2006). However, this study used serial histological sections, each stained with a single 
antibody. In contrast, my work used co-immunofluorescence to establish that endoglin 
and CD31 are co-expressed in the same endothelial cells. Furthermore, previous work 
has not clearly established whether endoglin is co-expressed with other (non-
endothelial) cell types in the normal heart. Chen et al reported that endoglin is co-
expressed with fibroblasts (K. Chen et al., 2004). Although their in vitro study is 
consistent with my results (chapter 4) showing endoglin expression in cardiac 
fibroblasts cultured in vitro, expression of endoglin in endogenous fibroblasts in the 
heart tissue was not shown. My data suggests that the level of endoglin expression is 
low in cardiac fibroblasts, certainly much lower than in endothelial cells. However, 
cardiac fibroblasts are large, flat cells that wrap around other cells within the 
myocardium in thin layers and so are not easily seen in tissue sections. Also, 
compared to other animal models where fibroblasts form the majority of cells, in the 
mouse heart, fibroblasts only account for around 27% of cells in the myocardium 
(Banerjee et al., 2007). Although endoglin expression in cardiomyocytes was not 
specifically tested in the co-immunofluorescence experiments, immunohistochemical 
staining of mouse hearts for endoglin clearly show that endoglin is expressed in the 
cells surrounding the cardiomyocytes, but not in cardiomyocytes. Recently published 
data from Kapur confirm that in mouse myocardium endoglin is expressed in 
endothelial cells but not cardiomyocytes (Kapur et al., 2012). This paper also reports 
endoglin expression in cultured cardiac fibroblasts. 
 
The cellular changes within the infarcted myocardium post MI are well described 
(Frangogiannis et al., 2002). My double immunofluorescence experiments confirmed 
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that there is an infiltration of inflammatory cells in the first 24 to 72 hours which is 
followed by proliferation of endothelial cells and fibroblasts by 5 days. There was 
also an increase in cells positive for αSMA between days 3 and 5 suggesting a 
proliferation of myofibroblasts in the injured myocardium. I have demonstrated that 
endoglin expression is increased in injured myocardium following infarction. This 
increase in expression is primarily driven by endothelial cell proliferation. However, 
endoglin expression was also seen in some αSMA-positive myofibroblasts infiltrating 
the wound by day 5. Macrophages and fibroblasts infiltrating the wound did not 
express endoglin. 
 
My data is consistent with the findings of van Laake (van Laake et al., 2006) who 
demonstrated an increase in endoglin expression in both mouse and human hearts 
following myocardial infarction. Tian and colleagues also demonstrated a similar 
increase in endoglin expression in the mouse myocardium following infarction (Tian 
et al., 2010). In both these studies, the increased endoglin expression was thought to 
be confined to endothelial cells as both endoglin and CD31 showed a similar pattern 
of expression in serial sections. Increases in endoglin expression are seen in models of 
injury in other organ systems and are not isolated to endothelial cells alone. For 
example, in a porcine model of coronary artery injury, endoglin expression was 
increased and co-localised to endothelial cells, adventitial fibroblasts and those 
expressing αSMA, thought to be vascular smooth muscle cells (Ma et al., 2000). 
Increased expression of endoglin has also been demonstrated in a variety of inflamed 
human tissues including bowel, liver, lung and skin (Torsney et al., 2002). Similar to 
the work described in this chapter, the increased endoglin expression seen in dermal 
wound healing is primarily due to increases in numbers of endothelial cells, with no 
expression seen in macrophages or fibroblasts. However, between 4 and 10 days after 
injury endoglin is seen to be expressed in myofibroblasts migrating through the 
wound (Torsney et al., 2002).  
 
In my experiments, although endoglin was expressed in myofibroblasts following MI, 
it was not expressed universally in these cells. This leads to interesting hypotheses as 
to the source and diversity of the myofibroblasts themselves. Work by Zeisberg has 
demonstrated that endothelial to mesenchymal cell transition (EndMT) contributes to 
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myocardial fibrosis in a mouse model of cardiac pressure overload (Zeisberg et al., 
2007). Therefore, it is possible that those myofibroblasts expressing endoglin are 
endothelial cells undergoing EndMT in the injured myocardium. However, in order to 
demonstrate this is the case then cell lineage tracing would be needed.  
 
In order to study the effects of endoglin depletion on the injured heart it was 
important to establish a knockdown model for this. Furthermore, as I had shown the 
endoglin was expressed in myofibroblasts and endothelial cells in the heart following 
myocardial infarction, I used a ubiquitous Cre to ensure knockdown in both cell types. 
I was able to demonstrate that the Rosa26-CreERT2 was expressed within the heart and 
that activation of the CreERT2 with intraperitoneal delivery of tamoxifen led to 
endoglin knockdown. The tamoxifen dose titration studies demonstrated that a 5 day 
course of tamoxifen was sufficient to do this. However, two mice in the 7 dose cohort 
demonstrated only partial endoglin knockdown. These mice were littermates. The 
reasons for this poor response are unclear but possibilities include genotyping errors, 
incomplete expression of the Rosa26-CreERT2 within the myocardium, dosing errors or 
problems with injection and absorption of tamoxifen. However, all further 
experiments used the 5 dose protocol and immunohistochemical analysis 
demonstrated a consistent knockdown even after 3 months. Also, all animals in the 
MRI experiments had a consistent phenotype suggesting efficient knockdown of 
endoglin. 
 
In their paper van Laake and colleagues (van Laake et al., 2006) demonstrated that 
cardiac function following myocardial infarction was significantly worse in endoglin 
heterozygous mice. My pilot experiment concurred with their findings with greater 
left ventricular adverse remodelling and worse cardiac function following myocardial 
infarction in Eng-iKOu mice than controls (table 5.1). However, group numbers were 
too small to perform statistical analysis. Nevertheless, it was clear from these 
experiments that considerable ventricular remodelling occurred in the sham operated 
Eng-iKOu mice. Unfortunately this finding meant that this was no longer a useful 
model for studying the effects of endoglin depletion on cardiac function post 
myocardial infarction. Instead there was a gradual ventricular remodelling, which was 
evident at the 3rd week following endoglin depletion. Without an earlier time point 
assessing cardiac function it is impossible establish if the greater remodelling and 
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worse function was due to the lack of endoglin in the healing infarct or secondary to 
further remodelling on the already infarcted heart. The fact that the infarct size was 
the same in both the Eng iKOu and control groups (table 5.1) points towards the latter. 
There appeared to be reduced LV ejection fraction in the injured Eng-iKOu mice 
compared with controls following MI (table 5.1), and this was not seen in the 
uninjured Eng-iKOu or Eng-iKOe mice (table 5.2, table 5.4 and table 5.7). There was 
no evidence of ventricular remodelling in the Engfl/+;Rosa26-CreERT2 mouse (table 
5.3) suggesting that the ventricular remodelling was endoglin-dose dependent perhaps 
making this a better model to study the effects of endoglin depletion post myocardial 
infarction. 
 
The finding that endoglin depletion leads to de novo ventricular remodelling in the 
absence of injury is novel and has not previously been described. My experiments 
clearly show that both left and right ventricles undergo remodelling. A note of caution 
must be introduced with regard to the right ventricular measurements as these were 
made using images orientated to the short axis of the left ventricle rather than the right 
ventricle. The complex geometry and the wide angle between the inflow and outflow 
of the right ventricle make accurate assessment of volume and function challenging 
(Wiesmann et al., 2002). Ideally images used to quantify right ventricular volumes 
and function should be orientated to the short axis of the RV (Wiesmann et al., 2002; 
Schneider et al., 2006) but this would increase imaging time if performed in addition 
to LV images. However, the changes in RV volume and function are consistent across 
different experiments and so likely represent a true finding.  
 
In Eng iKOu mice there is an increase in left ventricular mass and myocyte 
hypertrophy consistent with left ventricular hypertrophy. In these mice there are 
significant increases in ventricular volumes, stroke volume and consequently cardiac 
output. Significant remodelling has occurred by 3 weeks following gene knockdown 
and both left and right ventricles continue to enlarge; the latest time point used in this 
study was 3 months. Over this time period there is no reduction in systolic function as 
measured by left ventricular ejection fraction. Endoglin heterozygous mice do not 
develop a similar phenotype (Torsney et al., 2003; van Laake et al., 2006). This is 
consistent with the fact that tamoxifen treated Engfl/+;Rosa26-CreERT2 mice did not 
undergo cardiac remodelling. This suggests that there is a “dose” effect with endoglin 
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depletion needing to reach a critical, low level before the phenotypic changes 
manifest themselves. 
 
It has been described that expression of Cre recombinase within the myocardium can 
lead to toxicity (Buerger et al., 2006; Koitabashi et al., 2009).  Buerger and colleges 
demonstrated that the over expression of Cre recombinase within the myocardium, 
particularly at high levels, resulted in the development on a dilated cardiomyopathy 
(Buerger et al., 2006). This cardiomyopathy was not reversible but survival was 
improved with treatment with ACE inhibitors and beta blockers (Buerger et al., 2006). 
However, activation of Cre recombinase within the myocardium by a tamoxifen 
inducible, myocardial specific Cre (MerCreMer transgenic mice) resulted in a 
transient cardiomyopathy (Koitabashi et al., 2009). This transient cardiomyopathy 
was not evidence when lower doses of tamoxifen or raloxifene (another oestrogen 
receptor modulator). This may be due to reduced activation of Cre recombinase and 
hence lower toxicity or that tamoxifen may cause a transient cardiomyopathy at 
higher doses. However, control mice did not demonstrate any cardiac dysfunction 
following tamoxifen administration suggesting that tamoxifen toxicity was not the 
cause (Koitabashi et al., 2009). There is in vitro evidence that tamoxifen can cause 
impaired myocyte contractility and calcium handling (Asp et al., 2013). My 
experiments in mice expressing Rosa26-CreERT2 demonstrate that there is no evidence 
on myocardial toxicity from activation of Cre recombinase using this tamoxifen 
inducible Cre. It also suggests that there is no evidence of toxicity from tamoxifen 
treatment. This is supported by the time course experiment, where control animals 
were imaged prior to tamoxifen administration and did not demonstrate any cardiac 
dysfunction over the course on the experiment. 
 
The pattern of remodelling that occurred following endoglin depletion (table 5.8) is 
that of high output heart failure with left and right ventricular dilatation (in both 
systole and diastole) with increased cardiac output and is similar to that seen in 
models of volume overload heart failure. One such model induces volume overload 
by the creation of an aortocaval fistula. In this model there are no changes in heart 
rate or blood pressure but evidence of left ventricular dilatation and hypertrophy. 
However, there is evidence of reduced cardiac function, contractility and elevated 
venous and left ventricular pressures (Tanaka et al., 1996; Scheuermann-Freestone et 
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al., 2001). This contrasts with pressure overload following transverse aortic 
constriction where a reduced systolic blood pressure, ventricular hypertrophy and 
systolic dysfunction with LV dilatation developing later (Liao et al., 2002). These are 
extreme forms of cardiomyopathy and so the changes seen in my experiments may 
just represent a milder phenotype. However, the changes of left ventricular 
hypertrophy, ventricular dilatation, increased stroke volume and cardiac output with 
preserved systolic function are not dissimilar to those seen in the hearts of athletes 
(Maron and Pelliccia, 2006). Endoglin depleted mice could be left for a longer period 
(e.g. 6 months) to monitor progression of the ventricular remodelling. Specifically this 
may discriminate between athlete’s heart and high cardiac output heart failure. 
 
My data was consistent with previous data showing that ventricular volumes and 
ejection fractions are consistently lower when measured by conductance catheters 
compared to MRI (Jacoby et al., 2006; Nielsen et al., 2007; Winter et al., 2008). I did 
notice marked variation in data (particularly volumetric) collected using the 
conductance catheters and as consequence this limited the ability to discriminate 
between the experimental groups. My data did confirm LV dilatation in endoglin 
depleted mice compared to controls with no differences in resting systolic function. 
However, there did appear to be an impairment of contractile reserve as measures of 
myocardial contractility (dP/dt and the dP/dt-EDV relationship) did not increase 
following dobutamine administration. It is important to note that dP/dt is load 
dependent and so may be affected by differences in afterload induced by dobutamine, 
but the dP/dt-EDV relationship is load independent and so this is likely to reflect a 
true change. Also, there was not a reduction in afterload in endoglin deplete mice, 
unlike in control mice, following dobutamine (an inodilator). This change was not 
significant but does suggest that endoglin depletion has an effect on vasomotor 
function (see below). I would also have expected that total systemic resistance (TVR) 
should be lower in Eng-iKOu as the mean aortic blood pressure (MAP) was the same, 
compared to controls, but the cardiac output (CO) is higher in these mice 
(TVR=MAP/CO). However, there was no significant difference. 
 
 Initial studies examining the effects of dobutamine on the human heart demonstrated 
approximately 50% increase in cardiac output with dobutamine administration at 
8µg/kg/min, but no significant effect on heart rate (Rigaud et al., 1977). Therefore, 
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the increase in cardiac output following dobutamine administration in my experiments, 
approximately 25%, is lower than would be expected. In studies involving mice the 
effect of dobutamine is variable. For example, Bauer and colleagues demonstrated 
approximately a 2 fold increase in cardiac output, when measured by conductance 
catheters (Bauer et al., 2008; Bauer et al., 2010a). However, in studies using MRI to 
measure cardiac function the increase in cardiac output was in the region of 20 to 25% 
(Wiesmann et al., 2001b; Williams et al., 2001). It is unclear why these differences 
exist but it is likely due to differences in genetic background of the mice, the choice 
of anaesthetic agent and experimental variables such as temperature. 
 
The cardiac catheter data is inconclusive but this is technically a very challenging 
technique that requires a high level of experience to achieve good quality data. 
Comparing conductance catheters to cardiac MRI, Winter and colleagues 
demonstrated that MRI is more sensitive for detection changes post MI. They showed 
that in mice, following myocardial infarction, MRI had 100% sensitivity and 
specificity for distinguishing between mice with small infarcts (<30% of LV mass) 
and sham operated mice (Winter et al., 2008). For conductance catheters the 
sensitivity was 93% and specificity was 80% (Winter et al., 2008). This study also 
highlighted the advantages and disadvantages of these techniques. MRI is a sensitive, 
non-invasive technique that also allows measurement of global and regional cardiac 
function along with visualisation of myocardial structure and calculation of 
myocardial mass and infarct size. Although not used in my studies, stress cardiac MRI 
with dobutamine would offer an alternative, non-invasive measure of contractile 
reserve (Wiesmann et al., 2001b; Williams et al., 2001). Conductance catheters are 
invasive (with potential for blood loss during surgery which would affect outcomes) 
and are limited to single time point measurements. However, they have high temporal 
resolution (0.5ms) and provide sensitive, load independent measurements of systolic 
and diastolic function in real time. In addition, conductance catheters also provide 
insight into the interaction of the heart and vascular system (Winter et al., 2008). 
 
Endoglin is not expressed in cardiomyocytes in the adult heart (Kapur et al., 2012) 
and in the uninjured heart is primarily restricted to the endothelial cells. Furthermore, 
I have demonstrated that the cardiac phenotype is due to the effects of endoglin 
depletion in endothelium as the same phenotype was seen following endothelial 
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specific knockdown and ubiquitous endoglin knockdown.  Therefore, the phenotypic 
changes seen following endoglin depletion are due either to loss of endoglin function 
within the vasculature of the heart, or are secondary to an effect on the wider 
cardiovascular system. 
 
Endoglin has been shown to be important in the regulation of vascular tone. Jerkic 
and colleagues demonstrated that mean arterial blood pressure is higher in endoglin 
heterozygous mice and that there is an attenuation of the normal dose dependent 
reduction in mean arterial pressure with endothelial dependent vasodilators. They also 
demonstrated in an isolated, perfused hind limb model, that endothelium dependent 
reduction in vascular resistance was impaired in these mice (Jerkic et al., 2004). 
Levels of endothelial nitric oxide synthase (eNOS) and nitric oxide (NO) activity 
were reduced in endoglin heterozygous mice and Jerkic et al suggested this was the 
cause of the reduced effect of NO dependent vasodilatation. They hypothesise that 
this impairment in vasomotor control leads to AV shunting and that subsequent 
capillary remodelling results in AV malformations seen in HHT (Jerkic et al., 2004). 
In contrast to this Toporsian et al. found that there was an enhanced endothelium and 
eNOS mediated vasodilatation in pre-constricted, isolated mesenteric arterioles from 
endoglin heterozygous mice. They confirmed that eNOS was reduced in endothelial 
cells isolated from these mice and demonstrated that this was due to a reduced plasma 
half life. They also demonstrated that endoglin is important in the regulation of eNOS 
coupling. They found that treatment of the arteries from endoglin heterozygous mice 
with a superoxide scavenger reversed the vasomotor abnormalities suggesting that 
eNOS uncoupling resulted in this impaired response and may contribute to the 
pathogenesis of HHT (Toporsian et al., 2005). My data demonstrates that there was 
no reduction in cardiac afterload following dobutamine administration in Eng-iKOu 
mice. This suggests an abnormal vasodilator response, but could represent either the 
inability to vasodilate in an already maximally vasodilated circulation, which would 
be more consistent with Toporsian’s results, or a failure of vasodilatation, more 
consistent with Jerkic. I have also demonstrated that eNOS appears to be uncoupled in 
Eng-iKOu mice. If this is the case then examining alterations in cardiac afterload 
following administration of short acting vasodilators followed by vasoconstrictors 
may be able to clarify the effect of endoglin depletion on vasomotor function. Also if 
this effect is due to eNOS uncoupling then treatment of these animals with 
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tetrahydrobiopterin (BH4), an essential cofactor of endothelial NO synthase, may 
result in a rescue of this phenotype. 
 
These data show a novel phenotype in endoglin depleted mice and show that loss of 
endothelial endoglin has a major effect on both left and right ventricles of the heart 
(table 5.8). MRI experiments demonstrate that both ventricles are dilated by 3 weeks 
following endoglin knockdown and this phenotype persists for at least 3 months. Cell 
specific endoglin knockdown demonstrated that these changes are mediated by 
endoglin depletion in endothelial cells. Conductance catheters have suggested an 
impairment of vasomotor regulation may lead to this phenotype. It is possible that this 
is mediated by the effect of endoglin depletion on eNOS function in endothelial cells. 
However, further work is needed to establish the exact mechanisms behind this novel 
phenotype.
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Table 5.8 Summary of the changes in left ventricular mass and systolic function following 
myocardial infarction and endoglin knockdown. 
Eng-iKOu = ubiquitous endoglin knockdown, Eng-iKOe = endothelial specific endoglin knockdown,  
↑ = increased, ↓ = decreased, → = no change. 
 
 
Myocardial 
infarction Eng-iKO
u
 Eng-iKOe 
Left ventricular mass ↑ ↑ ↑ 
Left ventricular mass 
index ↑ ↑ ↑ 
End diastolic volume ↑ ↑ ↑ 
End diastolic volume 
index ↑ ↑ ↑ 
End systolic volume ↑ ↑ ↑ 
End systolic volume 
index ↑ ↑ ↑ 
Stroke volume ↓ ↑ ↑ 
Stroke volume index ↓ ↑ ↑ 
Ejection fraction ↓ → ↓ 
Cardiac output ↓ ↑ ↑ 
Cardiac index ↓ ↑ ↑ 
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Chapter 6  Discussion and future work 
 
It is well recognised that endoglin plays an important role in vascular development 
and disease (Lopez-Novoa and Bernabeu, 2010). However, little is known about the 
role of endoglin in cardiac fibrosis. My studies have demonstrated that endoglin is 
expressed in cardiac myofibroblasts in vitro, with expression seen in endothelial cells 
and cardiac fibroblasts in vivo. This is consistent with published studies showing 
endoglin expression in endothelial cells (van Laake et al., 2006; Kapur et al., 2012), 
cardiac fibroblasts (K. Chen et al., 2004; Shyu et al., 2010; Kapur et al., 2012) but not 
cardiomyocytes (Kapur et al., 2012). The published in vitro studies described in 
section 1.6.5 demonstrate that inhibition of endoglin can attenuate collagen I secretion 
from rat cardiac fibroblasts suggesting that endoglin is a positive regulator of 
fibrogenesis. Using Cre-lox technology I was able to efficiently knock down endoglin 
expression in primary cardiac fibroblasts and used this novel approach to study the 
effects of endoglin on the fibrotic response to TGFβ1. Stimulation of mouse primary 
cardiac fibroblasts by TGFβ1 led to the phosphorylation of Smad2 with no effect on 
the phosphorylation of Smad1/5/8 confirming that TGFβ1 signals via the Smad2/3 
pathway in cardiac fibroblasts (ten Dijke and Arthur, 2007). In their study, Shyu and 
colleagues examined the effects of TGFβ1 stimulation on Smad3 phosphorylation and 
confirmed that there is an increase in Smad3 phosphorylation following stimulation 
with TGFβ1. However, they demonstrated that TGFβ1 also signals via non-canonical 
pathways (Shyu et al., 2010). In endoglin depleted fibroblasts pSmad2 levels were 
similarly increased in response to TGFβ1. However, there did appear to be an increase 
in Smad1/5/8 phosphorylation albeit not statistically significant. Interestingly, gene 
expression of Id1, a downstream target of Smad1/5/8 signalling, was marginally 
increased in Eng iKOu fibroblasts compare to controls under basal conditions. There 
were significant reductions in collagen 1 and Mmp2 gene expression in Eng iKOu 
fibroblasts suggesting that endoglin depletion may result in modification of the 
fibrotic response to TGFβ1. However, the response of TGFβ signalling pathway genes 
following stimulation with TGFβ1 was similar between control and Eng iKOu 
fibroblasts. 
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In vitro studies using fibroblasts isolated from other organ systems give conflicting 
results with some suggesting endoglin is a negative regulator of fibrosis (Diez-
Marques et al., 2002; Leask et al., 2002; Burke et al., 2010; Holmes et al., 2011), 
with other suggesting the opposite (K. Chen et al., 2004; Meurer et al., 2010; Shyu et 
al., 2010; Morris et al., 2011; Kapur et al., 2012). The different methodologies used 
to investigate the effect of endoglin are likely to explain these differing responses. 
Those that suggest that endoglin is a positive regulator over-expressed endoglin in 
fibroblasts, whereas those that demonstrated negative regulation inhibited endoglin 
either by siRNA or endoglin specific antibodies. The over-expression studies do not 
take into account the possibility that soluble endoglin, which is known to antagonise 
TGFβ1 (Venkatesha et al., 2006; Walshe et al., 2009), may also be increased. This 
effect of over-expressing endoglin was confirmed by Kapur and colleagues who 
demonstrated that the over-expression of endoglin resulted in an increase in soluble 
endoglin in culture media and that soluble endoglin attenuated collagen 1 production 
in response to TGFβ1 (Kapur et al., 2012). It is likely that endoglin is indeed a 
positive regulator of fibrogenesis and this concept is supported by in vivo data 
investigating fibrosis in endoglin heterozygous mice. In two models of renal fibrosis 
(radiation induced fibrosis and infarct reperfusion injury) there was reduced fibrosis 
in endoglin heterozygous mice compared to controls (Docherty et al., 2006; 
Scharpfenecker et al., 2009). Equally, in pressure overload heart failure there was 
reduced fibrosis seen in endoglin heterozygous mice (Kapur et al., 2012).  
 
The lack of any significant difference in collagen expression between endoglin replete 
and depleted cells may be due to the dynamic responses to TGFβ1 stimulation. Shyu 
demonstrated that peak expression of collagen 1 and endoglin in rat cardiac 
fibroblasts following TGFβ1 stimulation is at 16 hours (Shyu et al., 2010). Also, 
growth arresting cardiac fibroblasts with serum starvation, as in my own studies, 
induces expression of extracellular matrix proteins (Leicht et al., 2001), and so further 
stimulation may not produce a further response. Further studies are needed to confirm 
the optimal culture conditions and duration of stimulation experiments to ensure 
maximal responses are seen. 
 
My studies have seen the successful introduction of pre-clinical cardiac MRI at 
Newcastle University and have highlighted the powerful nature of this technique. I 
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have demonstrated that MRI can be used in a number of models of cardiac disease 
and significant differences can be seen, even with small sample sizes. There are a 
number of methods available to measure cardiac structure and function in mice. As 
with any investigation there are advantages and disadvantages. The major advantage 
of MRI is that it provides true three dimensional images without relying on 
geometrical assumptions (Florentine et al., 1986; Shapiro et al., 1989; Ruff et al., 
1998). This is particularly important for studies following surgical myocardial 
infarction as there is significant deformation of the left ventricle as can be seen in 
figure 3.8 and figure 3.10. Given the accuracy and reproducibility of cardiac MRI 
(Ruff et al., 1998) it is ideally suited to longitudinal studies. In addition to simple 
functional assessment, MRI is ideally suited to performing multimodal studies 
investigating several pathophysiological parameters at a time including, perfusion, 
regional function and energy metabolism (Akki et al., 2013). The hardware 
requirements and consequently costs for MRI are greater. However, I have 
demonstrated that, despite the technical challenges of cardiac MRI, it is possible that 
the introduction of new techniques can be researcher led. Equally, I have 
demonstrated that it is possible to achieve moderate throughput with the acquisition of 
the dataset required for cardiac function assessment taking about 45 minutes and 10 
animals scanned in a normal working day. 
 
The other commonly used method for assessing cardiac structure and function are 
echocardiography and invasive cardiac catheterisation. Echocardiography has the 
advantages of being quick, so rapid throughput is achievable. However, as discussed 
in chapter 3 it has moderate correlation with MRI derived functional parameter but is 
less reproducible than MRI (Stuckey et al., 2008). Consequently, more animals would 
be needed to provide statistical power (Stuckey et al., 2008). Invasive cardiac catheter 
experiments provide volumetric and functional data, but not structural information. 
However, as discussed in chapter 5, it gives load dependent and independent measures 
of cardiac function with high temporal resolution. Also it allows rapid measurement 
of alterations to cardiac function following administration of cardio-active drugs, such 
as dobutamine. However, compared to MRI, it underestimates ventricular volumes 
and ejection fraction (Jacoby et al., 2006; Winter et al., 2008). Finally, its invasive 
nature means that longitudinal measurements are not possible. 
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Pragmatically the method used for measuring cardiac function depends on access and 
expertise of any given institution and on the information needed for any given study. 
However, these methods are not mutually exclusive and may give different 
information. Thus, a hybrid approach may give complementary data as in my studies 
whereby I was able to quickly establish the phenotype in a small number of mice and 
measure the longitudinal progression using cardiac MRI. This information was 
supplemented by invasive catheter data that demonstrated an impairment of 
contractile reserve and vasodilator response following dobutamine administration. 
 
One of the initial aims of my research was to examine the effects of endoglin on 
healing and fibrosis following myocardial infarction. However, I discovered that 
ubiquitous knock down of endoglin in adult mice resulted in a novel phenotype with 
biventricular dilatation and a high cardiac output. Consequently, a ubiquitous 
endoglin knockdown model is not suitable to study the effects of endoglin on post 
myocardial infarction healing. However, one of the advantages of the Cre-lox system 
is its flexibility (Davey and MacLean, 2006). As a result I was able to establish that 
the phenotype was not due to Cre toxicity seen in other models (Buerger et al., 2006; 
Koitabashi et al., 2009), that there was a ‘dose’ effect, with no phenotype seen 
following loxP recombination of a single floxed endoglin allele and that the 
phenotypic changes seen were due to endoglin knock down in endothelial cells, by 
using an endothelial specific Cre. There are a number of methods available to 
investigate the role of specific genes in animal models. In my experiments we used an 
inducible gene knockdown technique using Cre-Lox technology, as described in 
sections 1.7, 4.2.2 and 5.2.3. The advantage of using this technology is that endoglin 
can be knocked down in a time and tissue specific manner. Equally, the mice develop 
normally prior to Cre induction which is important where homozygous deletion of a 
gene result in embryonic lethality, as with endoglin (Arthur et al., 2000). There may 
also be adaptations to gene knockout when using global knockout models, such as in 
endoglin heterozygous endothelial cells where there is a down regulation of Alk5 
expression (Lebrin et al., 2004). Therefore, one advantage of using Cre-Lox 
technology is that these adaptations may not have time to develop following gene 
knockdown. 
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My studies revealed that depletion of endoglin results in biventricular dilation and a 
high cardiac output state which, based on the cardiac catheter data, may be 
progressing to cardiac failure. The catheter data also suggests that there is an impaired 
vasomotor response which is discussed in section 5.3. My data and that of van Laake 
(van Laake et al., 2006) suggest that endoglin is essential for the maintenance of 
normal cardiac structure and function in health and disease. It is important to consider 
how these findings relate to previous work by Kapur et al (Kapur et al., 2012) 
showing that a reduction in endoglin results in improved haemodynamics, reduced 
fibrosis and increased survival in a pressure overload model of heart failure. There are 
a number of possible explanations. Firstly following myocardial infarction there is a 
significant insult followed by inflammation and fibrosis. So it may be that impairment 
of the inflammatory response, particularly recruitment of mononuclear cells (Post et 
al., 2010) results in delayed infarct healing and consequently greater adverse 
remodelling in endoglin heterozygous mice. However, it may also be that reduced 
fibrosis results in infarct expansion and more severe LV dysfunction. My studies 
initially aimed to address this hypothesis. Unfortunately, with the ubiquitous Cre used 
and subsequent effects of endoglin knockdown on the heart, there were endogenous 
changes to so I was unable to address this. However, my host laboratory has now 
acquired a collagen specific inducible Cre which may aid future studies of this 
hypothesis. Also, Zeisberg demonstrated that endothelial to mesenchymal transition 
(endMT) contributes to fibrosis in a pressure overload model (Zeisberg et al., 2007) 
and as endoglin is predominantly expressed in endothelial cells, it would be important 
to investigate its role in the contribution of endMT to fibrosis in both MI and pressure 
overload models. 
 
The second possibility is that in the pressure overload heart failure model it is the 
reduced level of endoglin and its effects on vascular function that results in beneficial 
effects on the myocardium. If endoglin depletion does result in vasodilatation then 
that could be responsible for the favourable effects. Inhibition of the renin angiotensin 
system results in vasodilatation. Treating mice with either angiotenisn converting 
enzyme inhibitors or angiotensin receptor blockers following aortic constriction 
results in reduce myocyte hypertrophy, improved cardiac function and reduced 
fibrosis.(M. A. Rossi and Peres, 1992; Rockman et al., 1994; Lei Li et al., 2010; 
Martino et al., 2011; Muller et al., 2012). These changes are not dissimilar to those 
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seen in endoglin heterozygous mice. Interestingly, soluble endoglin also reduced 
fibrosis but did not improve cardiac haemodynamic following aortic constriction 
(Kapur et al., 2012), perhaps suggesting that the mechanism of action of soluble 
endoglin may be different to that of tissue endoglin. 
 
With regard to the work presented in this thesis future studies will help to clarify 
some of these points. Specifically: 
1. Further longitudinal studies following endothelial endoglin knockdown will 
allow us to determine if these mice eventually develop heart failure. 
2. Carefully performed cardiac catheter studies investigating the response to 
vasodilators and vasoconstrictors may help clarify the haemodynamic effects 
endoglin depletion has in vivo on the vascular system. 
3. Further studies investigating the role of eNOS in mediating the effects of 
endoglin knockdown and possible rescue using BH4. 
4. Evaluation of vasomotor responses in Eng-iKOe resistance arteries ex vivo 
(e.g. mesenteric artery) 
5. The use of an inducible collagen 1 Cre will allow us to examine the effects of 
endoglin depletion on fibrosis following myocardial infarction. 
6. The use of lineage tracing with Cdh5(PAC)-CreERT2;Rosa26-floxedstopYFP 
line would allow examination of the endothelial contribution to fibrosis 
following myocardial infarction in a manner similar to Zeisberg (Zeisberg et 
al., 2007). 
 
However, one of the main limitations in mouse models, including those described in 
this thesis, are that they use young, healthy animals which don’t readily mimic human 
cardiovascular disease. Therefore, it may be appropriate to choose a different model, 
for example, the ApoE knockout or the ApoE/LDL double knockout mice which 
show features of atherosclerosis when fed high fat diets. Indeed endoglin is expressed 
in human atherosclerotic plaque (Piao and Tokunaga, 2006) and statins appear to 
modulate the expression of endoglin (Rathouska et al., 2011). So modulating the 
expression of endoglin may lead to new therapies designed to prevent or slow the 
progression of atherosclerosis before a major cardiovascular event has occurred. In 
addition myocardial infarction induced by permanent LAD occlusion does not allow 
study of the effects of reperfusion injury and perhaps is a better model for studying 
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chronic heart failure. In this case an infarct reperfusion MI model (Michael et al., 
1995) may be better suited given the majority of patients receive reperfusion therapy 
following STEMI (Gavalova and Weston, 2012). 
 
In conclusion, the work in this thesis has demonstrated that the depletion of endoglin 
in vivo results in significant ventricular remodelling with onset of a high cardiac 
output state. This is due to knockdown of endoglin within endothelial cells and is 
likely due to changes in the wider cardiovascular system rather than specific effects 
on the heart. I have also demonstrated the power of cardiac MRI to identify these 
changes and to monitor them longitudinally. It is clear that endoglin expression is 
increased in patients with heart failure (Kapur et al., 2010; Kapur et al., 2012), and 
that a reduction in endoglin is associated with haemodynamic benefits (Kapur et al., 
2012). However, the work presented in this thesis and that of van Laake (van Laake et 
al., 2006) suggest caution as reduced endoglin can also lead to deleterious effects on 
the heart. So further work is needed to identify how and when modification of 
endoglin would be beneficial. 
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